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ABSTRACT 
 
Synthetic Studies Toward Selected Members of the Pyrrole-imidazole Alkaloids: 
Axinellamine, Konbu’acidin and Palau’amine. 
 (August 2010) 
Manuel Zancanella, B.S., University of Texas at Tyler 
Chair of Advisory Committee: Dr. Daniel Romo 
 
The pyrrole imidazole alkaloids (PIA) is an ever-growing family of structurally 
related natural products isolated from several species of sponges which now features 
more than one hundred memebrs. Their complex molecular architectures, and in some 
cases, significant biological activities, have made these alkaloids the synthetic targets of a 
number of research groups across the world. In our approach, following early 
biosynthetic proposal by Kinnel and Scheuer and Al-Mourabit and Potier, it was 
envisioned that several of these alkaloids, namely palau’amine, axinellamine, 
konbu’acidin, styloguanidine and massadine, could be derived from a common 
chlorocyclopentane precursor through different modes of intramolecular cyclization. 
Building on the work done previously in our research group by Dr. Anja Dilley, Dr. 
Paul Dransfield, and Dr. Shaohui Wang, my investigations led to the synthesis of the 
angular aza-triquinane core of axinellamine and the peculiar trans-
azabicyclo[3.3.0]octane core of palau’amine. In my further studies mono- and bis-pyrrole 
advanced intermediates were synthesized that contain the complete carbon framework of 
the target natural products. However, attempts to induce the pivotal, potentially 
biomimetic cyclizations expected to deliver the cores of the target alkaloids proved to be 
rather challenging, resulting in inconsistent and irreproducible results and leading to the 
exploration of an alternative, “abiotic” approach. 
My efforts in this direction resulted in the synthesis of a pentacyclic enamine 
precursor to styloguanidine and a pentacyclic carbinolamine suitable for the synthesis of 
palau’amine. Final attempts to complete the target natural products were however 
unsuccessful.  
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CHAPTER I 
 
INTRODUCTION: ENANTIOSELECTIVE SYNTHESES OF THE PYRROLE-
IMIDAZOLE ALKALOIDS  
 
1.1 Structural Diversity and Biosynthesis of the Pyrrole-Imidazole Alkaloids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.  Structural complexity and common descent of selected pyrrole-
imidazole alkaloids. 
 
The pyrrole-imidazole alkaloids (PIAs henceforth) constitute a biogenetically 
unique family of natural products, which to date have been isolated exclusively from 
several species of marine sponges. A small sampling of theses metabolites, relevant to the 
present work is shown above. 
 _______________ 
This dissertation follows the style of the Journal of Organic Chemistry. 
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NN
NH2
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NN
NH2
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H
Already numbering more than one hundred and fifty members, new congeners 
continue to be detected and characterized while at the same time known metabolites are 
isolated from new sources, and their intriguing structural complexity, rich and compact 
stereochemical content, high N to C ratio (~1:2), and increasingly studied biological 
activities are attracting a growing number of researchers from numerous disciplines 
world-wide. 
It has been proposed that the more complex members of this family are forged in 
nature via dimerization and additional intramolecular cyclization events of oroidin and 
congeners (1a-c), derived in turn from naturally occurring aminoacids 1 (Figure 1.1), 
giving rise to a great number of diverse constructs. This presumed biosynthetic common 
descent is one of the guiding principles of our strategy for the synthesis of selected PIAs 
(vide infra).  
While biosynthetic details are completely lacking, biomechanistic analysis of 
isolated PIAs and successful synthetic strategies premised on speculative biosynthetic 
pathways have provided some indirect evidence regarding biosynthetic feasibility. Insofar 
that inherent reactivity of biosynthetic intermediates may offer clues about actual 
biosynthetic pathways, isolation of an increasing number of putative biosynthetic 
intermediates has also been extremely important in developing biogenetic hypotheses. 
The evolution of these pathways appears to be based in large part on the very interesting 
ambivalent reactivity embedded in the 2-aminoimidazole nucleus (Figure 1.2).  Thus, 
great efforts have been devoted to unveiling the mechanistic and stereochemical details of 
reactions involving these pivotal intermediates. 
 
 
 
 
 
 
Figure 1.2.  Dual reactivity of the common 2-aminoimidazole nucleus found in the PIAs. 
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The chemical reactivity and hypothetical chemical pathways leading to complex 
PIA metabolites were reported by Al-Mourabit in 2001.2  Extension of these hypotheses 
to include stereochemical relationships, especially in light of the structural revision of 
palau’amine (discussed in Chapter II)3 and extension to the recently isolated tetrameric 
PIA members, was reported by Köck and Baran in a 2007 mini-review.4  In addition, 
several review articles have compiled synthetic advances within the PIA metabolites and 
partial descriptions of biosynthetic aspects of selected members of this family.5  
One of the first biosynthetic proposals for the generation of higher order PIA 
however was advanced by Kinnel and Scheuer6 who envisioned a Diels-Alder 
cycloaddition between a hypothetical ‘dihydrophakellin’ dienophile and aminoimidazolyl 
propeneamine (AAPE). A subsequent chloroperoxidase-initiated oxidation/ring-
contraction event would deliver the hexacyclic core of the originally assigned structure of 
palau’amine (11).7 In addition, the isolation of cis-12-chloro-11-
hydroxybromoisophakellin (12)8 resulting from chlorohydration of the hypothetical 
‘dihydrophakellin’ which would serve as a dieneophile in the proposed Diels-Alder 
reaction, seemed to support this hypothesis.  
 
Scheme1.1 
 
 
 
 
 
 
 
 
 
 
 
 However, it should be noted that the cis-stereochemistry of the chlorohydrin found 
in this metabolite suggests chlorohydroxylation of the trans-alkene found in oroidin 
 4 
followed by cyclization to the phakellin core and points to an alternative Diels-Alder 
process. Indeed, the revision of the azabicyclo[3.3.0]octane core of palau’amine to the 
trans-ring fusion3 suggested that if a [4+2] cycloaddition does occur to deliver a 
cyclohexene adduct intermediate, it must involve a non-cyclic dienophile (e.g. oroidin) 
possessing an E olefin geometry to provide the observed trans relative stereochemistry 
common to several higher order PIAs (vide infra). 
The landmark universal chemical pathway for the formation of higher PIA 
members known up to 2000, proposed by Al-Mourabit and Potier2 and subsequent 
refinements thereof (vide supra), involves the dimerization of clathrodine (1a) (and 
brominated derivatives) tautomers, and the decisive first C-C bond establishes the 
propensity for numerous cascades of cyclization reactions with nucleophilic and 
electrophilic reacting position varying with the tautomer engaged in the dimerization 
step. 
Recently, based on DFT and ab initio calculations Zipse advanced some doubts 
about the purported stability of some of these tautomers, thereby questioning their 
involvement in biosynthetic reactions,9 however, the fact that all the dimeric PIAs 
isolated during the last decade fit in the general chemical pathway suggested for their 
formation, seems to attest to the soundness of this proposal. In addition, the revision of 
palau’amine’s relative configuration gave even more consistency to the hypothesis, 
revealing complete uniformity of stereochemical relationships within the PIA dimer 
subclass. 
Among the possible first C-C dimerization bonds, a C7-C7’ dimer1 provides the 
highest potential for the generation of the greatest structural diversity, and when 
analyzing various congeners having a C7-C7’ connection (C12-C18 bond in the dimeric 
PIAs), it appears that all could be derived from intermediates A and B (Scheme 1.2) via 
different modes of intramolecular oxidative cyclizations. 
Intermediate A could undergo an enzymatic chloro-hydroxylation, followed by 
intramolecular cyclization generating intermediate B, establishing the common 
                                                
1 The numbering of the linear precursors differs from the numbering of the PIA dimers. 
Throughout this document the original palau’amine numbering system7 will be used for 
the dimeric PIAs. 
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spirocyclic subunit. The different modes of proposed oxidative cyclizations summarized 
below, would then deliver the variety of complex molecular architectures observed in 
these metabolites. In particular, oxidative cyclization of the spiroguanidine hemiaminal 
nitrogen onto the pendant aminoimidazole would give rise to the structure of 
axinellamine (3), while attack of the C20 oxygen in a similar fashion would generate 
massadine (6), after hydrolysis (vide infra). Alternatively, a bis-cyclization of the C12 
pyrrole carboxamide side chain would deliver palau’amine (2) (N14, N1 cyclization) and 
styloguanidine (4) (N14, C3 cyclization). Whether these transformations occur in a 
concerted fashion or proceed instead through the fleeting macrocyclic intermediates 15 
and 16 remains the subject of speculation.  
 
Scheme1.2 
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Differing only at the C19 amine terminus and in the bromine content, konbu’acidin 
and carteramine (Figure 1.1) would be derived in a similar fashion as palau’amine and 
styloguanidine respectively, from the halogenated clathrodine analogs.  
Finally, it is important to note that intermediate B, putative common precursor to 
several higher order PIAs, could also be derived via a variation of the “Diels-
Alder”/oxidative ring contraction sequence posited by Kinnel and Scheuer involving two 
units of the linear precursors. 
In the dimeric PIA subclass, massadine (6) stands out, as it is the only metabolite 
featuring a pyran core and a hydroxy substituent in place of the otherwise ubiquitous 
chlorine. In spite, or perhaps because of this apparent oddity, speculations on its 
biogenesis were rather scarce, until in 2006 our group reported that an unexpected 
displacement of the chloride on cyclopentanes 17 by azide surprisingly proceeded with 
retention of configuration.10 It was concluded that a mechanism involving neighboring 
group participation of the spiroaminoimidazole might be in operation involving 
aziridinium species 19. It was also postulated that a similar process could account for the 
biosynthesis of massadine (6) from an earlier chlorinated precursor 20, through a similar 
aziridinium intermediate 21 (Scheme 1.3). 
Scheme 1.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 7 
Confirmation of this hypothesis came in 2007 when Baran and Köck provided 
direct evidence for this pathway by isolating one such chlorinated precursor and reporting 
its rapid conversion into massadine (6) in an aqueous medium at 60 ºC. They also 
advanced an excellent analysis as to the reason why this peculiar behavior is not observed 
in any other PIA metabolite, namely due to the favorable geometrical disposition and the 
dihedral angle between the aminoimidazole nitrogen and the chlorine atom.11 
 
1.2 Enantioselective Syntheses of the Pyrrole-Imidazole Alkaloids 
Given the immense structural diversity and architectural complexity of the PIAs, it 
is understandable that efforts toward the asymmetric, total synthesis of these marine 
alkaloids have been a very prolific domain of study for chemical synthesis. Numerous 
synthetic groups continue to be active in the area and a significant amount of progress has 
been achieved recently, including the first completed enantioselective syntheses of 
monomeric PIAs and racemic syntheses of long elusive, complex dimeric alkaloids.  A 
detailed and exhaustive account of the synthetic endeavors in this area goes beyond the 
scope of the present review, however mention must be made of the outstanding 
contributions by Overman,12 Horne,13 Carreira,14 Otha,15 Lovely,16 Harran,17 and Chen,18 
along with many others, whose asymmetric syntheses are discussed herein. In addition, 
interesting methodologies leading to the construction of key structural subunits of these 
alkaloids have been presented by Gin,19 Gleason,20 and Nishizawa.21 Furthermore, a 
majority of the synthetic work toward the PIAs is the subject of several recent reviews.5 
The enantioselective synthesis of natural products is paramount to subsequent 
studies of bioactivity including pharmacology, cellular receptor isolation, and structure-
activity studies (SAR) for potential drug discovery and development. For this reason only 
enantioselective routes to PIA’s are described herein with the exception of the landmark 
synthesis of racemic palau’amine. 
One of the earliest marine PIAs isolated is girolline (22) in 198822 (a.k.a. 
girodazole), which despite lacking a pyrrole sub-unit is always included in any discussion 
about PIAs as it is proposed to be derived from the same simple precursor to many of the 
more complex alkaloids in this family.1 Shortly after its isolation, synthetic efforts by 
Ahond and Commerçon led to the elucidation of the absolute configuration of girolline. 
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N
N
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+
O OH
HO
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N
H
N
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N
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Cl
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N
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O
O
3) (MeO)2CMe2, pTsOH, THF
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7) NaN3, DMF
8) HOAc, THF
28
(22)
6) p-ClC6H4N2+ Cl-,
    Na2CO3, MeOH/H2O
7) H2, PtO2, MeOH, HCl
8) HCl
26
(28%, 4 steps)
(28%, 
3 steps)(32%, 5 steps)
(23%, 3 steps)
HN
H2N
H
23
In his approach Commerçon23 employed an Evan’s aldol strategy to establish the 
chlorohydrin relative and absolute stereochemistry. Subsequently, Ahond and Poupat24 
disclosed a chiral pool approach that generated the target stereochemical relationship via 
elaboration of D-arabinose (24).  
Scheme 1.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Despite several completed syntheses, many of the simpler “linear” PIAs either lack 
any stereogenic centers (e.g. oroidin and analogues) or are naturally occurring as 
racemates (e.g. midpacamide, 25 dispacamides C and D, 26 and tauroacidin B 27). Yet other 
hydroxylated metabolites which showed optical rotation were revealed, upon further 
investigation, to exist as non-racemic mixtures of enantiomers like tauroacidin A27  and 
mukanadin A (which, despite having been isolated two years later is identical to 
dispacamide D).28 Debromodispacamide D (29) possessing a single carbinol stereogenic 
center was also isolated as a racemate, and its synthesis in optically active form starting 
from hydroxyproline (Scheme 1.5)29 and subsequent stability studies were instrumental in 
confirming that racemization does not occur during the purification process. The key step 
was an intriguing, presumably biomimetic oxidative reaction that generated the 
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- Oxidave Guanidine 
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O
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N
N
O
O
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m. s. 4 Å, DMF, O2
90 °C, 30 mn
H
N
N
H
O
NH
N
O
NH2
OH
NH
NH2•1/2 H2CO3H2N
+
OH
N
H
O
OH
trans-L-hydroxyproline
methyl ester (31)
Pyrrole-2-
carboxylic acid (30)
- Cyclization
H
N
MeO
O
OH
+N
H
O
OH
• HCl
• HCl
N
O
MeO
OH
N
H
O
CH2Cl2, reflux
(71%)(30)
(31)
N
N
O
O
OH
N
N
H
O
OHO O
O
O2
NH
NH2H2N NNH
O
OH
O N
H NH2
NHHO
HO
-H2O
H
(29)
(27%)
32 33a
33b 33c 33d
33a
aminoimidazolone moiety via the fragmentation of a proposed spirocyclic dioexetanone 
(33b) intermediate. 
 
Scheme 1.5 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A presumed intramolecular oxidative cyclization introduces elements of 
stereochemistry also in cyclooroidin (34) and in the slagenins (40). After two racemic 
syntheses, the absolute configuration of natural cyclooroidin was confirmed by synthesis 
in 2006 by Pelloux-Leon and Minassian, 30 expanding on their previous synthesis of the 
related longamide B (35 Scheme 1.6). 31 After conversion of the carboxylate moiety in 
this natural product into the corresponding mixed anhydride, sequential treatment with 
diazomethane and aqueous hydrogen bromide delivered the optically active bromoketone 
39. Subsequent reaction with Boc-guanidine generated the aminoimidazole ring, and 
cleavage of the carbamate protecting group delivered the target product.    
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Synthetic Plan
- Guanidine 
  Cyclization
Cyclooroidin (34)
NH
N O
NH
NHBocH2N
- Cyclization
longamide B (35)
HO2C
Br
Br
CO2H
NH2
MeO2CNH
N OBr
Br
N
N
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CO2H
NH2
MeO2C
NH
N O
HO2C
Br
Br
NH
N OO
Br
Br
Br
Cl O
O
14)                NMM
15) CH2N2
16) aq. HBr
17)
18) TFA
(34)
longamide B (35)
(36)
39(70%, 3 steps)
(60%)
(50%)
NMeO
NBn2
CO2Me
OMeO OMe
1) 
    ClCH2CH2Cl, H2O
2) CuCl2, HOBT, DCC
        BnNH2, DMF
3) BH3, THF
NOH
NHBn
4) BnBr, K2CO3, MeCN
5) NaH, MeI, THF
6) ClCOCl3, THF 
7) NaOMe, MeOH
   (39%, 4 steps)
10) NBS, THF
11) BBr3, CH2Cl2
    (70%, 2 steps)
12) IBX, EtOAc
13) Pinnick oxidation
     (54%, 2 steps)
37 38(32%, 3 steps)
8) H2, Pd(OH)2, MeOH
9) PhMe, reflux
      (89%, 2 steps)
Scheme 1.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The absolute configuration of the slagenins (40) was established by Jang, who 
completed the first total synthesis of the antipodes of natural slagenins B and C (Scheme 
1.7a). 32 After Noyori reduction of ethyl-4-chloroacetoacetate (41), the newly generated 
alcohol was protected as the TBS ether. Azide displacement of the terminal chloride, was 
then followed by conversion of the ethyl ester to glyoxal 42. One pot intermolecular urea 
cyclization/intamolecular THF annulation then generated a 50% yield of a 9:5 (H, OMe α 
to β) mixture of inseparable diastereomeric bicyclic cores of the target products 43. 
Finally, azide reduction and acylation of the resulting primary amines delivered the 
slagenins antipodes, which could be separated by column chromatography.         
The following year Jang33 and Gurjar34 independently but virtually simultaneously 
arrived at the synthesis of the natural enantiomers starting from L-xylose (not shown) and 
L-arabinose (Scheme 1.7b) respectively. In Gurjar’s approach starting from known L-
arabinose derivative 44, Barton-McCombie deoxygenation of the free hydroxyl, was 
followed by azide displacement on the activated primary alcohol and selective protection 
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Synthetic Plan
Slagenins
Gurjar
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Urea
cyclization
Jang
(2001)
Urea/THF
bis-cyclization
a)
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O NH
H
N OH
ORYHN
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H
O
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NH2
H2N O
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O
OEt
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    ii) CH2N2, Et2O (90%)
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N3
TBSO O
O
7) Urea, 
    40% aq. HF
MeOH, r.t.
(50%)
O NH
H
N OH
OMeN3
2 steps to unnatural
 slagenins B and C
1) NaH, CS2, MeI, THF (98%)
2) Bu3SnH, AIBN, PhMe (84%)
3)TBAF, THF (81%)
4) TsCl, Et3N, CH2Cl2 (92%)
5) NaN3, DMF (85%) 
6) TBSCl, Im, CH2Cl2 (72%)
7) Swern ox. (72%)from L-arabinose
42
2 steps to natural
slagenins B and C
O O
O
OH
TIPSO O O
OTBS
N3
O NH
H
N OH
OMeN3
8) Urea, 
    40% aq. HF
MeOH, r.t.
(64%)
43
45 46
44
and oxidation to generate the 2-ulose derivative 45. Intermolecular urea cyclization in the 
presence of hydrogen fluoride and methanol, then generated an inseparable mixture of the 
bicyclic cores of natural slagenin B and C 46. The natural products were then completed 
by installation of the pyrrole side chain as described above.     
 
Scheme 1.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
While no significant biological activity has yet been reported for phakellin (47), 
several groups actively pursued its synthesis given that it is one of the simplest tetracyclic 
PIA congeners and for at least two additional reasons.  One motivation was the 
hypothesis first proposed by Sharma who suggested that an elusive antibiotic activity was 
in fact possibly due to phakellin proposed to be an unidentified “natural product. A 
second motivation was the possibility of using phakellin annulation strategies in total 
synthesis approaches toward palau’amine (vide supra). The synthesis of (+)-phakellin by 
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49
52 49
51
Romo (2008)
Overman
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N
N
O
HO
H
NH
HO O
HO
HN
OHO
+
10) Cl3CCN,
DBU, CH2Cl2 
     (48%)
N
N
O
AcO
O
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N
N
H
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O
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    CH2Cl2 (92%)
4) NaH, THF (85%)
5) IBX • Me3N N-oxide, DMSO
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N
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O
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HO
N
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N
N
BocN HN
O
BocHN
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31
30
53 54
55 56
3 steps to (+)-47
48
Romo35 began with L-proline (50) and trichloroacetylpyrrole (51) to construct the 
tricyclic ketopiperazine 52. Installation of the pendant guanidine then set the stage for the 
key microwave-mediated oxidative cyclization leading to the formation of the target 
product. The strategy employed by Nagasawa36 for the synthesis of (+)-phakellin (47) 
started with the construction of hydroxyketopiperazine 53 from hydroxyproline (31) and 
pyrrole carboxylic acid (30). Overman rearrangement of the trichloroacetylimidate 
transient intermediate 48 obtained from treatment with trichloroacetylnitrile then installed 
the tertiary amide precursor to the required guanidine. Intramolecular cylization of 
pendant guanidine 56 finally delivered the desired product.     
 
Scheme 1.8 
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The tetracyclic phakellstatins (57), which appear to be hydrolyzed phakellins (47), 
have attracted significant interest because of their biological activity and since their 
isolation a number of racemic syntheses have been reported.37  
 
Scheme 1.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The first asymmetric synthesis of (+)-phakellstatin ((+)-57), the enantiomer of the 
natural product, was completed by Romo in 2003.38 This synthesis employed a 
desymmetrization strategy of a diketopiperazine 58 (Scheme 1.9a) derived from 
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dimerization of proline and a Hoffman rearrangment simultaneously introduced the C10-
N9 bond and formed the final cyclic urea.  The synthesis confirmed the absolute 
configuration of the natural product. In 2007, Lindel disclosed the completion of the 
synthesis of the natural (-)-enantiomer starting with the quick construction of optically 
active tricyclic enamide 66 from hydroxyproline methyl ester (63) and dibromopyrrole 
carboxylic acid (64) (Scheme 1.9b). The key step then involved a diastereoselective, 
intermolecular 3-component imidazolone cyclization proceeding through the presumed 
transient bis-carbamate intermediate 67.39 
Of all monomeric PIAs, agelastatin (69) has garnered the most synthetic interest 
and this is undoubtedly due to its potent antitumor activity.  Eight asymmetric syntheses 
have been reported to date along with a several racemic approaches.40 While unique and 
creative, each synthesis features an appended acyl-pyrrole moiety, which enables a late-
stage cyclization of the pyrrole and a pendant urea onto the C ring.  These ring closures 
construct the B and D rings respectively, delivering the tetracyclic core of agelastatin. 
Thus, the primary differences in synthetic approaches are mainly the routes taken to the 
optically active, functionalized C ring.  Enantioselective strategies to agelastatin along 
with starting materials employed are summarized in Schemes 1.10 and 1.1. Feldman was 
the first to synthesize the natural enantiomers of agelastatin A and B.41 In his strategy, the 
intra-molecular oxidative cyclization of acetylene 71, readily obtained from (R)-
epichlorohydrin 72, generated cyclopentene 70 a precursor efficiently elaborated to the 
ABC ring system of the agelastatins. In 2003 Hale reported a formal synthesis of 
agelastatin A42 constructing enantiospecifically an advanced intermediate previously 
reported as a racemate by Weinreb.43 Several manipulations of the known aziridine 75 led 
to diene 74, which was readily converted to cyclopentene 73 via ring-closing metathesis. 
The following year cyclopentene 73 was advanced through a 9-step route generating 
several hundred milligrams of enantiomerically pure agelastatin A. 44 In Davis’s 2005 
synthesis the key intermediate cyclopentenone 76 was forged by alkylation of sulfinimine 
78 and ring closing metathesis of the advanced allyl-enone 77. 45 The asymmetric allylic 
alkylation (AAA) protocol reported by Trost in 2006, 46 and again in 2009 47 rapidly 
assembled the pyrrole-cyclopentene 79, precursor to the ABC ring system of agelastatin 
A. Remarkably, the target was then completed efficiently in only 8 steps.  
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Scheme 1.10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In 2007 Ichikawa constructed the functionalized C ring 82 via a [3,3]-sigmatropic 
rearrangement of an allylic isocyanate, which proceeded very efficiently with complete 
transfer of chirality.48 The synthesis disclosed by Tanaka and Yoshimitsu in 2008 
commenced with the hetero Diels-Alder cycloaddition of pentadiene 87 and acylnitroso 
dienophile 86, followed by reductive N-O cleavage and enzymatic resolution, which 
delivered the enantiomerically pure C ring precursor 85.49 The same approach was also 
utilized in their second generation synthesis completed the following year.50 Also in 2009 
the strategy employed by Chida featured an elegant sequential Overman/Mislow-Evans 
rearrangement of bistrichloroimidate 89 followed by ring-closing metathesis that 
established cyclopentene 88.51 In 2009, Du Bois disclosed an 11-step synthesis of (-)-
agelastatin A,52 hinging on a new catalytic intramolecular aziridination method applied to 
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sulfonamide 92, followed by sequential regioselective ring openings affording the 
completely functionalized C ring 91. 
 
Scheme 1.11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sceptrin (94) is one of the simplest “dimeric” PIAs and it has been proposed as the 
natural precursor of the more complex and highly sought-after members of the family 
(e.g. palau’amine). After two racemic syntheses appeared virtually simultaneously, Baran 
revised his original approach and established the key optically active cyclobutane 
intermediate 99 through the enzymatic resolution of the previously reported Diels Alder 
adduct 98, followed by photo-induced oxaquadricyclane rearrangement. Introduction of 
the bromopyrrole side-chains and aminoimidazole annulation, then completetd the first 
and still only enantioselective synthesis of sceptrin (94) (Scheme 1.12).53 
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Expanding on early investigations in the Baran laboratory that led to the discovery 
that sceptrin (94) could be induced to ring expand in an aqueous medium at high 
temperatures, this group disclosed the first enantioselective synthesis of (–)-ageliferin ((-
)-104) (Scheme 1.13) and its antipode (not shown). 53 
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Baran’s recent synthesis of the long elusive palau’amine (2)54 represents an 
outstanding accomplishment and raises the bar for future endeavors in the PIAs field, and 
is therefore included here, despite being racemic.   
 
Scheme 1.14 
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Starting from the previously reported chlorocyclopentane precursor 110, guanidine 
annulation and Silver-mediated oxidation of the unprotected resulting aminoimidazole 
generated the spirocyclic core of the target product. After construction of the pendant 
aminoimidazole, treatment with bromine and pyrrole precursor 113 followed by 
cyclization delivered biz-azide 114. Following reduction of the azide functionalities, 
chemical ligation of the pyrrole carboxylate moiety and the vicinal primary amine then 
established a “macropalau’amine” advanced intermediate 115. Finally, acid promoted 
transannular cyclization afforded the strained azabicyclo [3.3.0] core of palau’amine (2). 
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CHAPTER II 
 
PREVIOUS WORK IN THE ROMO GROUP 
 
2.1 Unified Strategy Toward the Axinellamines and the Original Structure of 
Palau’amine: Synthesis of a Common Chlorocyclopentane Precursor 
At the onset of our investigation into the pyrrole-imidazole alkaloids we were 
inspired by the biosynthetic proposals by Kinnel and Scheuer6 and Al-Mourabit and 
Potier2 (see Chapter I). Intrigued by the homogeneity of their structural features, in our 
approach we sought to emulate the presumed natural pathway and develop a unified 
strategy for the synthesis of both palau’amine6,7 and axinellamine55 from a common 
chlorocyclopentane intermediate such as 122 (Scheme 2.1). In our strategy we envisioned 
a late-stage, simultaneous introduction of the guanidine moieties from corresponding urea 
precursors, which would be more manageable from a polarity and solubility standpoint. 
This approach would also give us an opportunity to probe potentially as of yet 
unidentified “oxo” analogues of specific natural products for biological activity. 
Phakellstatin (57) (see Chapter I), for instance displayed greater bioactivity than its de 
facto congener phakellin (47), in which the urea functionality is replaced by a guanidine.   
 
Scheme 2.1 
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In chlorocyclopentane 122 three of the six rings of palau’amine (highlighted in 
Scheme 2.1) would already be established, and a few modifications (notably the 
epimerization at C12) would also make 122 a viable precursor for the synthesis of 
axinellamine. Following biosynthetic suggestions, 122 would be generated via an 
oxidation/ring contraction event from tricycle 121, which in turn is the Diels Alder 
adduct of a vinyl-imidazolone diene 120 and a pyrrolidinone dienophile 119, derived 
from commercially available and inexpensive materials. Preliminary work in our group 
by Dr. Anja Dilley56 led to the identification of the crucial factors that affect the 
selectivity in the key Diels-Alder cycloaddition. High levels of facial selectivity had 
previously been reported for related systems57 as a consequence of the expected approach 
of the diene from the less sterically hindered face of the dienophile, resulting in two 
potential endo transition states arrangements. 
 
Figure 2.1.  Potential endo transition state arrangements in the Diels Alder reaction. 
 
 Control on the regiochemistry on the other hand proved to be strongly related to 
the substitution of the imidazolone nitrogens of the diene. It was found that an electron-
donating group on the nitrogen proximal to the alkyl substituent (R1) paired with an 
electron-withdrawing group on the distal nitrogen (R2) led to the exclusive generation of 
the desired adduct 121 through transition state A (Figure 2.1). Although the nature of the 
protecting group on the hydroxyl moiety of the dienophile (R4) had no bearing on the 
outcome of the cycloaddition it was noted that a tosyl substituent on the nitrogen (R3) 
gave consistently better yields under milder reaction conditions, than the initially 
employed carbamate (Boc) protection. By contrast however, the following oxidation step 
(vide infra) gave dismal results and it become apparent that a significantly different 
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electronic environment was required. To address this issue an “electronically switchable” 
protecting group was developed; thus the electron-withdrawing tosylvinyl group (Tsv), 
that provided the desired regiochemistry in the Diels Alder reaction exclusively, could be 
efficiently converted to the electron-donating tosylethyl (Tse) moiety under standard 
hydrogenation conditions. This change then provided the appropriate environment for the 
required oxidation, leading to good yields of key spirochlorocyclopentane 123.58 
 
Scheme 2.2 
 
 
 
 
 
 
 
 
 
 
Due to a rather tedious synthesis of the Tsv-diene, and the occurrence of some 
undesired side reaction however, it was decided to introduce the Tse group directly in the 
diene, prior to the Diels Alder step. Even though the cycloaddition was significantly 
affected, resulting in a 2.5:1 mixture of regioisomers, the overall reaction sequence was 
decidedly more efficient, and the undesired adduct could easily be separated via MPLC 
or simple column chromatography.  
The synthesis of the Diels Alder partners is summarized in Scheme 2.3. The choice 
of the indicated protecting groups came as a result of the intensive investigations by Dr. 
Dilley,56a later expanded upon by Dr. Dransfield.59 These endeavors predate my 
involvement with the project and a detailed account has been published.59 Upon repetition 
and scale-up of these procedures however, further improvements were made and 
remarkably the 8-step synthesis of the diene could be performed entirely without the need 
for column chromatography purification and has been carried out in decagram scale. 
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In addition recent studies that I personally performed using chiral HPLC (Figure 2.2) 
revealed that the desired Diels Alder product was enantiomerically pure, confirming that 
no epimerization of the dienophile occurred under the standard heating reaction 
conditions.  
 
Figure 2.2.  HPLC analysis of the D A adduct 121; a) co-injection. b) pure 121. c) 
racemic control. 
a 
b 
c 
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By contrast when the cycloaddition was carried out under microwave irradiation,60 
which greatly shortened the reaction time but required higher temperatures, partial to 
complete erosion of enantiomeric purity was observed. 
Following biosynthetic suggestions (see Chapter I) the Diels Alder adduct 121c was 
oxidized with freshly prepared dimethyldioxirane (DMDO) and the resulting crude allylic 
alcohol 130a was treated with a commercially available source of electrophilic chlorine 
(N-chlorosuccinimide or Chloramine-T) triggering the semi-pinnacol rearrangement that 
delivered the desired tricyclic intermediate 123 with complete diastereoselectivity for the 
key spirocyclic quaternary center (C16). 2  
Scheme 2.4 
 
 
 
 
 
 
 
 
 
 
 
It is noteworthy that the reaction temperature for the DMDO oxidation step was 
crucial, resulting in a very clean conversion at –50ºC, but generating increasing amounts 
of byproducts at lower temperatures. In addition, it was observed that in the following 
step the chlorinated product was often isolated with varying amounts of tosylamine (not 
reported before), which refused to be separated by column chromatography. This 
however did not seem to have any effect on the subsequent reaction, after which the 
impurity was easily separated. It was later, and entirely serendipitously discovered that 
                                                
2 Numbering for compounds throughout this dissertation follows the original numbering 
system introduced by Kinnel and Scheuer in the palau’amine isolation and 
characterization publication.6 
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the tosylamine impurity could be selectively precipitated in benzene and separated by 
simple filtration. As anticipated (vide supra) chlorocyclopentane 123 constitutes the point 
of divergence in our unified approach to both the axinellamines (3) and palau’amine (2). 
The work done in our group in these directions prior to my involvement is summarized 
below. 
 
2.2 First Generation Approach to the Core of the Axinellamines 
In the original approach to the axinellamines the necessary C12 epimerization was 
envisioned to come at a later stage, giving priority instead to the construction of the C 
and D rings of the tetracyclic core (131c in Scheme 2.5).  
 
Scheme 2.5 
 
 
 
 
 
 
 
Following biosynthetic inferences it was proposed that an oxidative cyclization of 
the “lactam” nitrogen of the spirohydantoin onto a pendant imidazolone would deliver the 
fully functionalized carbon skeleton of the axinellamines (131c Scheme 2.5). The 
imidazolone would in turn derive from nucleophilic opening of the northern lactam of 
123, followed by cyclization of a protected urea onto an aldehyde (131b  131c). This 
route would also provide a carbonyl moiety at C12, following lactam opening, suitable 
for the required projected epimerization. 
Although I have personally performed multiple times all the reactions described in 
this section, occasionally exploring alternatives and or making slight modifications (vide 
infra), it must be emphasized that only the latest optimized approach is described which 
represents but a small sampling of the extensive synthetic investigations pioneered by Dr. 
Paul Dransfield,61 and a detail account of these studies will not be included herein.  
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Selective TIPS desilylation of spirocycle 123 then, using one equivalent of TBAF 
at –40 ºC proceeded typically in a very efficient manner without affecting the more 
robust TBDPS protecting group (Scheme 2.6). Oxidation of the free hydroxy 
functionality using Dess Martin periodinane (DMP) at room temperature followed by 
treatment of the crude aldehyde 133, with trimethylorthoformate in MeOH at 60 ºC in the 
presence of p-TSA, provided dimethyl acetal 134 in generally excellent yields.    
 
 
Scheme 2.6 
 
 
 
 
 
 
 
 
  
 
 
Cleavage of the tosyl protecting group from the northern lactam was efficiently 
accomplished by treatment of 134 with 2 equivalents of freshly prepared samarium iodide 
(SmI2) in THF at 0ºC (Scheme 2.7). Installation of the required protected urea in 137 was 
achieved by heating intermediate 135 to 110ºC in toluene with 10 equivalents of 
tosylethylacylazide 136. Under these conditions 136 undergoes a Curtius rearrangement 
generating in situ an isocyanate that reacts with the nucleophilic lactam nitrogen in 135 
leading to quantitative yields of the desired urea. Remarkably, no base was required in 
this procedure.   
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At this point, our strategy required the opening of the northern lactam to allow for 
the subsequent reaction of the pendant urea to generate the imidazolone necessary for the 
key late-stage oxidative cyclization that would deliver the tetracyclic core of 
axinellamine. After fruitless attempts to generate the imidazolone first, and then open the 
lactam,61 we considered an intramolecular nucleophilic lactam opening, and it was 
reasoned that a nitrogen nucleophile in the C18 side-chain would be ideal for this purpose 
as it would also introduce a key feature of the natural product. Thus, conversion of 
protected alcohol 137 to azide 138 was achieved by a three-step sequence (Scheme 2.8), 
involving removal of the TBDPS group under acidic conditions, activation of the free 
hydroxyl moiety with tosyl anhydride, and displacement of the tosylate with sodium 
azide. Treatment of 138 with PPh3 in MeOH/H2O, then generated the desired amine 
nucleophile which efficiently proceeded in the same pot to open the northern lactam, 
providing urea 139 in good yield.  
 
Scheme 2.8 
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Alternatively, I investigated the direct installation of the azide on the free alcohol 
under Mitsunobu conditions using diphenylphosphoryl azide (DPPA). Although this 
protocol efficiently provided the desired azide 138, eliminating one step in the overall 
sequence, a significant amount of triphenylphosphine oxide byproduct was generated 
which could not be separated by silica gel chromatography. As in the following step, 
however, more triphenylphosphine oxide was generated and previous results had shown 
that urea 139 could be obtained in excellent purity, it was decided to subject the semi-
purified intermediate to the reaction conditions. Indeed, very pure urea 139 was isolated 
after flash chromatography, albeit in a modest 20% yield for the two steps. Overall the 
original three-step sequence proved to be more efficient. 
Urea 139 is the last fully characterized intermediate generated by Dr. Dransfield 
and a brief account on further studies he initiated, which I integrated and expanded is 
introduced below and will be further discussed in Chapter VI. Microwave irradiation of 
urea 139 promoted cyclization onto the dimethylacetal delivering the anticipated 
imidazolone 140 along with varying amounts of carbinolamine 141. 
 
Scheme 2.9 
 
 
 
 
 
 
 
 
After orthogonal protection of the free nitrogens (discussed in Chapter VI), efforts 
were than focused on the reversal of configuration at C12, to deliver the “all-trans” 
relative stereochemistry of the chlorocyclopentane core (A ring) of the axinellamines.   
In our initial approach to this issue we envisioned reducing the Boc-lactam to the 
corresponding carbinolamine and promoting epimerization of the equilibrating aldehyde 
tautomer under basic conditions (Scheme 2.10).  
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While the reduction proceeded smoothly generating the expected aminal 143 in 
good yield, several attempts to invert the stereochemistry as anticipated (Scheme 2.10), 
resulted in sluggish reactions and no significant products could be isolated. 
Given these discouraging results and the lengthy route that provided only small 
amounts of advanced intermediates, it was decided at this point that the epimerization at 
C12 should be addressed earlier in the synthetic sequence. Ideally, this approach would 
be overall shorter and require less protecting groups. Work done in this direction is 
detailed in Chapter III. 
 
2.3 Epi-palau’amine Investigation and Palau’amine Structural Revision 
As explained above, spirocycle 123 was the projected point of divergence in our 
common intermediate strategy toward the synthesis of palau’amine, as it featured the 
completely functionalized tricyclic core of the target alkaloid (Scheme 2.1), with the 
exception of the chlorine-bearing C17. Several attempts to adjust the stereochemistry of 
this center to match that of the natural product were unsuccessful62 and a C17 epi-
palau’amine became our target.  Investigations in this direction, carried out by Shaohui 
Wang, led to the synthesis of pentacycle 152 (Scheme 2.11). Once again the sequence 
presented herein only describes the latest successful approach and in the interest of 
conciseness the details of the synthetic studies that led to it will not be discussed here.   
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After initial attempts to reduce the lactam in spirocycle 123 to the corresponding 
pyrrolidine, it was discovered that this transformation gave significantly better results on 
the protected Diels Alder adduct 121c. Thus, treatment with DIBAL-H, followed by 
activation of the resulting carbinolamine with acetic anhydride and Lewis acid-mediated 
hydride substitution efficiently generated pyrrolidine 146. Oxidative ring contraction as 
described before, followed by single-electron-transfer cleavage of the sulfone protecting 
groups provided chlorocyclopentane 147 in modest yield over the three steps. Acylation 
of the pyrrolidine nitrogen with pyrrole carbonyl chloride 148 then, followed by selective 
cleavage of the TIPS ether set the stage for the construction of the D ring of palau’amine. 
Surprisingly, after oxidation of the primary alcohol with IBX at room temperature the 
anticipated cyclization of the pyrrole nitrogen onto the newly generated aldehyde did not 
occur and more forcing conditions had to be utilized to accomplish this transformation 
(step 10, Scheme 2.11). Introduction of an azide functionality under Mitsunobu 
conditions then, followed by reduction to the corresponding amine and treatment with 
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151, generated pseudothiourea 152 which is the most advanced fully characterized 
intermediate prepared by Dr. Wang.   
At this point, generation of a pendant guanidne by displacement of the thiomethyl 
substituent with a nitrogen source would provide a suitable precursor for the completion 
of the synthesis. Following recent literature reports by DuBois,63 it was envisioned that 
intramolecular C-H amination at C10, would deliver the completely functionalized 
hexacyclic core of palau’amine. The projected C17 epimer of the natural product would 
then be completed by reduction and guanidinylation of the spirocyclic hydantoin and 
introduction of the primary amine at C19. 
 
Scheme 2.12 
 
 
 
 
 
 
 
Although our synthetic efforts delivered gratifying results, as we were exploring the 
final steps of our strategy, independent but virtually simultaneous reports from the groups 
of Matsunaga,3d Kock,3c and Quinn3a,b appeared that called into question the original 
structural assignment of palau’amine. In particular, based on new and improved 
spectroscopic data all agreed that the stereochemistry at C12 and C17 had to be inverted. 
 
 
Figure 2.3.  Original and revised structure of palau’amine. 
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If, from a biosynthetic perspective this assessment was sound, and in retrospect, 
fitting as virtually all PIAs now exhibited identical stereochemical relationships, it 
introduced on the other hand a very peculiar structural feature. Palau’amine (and by 
extension the related konbu’acidins (5)64 and styloguanidines (4);65 see Chapter I) now 
featured a trans-[3.3.0]-azabicyclooctane (i.e. two five-membered rings trans-fused), a 
construct that, as reported by Kock and Baran,4 is exceedingly rare in natural products. 
We realized at this point that our advanced intermediate pentacycle 152 was indeed 
an epimer of the natural alkaloid, albeit a C12 epimer and not a C17 epimer as originally 
thought. Fortunately in the course of our investigation toward the synthesis of the 
axinellamines we had already identified conditions to effect the desired inversion of 
stereochemistry at C12 (Chapter III). We reasoned that this provided us with an 
opportunity to revise our common intermediate approach, allowing us to potentially delay 
the point of divergence until much later in the synthesis. Recognizing that the newly 
isolated konbu’acidin B3a and the known axinellamines possessed identical carbon 
frameworks we envisioned that a bis-pyrrole intermediate such as 155 could give rise to 
the fully functionalized cores of either or both targets in one step through different modes 
of intramolecular cyclization (Scheme 2.13). In this scenario the spirohydantoin DMB 
protecting group would be the discriminating element that would allow us to select a 
specific mode of cyclization. Development and implementation of this strategy will be 
expanded upon in Chapter VI. 
Scheme 2.13 
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CHAPTER III 
 
EARLY STAGE C12 EPIMERIZATION STRATEGY TOWARD THE 
SYNTHESIS OF THE AXINELLAMINES* 
 
3.1 Initial Early C12 Epimerization Studies Toward Axinellamine 
After the unsuccessful attempts to effect the late stage C12 epimerization required 
for the synthesis of the axinellamines as projected in our original strategy (see Chapter 
II), we revised our approach and initiated studies to address this key issue earlier in the 
synthetic sequence. We reasoned that the most convenient point to investigate the 
necessary inversion of configuration was after the establishment of the crucial spirocyclic 
system. Nucleophilic opening of the lactam moiety in tricycle 123 would provide a 
carboxylate functionality suitable for epimerization via equilibration of the intermediate 
enolate species 156b (Scheme 3.1).  
 
Scheme 3.1 
 
 
 
 
 
 
 
 
  
 
 
                                                
* Part of this chapter is reprinted with permission from “Facile Synthesis of the Trans-
Fused Azabicyclo[3.3.0]octane Core of the Palau’amines and the Tricyclic Core of the 
Axinellamines from a Common Intermediate” by Zancanella, M. A.; Romo, D. Org. 
Lett. 2008, 10, 3685-3688. Copyright 2008 American Chemical Society. 
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To investigate the reactivity of the northern lactam, we decided to initiate a model 
study, and we reasoned that diene precursor (124 or 158 Scheme 3.2) would provide a 
convenient and readily accessible substrate that would adequately mimic the real system. 
In addition, dimethyl acetal 159, which had been previously prepared and was available 
in large quantities, could also provide valuable information as to the reactivity of these 
systems. 
 
Scheme 3.2 
 
 
 
 
 
 
 
 
 
 
 In initial trials, both the TIPS protected lactam 158 (R = Boc) and dimethyl acetal 
159 reacted with excess NaBH4 in alcoholic solvent to deliver modest yields of the 
corresponding primary alcohols. Further manipulation of the former substrate however 
proved not to be trivial.  
 
Scheme 3.3 
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Attempts to oxdize the primary alcohol moiety to the corresponding aldehyde 164 
under a variety of conditions (Table 3.1) resulted in rather sluggish reactions with no 
discernible desired product. In some cases spectroscopic data seemed to be consistent 
with carbinolamine 165, although identity of this product could not be unambiguously 
established. An attempt to oxidize the alcohol moiety in the presence of an amine to trap 
the presumed unstable aldehyde intermediate66 led only to complete recovery of the 
starting material.    
 
Table 3.1 Attempted oxidaton of amino alcohol 162. 
 
Entry Conditions Outcome 
1 DMPa, 23 ºC Fast reaction but no aldehyde. Sluggish NMR. Probably aminal 
165. 
2 SO3/py, 23 ºC Reaction time 2 h. No aldehyde. Unidentified product. 
3 Swernb Aldehyde signal at 9.5 ppm on crude 1H NMR. Lost after work-
up 
4 Swernc No Reaction. Probably bad Swern reagent 
5 Swernc Aldehyde signal at 9.5 ppm on crude 1H NMR. Lost after 
column. 
a = Dess-Martin Periodinane; b = addition of substrate to Swern reagent. c = addition of Swern reagent to 
substrate.  
  
 
Treatment of Boc-lactam 158 with DIBAL-H under standard conditions cleanly 
delivered the expected mixture of carbinolamines 165. After exposing the crude material 
to aniline, in an attempt to isolate a stable imine derivative however, multiple products 
were generated (by TLC analysis) that could not be separated and characterized, 
furthermore no starting material could be recovered. 
 
Scheme 3.4 
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Reaction of boc-lactam 158 with methoxy-methylamine in the presence of an 
aluminum Lewis acid to generate the corresponding Weinreb amide derivative 167, led 
instead to the fast, quantitative cleavage of the carbamate protecting group. By contrast, 
when the analog tosyl-lactam 124 was subjected to identical reaction conditions, 
excellent yields of the desired amide could be isolated after 24 hours at ambient 
temperature. 
Scheme 3.5 
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With a suitable substrate in hand we then tried to establish the propensity of this 
system to undergo enolization, by attempting to introduce deuterium labels alpha to the 
carbonyl of the Weinreb amide under basic conditions. Most conditions surveyd led to 
recovery of unaltered starting material. DBU in CD3OD at room temperature for 24 h, 
NaHMDS at –78ºC for 30 min. then quenched with D2O, and LiHMDS at –78ºC for 30 
min. then quenched with D2O, all gave no deuterium incorporation. 
Heating the substrate in CD3OD to 80ºC for 20h in the presence of DBU led to the 
isolation of a new product, which by preliminary 1H NMR analysis was assigned 
structure 169 (Scheme 3.6). This compound was presumably formed either by deuterium 
incorporation followed by nucleophilic attack of CD3O- onto the amide, or by the reverse 
order of events. 
 
Scheme 3.6 
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Reduction of the amide moiety proceeded pleasingly smoothly under mild 
conditions. Interestingly when MeOH was used instead of EtOH, a large excess of 
reducing reagent and longer time were required to drive the reaction to completion. Use 
of LiAlH4 in THF solution led to very sluggish reaction and no detectable amounts of 
desired product were generated. Several other conditions resulted in no reaction. 
 
Scheme 3.7 
 
 
    
 
 
 
Having identified promising conditions for the lactam opening, and gained good 
insight on the propensity of the resulting open derivative to undergo enolization we 
returned to the real system 123, with reason to believe that the key C12 epimerization 
would be readily accomplished. Unfortunately we soon discovered that the reactivity of 
the model system did not parallel that of more complex advanced synthetic intermediates. 
 
Scheme 3.8 
 
 
 
 
 
 
 
Several runs of the established conditions for the lactam opening to the 
corresponding Weinreb amide on chlorocyclopentane 123 (Scheme 3.8), led to no 
reaction even after extensive heating (60 ºC for 10 hours). Equally disappointing results 
were obtained under the same conditions on more advanced intermediate 137b and Diels 
 38 
N O
OH
MeO
TseN
N Cl
O
O DMB
MeO
O NHTse Ts
N
TseN
N
DMBO
O
TIPSO
OTBDPS
Me2AlCl, CH2Cl2
0ºC to 23ºC
HN(OMe)Me. HClor
N. R.
121c137b
Ts
N
TseN
N
DMBO
O
TIPSO
OTBDPS
NaBH4, Solvent
230C
Ts
N
TseN
N
DMBO
OH
TIPSO
OTBDPS
68% in MeOH
77% in EtOH
1313
121c 172
Alder adduct 121c, in both instances leading to nearly complete recovery of unreacted 
starting materials. 
Scheme 3.9 
 
 
   
 
 
 
 
Further confirmation that the tricyclic substrates showed very different reactivity 
than the monocylic model system was provided by the reaction with NaBH4. While the 
model system was converted exclusively to the corresponding open amino-alcohol (vide 
supra), the Diels Alder adduct 121c provided good yields of the half-reduced 
carbinolamine in both MeOH and EtOH. In this particular instance it seems plausible to 
infer that, even if after initial reduction the lactam ring is opened, the constraint imposed 
by the tricyclic system places the tosylamine and the aldehyde termini in close proximity 
so that the closed aminal tautomer is exclusively favored over the open amino-alcohol 
form. The stereochemistry at C13 was not firmly established, but significantly, the 
reaction provided complete diastereoselectivity. The structure indicated in Scheme 3.10 is 
the kinetic product deriving from hydride attack on the concave face of the tricyclic 
system. The opposite configuration would be expected if a transient open amino-aldehyde 
species was generated in the process. 
 
Scheme 3.10 
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Other attempts to open the tosyl lactam under basic conditions using methanol as 
the nucleophile provided no reaction even at relatively high temperatures and after 
prolonged reaction times. Similarly, a further run of the established conditions for the 
generation of the Weinreb amide (Scheme 3.5) on alcohol 132, obtained from selective 
cleavage of the TIPS ether (vide supra) led to complete recovery of the starting material. 
 
Scheme 3.11 
 
 
 
 
 
 
 
 
 
 
3.2 Successful Lactam Opening and C12 Epimerization Toward Axinellamine 
Eventually, the tosyl-lactam ring could be opened to primary alcohol 175 using 
excess LIBH4 after overnight stirring at ambient temperature, albeit a significant amount 
of an unknown byproduct was also generated in the process. Although this undesired side 
reaction could be minimized by using a controlled excess of reagent, optimization of this 
procedure was not pursued in light of more promising results obtained with an alternative 
approach that was being investigated concomitantly (Scheme 3.13).   
 
Scheme 3.12 
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Using a procedure with which Dr. Dransfield had had some success (on a different 
substrate) it was discovered that treatment of TIPS deprotected spirocycle 132 with 
catalytic KCN in MeOH at room temperature delivered after extended reaction time (up 
to 4 days) a methyl ester, as confirmed by the appearance of a diagnostic signal at δ 3.83 
ppm (s, 3H OCH3) in the 1H NMR spectrum (C6D6). As the product and the starting 
material had identical Rf values, the reaction could not be monitored by TLC and after 4 
days a 9:1 mixture of the two species (the product being the major) was isolated. The 
product was tentatively assigned structure 176, which is consistent with mass 
spectrometry data; m/z = 1082 (M+Na) and m/z = 1098 (M+K). The stereochemistry at 
C12 could not be unequivocally assigned, as interpretation of the 1D and 2D NMR data 
was made difficult by the overlap of key signals. In an attempt to shorten the reaction 
time, in a second run heat was applied to the reaction mixture.  
 
Scheme 3.13 
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As predicted, nearly complete loss of starting material was observed in less than 18 
hours, leading to the isolation of ~ 60% of a pure methyl ester. Unexpectedly however, 
although the mass spectrometry data were identical to those of 176, the 1H NMR 
spectrum of this material (identified as 177) was entirely different (Figure 3.1).  
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Figure 3.1. Spectral comparison of methyl esters 176 and 177. 
 
 
It seemed conceivable at his point to deduce that methyl esters 176, and 177 were a 
pair of C12 epimers, but further spectroscopic evidence to unambiguously assess this 
possibility was required. In addition, these initial promising results provided the impetus 
for further investigations aimed at optimizing the reaction conditions and possibly 
gaining an insight into the mechanistic details of the transformation.  
Initial attempts to explore further reactivity of ester 177 (which was presumed to be 
the epimerized one) using conditions utilized before (see Chapter II) resulted in quite 
sluggish reactions but provided nonetheless modest yields of dimethyl acetal 178 
Assignment of the stereochemistry at C12 remained at this point elusive. 
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Further studies seemed to indicate that the lactam opening reaction required both a 
free hydroxy moiety, and a tosylated lactam to proceed to the formation of a methyl ester. 
When substrates 121c, 123 and 137b were subjected to the reaction conditions in fact, 
only unreacted starting materials were recovered even after prolonged reaction times. On 
the other hand, treatment of advanced intermediate 179 led to complete and clean 
conversion to methyl ester 180 in less than 24 hours at room temperature, as confirmed 
by the appearance of diagnostic signals at δ 3.70 ppm (s, 3H OCH3) and δ 4.70 ppm (d, 
1H NH) in the 1H NMR spectrum (C6D6).  
 
Scheme 3.15 
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The isolation of ester 180 provided a convenient opportunity to more accurately 
characterize these systems as well as to gain more insight into their reactivity. Protection 
of the free alcohol as the TBDPS ether would in fact generate an intermediate that had 
previously been observed (178 in Scheme 3.14), and spectroscopic comparison of the two 
substrates would be extremely valuable. Surprisingly however, when ester 180 was 
treated with TBDPSCl under standard conditions the only product isolated was the 
starting lactam 179, presumably deriving from intramolecular attack of the sulfonamide 
onto the methyl ester. Although direct comparison with acetal 178, synthesized from the 
ester 177 (presumably epimerized at C12) was not possible, this result seemed to provide 
indirect evidence that the configuration of C12 had not been inverted in 180 after lactam 
opening at room temperature. 
 
Scheme 3.16 
 
 
 
 
 
 
 
Interestingly on the other hand the attempted reduction of the methyl ester moiety 
in dimethyl acetal 178 using DIBAl-H resulted in an approximately equimolar (by 
comparison of key signals in the crude 1H NMR spectra) mixture of the desired alcohol 
181 and the half-reduced corresponding aldehyde 182.  
 
Scheme 3.17 
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The isolation of a stable aldehyde provided further strong, albeit indirect evidence 
that the stereochemistry at C12 of the starting methyl ester 177 had been inverted upon 
lactam opening. It seemed plausible in fact to expect that if the C12 center was not 
epimerized, the sulfonamide nitrogen would easily attack the available vicinal 
electrophile, as had presumably been observed before (Scheme 3.16), generating, in this 
instance, a carbinolamine. Conversely, after epimerization, the aldehyde would be on the 
opposite face of the chlorocyclopentane core with respect to the sulfonamide, and 
interaction between these two termini would appeared to be highly unlikely, as it would 
give rise to a very strained bicyclic system housing two trans-fused five-membered rings. 
Were a carbinolamine to form under these circumstances, it seems reasonable to 
anticipate that it would easily revert back to the thermodynamically more stable open 
aldehyde tautomer.    
Strong evidence for the C12 epimerization was finally provided by a deuterium 
incorporation study. Treatment of lactam 132 with freshly prepared deuterated sodium 
methoxide, in deuterated methanol solution under the established heating conditions 
(Scheme 3.13) cleanly generated a new product that based on mass data and 1H NMR 
comparison with amino alcohol 177 was assigned as deuterated ester 183. 
 
 
Scheme 3.18 
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The NMR comparison in particular (Figure 3.2) showed that although the two spectra 
were virtually identical, some significant changes had occurred in key diagnostic signals.  
 
Figure 3.2. Spectral comparison of a) aminoalcohol 177 and b) deuterated ester 183. 
 
Namely, the methoxy signal of the methyl ester had disappeared, which indicated 
the formation of the expected deuterated methyl ester, also confirmed by mass data. Most 
importantly however, the signal relative to H12 had also disappeared and the multiplicity 
of the vicinal H11 proton had changed from a doublet of doublets (apparent triplet) to a 
doublet, which was consistent with the incorporation of a deuterium atom at C12 (α to 
the methyl ester), supporting in turn the formation of the enolate transient intermediate 
necessary for the desired inversion of stereochemistry. In addition, though unexpectedly, 
deuterium incorporation α to the sulfone in the Tse protecting group was also observed, 
as determined by the disappearance of the relative signal in the 1H NMR (Figure 3.2). In 
retrospect, given the enhanced acidity of these protons due to the presence of the sulfone, 
this outcome is not surprising, and it could potentially account for the relative low yield 
of the process. It is conceivable, in fact, that under the basic reaction conditions, proton 
abstraction at the α position of to the sulfone could trigger cleavage of the Tse group. 
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Unfortunately several attempts to isolate this presumed by product met with no success 
and the possibility of its existence remained a mere speculation. 
Considering the experimental information accumulated up to this point, a plausible 
mechanistic rationale for the C12 epimerization could be advanced (Scheme 3.19).  
 
Scheme 3.19 
 
 
 
 
 
 
 
 
 
 
 
 
Given the non-reactivity of substrates featuring a protected northern primary 
alcohol (either as the TIPS ether or the dimethyl acetal (vide supra) it seemed reasonable 
to conclude that direct attack of a methoxy nucleophile on the lactam carbonyl was highly 
unlikely. On the other hand if this lack of reactivity were to be the consequence of steric 
hindrance generated by the protecting group, impeding the approach of the nucleophile, 
this avenue would return to be a viable one once the protecting group was removed. The 
result obtained with dimethyl acetal 179 however (Scheme 3.15) seemed not to support 
this assessment, as the desired methyl ester was in fact generated as the sole product. It 
appeared that a reasonable alternative could involve the alkoxide generated on the free 
alcohol under the reaction conditions, acting either as an internal nucleophile or an 
internal base, or potentially as both. We envisioned that the newly generated alkoxide I 
could attack the lactam carbonyl (path a) generating a bicyclic tetrahedral intermediate 
such as IIa, which could then collapse providing neutral pyranone IIIa. Nucleophilic 
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methoxide attack on the carbonyl of this system would then deliver a methyl ester IVa 
regenerating the initial alkoxide. This could in turn act as a base abstracting the α-proton 
of the methyl ester, giving rise to the corresponding enolate IIIb, which could then be 
reprotonated under the reaction conditions generating the thermodynamically favored 
epimerized ester 177. Alternatively, the initial alkoxide, acting as a base, could directly 
abstract the α-proton of the tosyl lactam (path b) generating transient ketene species IIb, 
which could be trapped by methoxide providing the same enolate IIIb, thus leading to the 
thermodynamic product. 
The evidence gathered up to this point supported the desired C12 epimerization, and 
methyl ester 177 was advanced to further studies that are described in the following 
Chapters. The results obtained in the course of these studies provided ulterior 
confirmation of the required inversion of configuration, but it was not until several 
months later that we were able to obtain crystallographic confirmation of the proposed 
structure. 
Scheme 3.20 
 
 
 Reaction of ester 177 with p-bromobezoyl chloride provided benzoate derivative 184 
which, after several attempts, could be recrystallized, providing crystals suitable for X-
ray analysis. The crystal structure obtained (shown in Scheme 3.20 devoid of protecting 
groups for clarity) not only clearly confirmed the “all-trans” arrangement of the 
substituents on the chlorocyclopentane core, but also provided unequivocal evidence of 
the correct configuration of the key spirocyclic hydantoin, which had been assigned on 
the basis of extensive NMR analysis.   
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CHAPTER IV 
 
SYNTHESIS OF THE CORE OF AXINELLAMINE AND PALAU’AMINE FROM 
A COMMON CHLOROCYCLOPENTANE PRECURSOR* 
 
4.1 DMB Deprotection Studies  
With the structure of the C12 epimerized ester 177 firmly secured and some 
promising preliminary results for the formation of the northern pendant imidazolone 
(discussed in Chapter V), we then focused our efforts on the removal of the DMB 
protection from the spirohydantoin “lactam” nitrogen, in order to generate the required 
nucleophile for the projected intramolecular oxidative cyclization that would deliver the 
tetracyclic core of the axinellamines (187, Scheme 4.1).  
 
Scheme 4.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
* Part of this chapter is reprinted with permission from “Facile Synthesis of the Trans-
Fused Azabicyclo[3.3.0]octane Core of the Palau’amines and the Tricyclic Core of the 
Axinellamines from a Common Intermediate” by Zancanella, M. A.; Romo, D. Org. 
Lett. 2008, 10, 3685-3688. Copyright 2008 American Chemical Society. 
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Even though the literature precedents for the cleavage of activated benzyl ethers 
were abundant and quite encouraging, our preliminary investigations on a simplified 
model system (Scheme 4.2) provided mostly sluggish and inconsistent results, leading to 
undesired outcomes or generating complex mixture of products that could not be neatly 
separated and characterized. Reaction of hydantoin 188 with trifluoroacetic acid (TFA) in 
the presence of anisole for instance, led to complete cleavage of the TBDPS group 
leaving the target DMB ether unaltered. On the other hand treatment with 
dichlorodicyanoquinone (DDQ) gave no appreciable reaction even after overnight 
stirring.  
Scheme 4.2 
 
  
 
 
 
 
These initial inconclusive results led to consider different model systems, and 
having large quantities of Tse-spirohydantoins 191 and 192 in hand from previous 
endeavors, we anticipated that protection of the free nitrogen would quickly provide 
convenient platforms to thoroughly investigate the desired transformation. The seemingly 
trivial benzylation of the free nitrogens of 191 and 192 however, proved in fact to be 
unexpectedly problematic.  
Scheme 4.3 
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In the case of t-butyl-cyclohexyl derivative 191 the use of excess sodium hydride 
promoted the cleavage of the base-sensitive Tse group resulting in the alkylation of both 
nitrogens generating bis-DMB hydantoin 194. Though unplanned, this result provided 
nonetheless a suitable material for DMB deprotection studies, and it was therefore treated 
with ceric ammonium nitrate (CAN) resulting in complete loss of starting material in less 
than one hour. Appearance of the expected aldehyde signals in the crude 1H NMR 
spectrum confirmed the desired oxidative cleavage of the benzyl groups, however the 
deprotected spirohydantoin 195 was not isolated and characterized.  
Several attempts to introduce the DMB moiety onto the cyclopentyl hydantoin 192 
resulted in slow and incomplete reactions generating only trace amounts of desired 
product 196. Deprotection studies on very small amounts of material were deemed not 
worthwhile at this juncture, and this model study was abandoned.  
Pleasingly, testing dimethyl acetal 197, a potential advanced intermediate en route 
to the axinellamines (discussed in Chapter V), provided the first breakthrough. Treatment 
with CAN under the conditions identified in the course of the model study in fact, led to 
rather clean cleavage of the DMB group. The required reaction time could not be exactly 
identified in this instance because what was initially thought to be unreacted starting 
material by TLC analysis, proved instead to be the aldehyde byproduct of the oxidative 
cleavage. Due to the small scale of the reaction, the exact yield could not be determined 
either.  
 
Scheme 4.4 
 
 
 
 
 
 
  
After a few fruitless attempts to remove the DMB protection from the advanced 
imidazolone 185 (discussed in Chapter V), it was decided to explore an early 
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deprotection on the C12-epimerized methyl ester 177 (Scheme 4.1). Treatment of the 
starting material with 2 equivalents of CAN (in MeCN/H2O 4:1) at room temperature 
seemed to lead to no reaction (by TLC) after overnight stirring. Adding excess (4 more 
equivalents) reagent and increasing the temperature (55ºC for 16h) seemed to have no 
effect. Upon analysis of the 1H NMR spectrum of the crude material however it was 
discovered that a reaction had indeed occurred as confirmed by the appearance of the 
very diagnostic DMB aldehyde signals. Disappointingly however, the characteristic 
methoxy signals of the DMB group were still clearly visible in the two products isolated 
after purification. Based on these preliminary observations a potential scenario began to 
emerge in which, under the reaction conditions the aldehyde byproduct 199 generated by 
the oxidative cleavage was captured by either of the nucleophilic termini of the amino 
alcohol 200 (Scheme 4.5), generating either a stable hemi-acetal (red path) or a stable 
carbinolamine (blue path). Alternatively it is plausible to envision that CAN could 
promote complete benzylic oxidation of the DMB group generating transient extended 
imide 201, which could in turn be the target of the nucleophilic attack of the amino 
alcohol (intra- or inter-molecularly), resulting in the formation of either an ester or an 
amide. The relatively small scale of these preliminary trials however, did not allow at this 
point for a complete, unambiguous characterization of the byproducts obtained.  
 
Scheme 4.5 
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Treatment of the starting material with TFA and anisole at room temperature led to 
complete recovery of the unreacted amino-alcohol. Heating to 65ºC overnight resulted in 
the isolation of a mixture of products, tentatively assigned (based on 1H NMR analysis) 
as the free diol 204, and the mono- and/or bis- corresponding TFA derivatives 205 
(Figure 4.1). In all the products the DMB group appeared to have remained unaltered. 
Given the small scale of the reaction and the sluggish outcome, resolution of the complex 
mixture by purification was not attempted. 
 
 
 
 
 
 
Figure 4.1.  Potential products of the TFA/anisole reaction.  
 
The above results seemed to have established that DMB cleavage with CAN could 
potentially be facile provided that the presumed departing aldehyde be properly trapped 
or that any possibility of latent nucleophilic attack be prevented. To test the latter 
approach the amino alcohol termini were blocked by the formation of the corresponding 
oxazolidinone using triphosgene. Gratifyingly, the resulting crude material underwent 
smooth and fast DMB cleavage under the established reaction conditions (5 equivalents 
of CAN in 3:1 MeCN/H2O at 0ºC for 1 hour) generating a remarkable 80% yield of 
desired product 206 over the two steps.  
 
Scheme 4.6 
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Interestingly, the des-DMB product 206 was less polar than the starting material, 
although it was UV active it was not stained by Cerium Ammonium Molybdate (typically 
used for these molecules), and had an Rf value virtually identical to that of DMB 
aldehyde (199, Scheme 4.5). In spite of this, however, separation of the two species by 
flash column chromatography proved to be extremely easy. 
It was also pleasing to find that the cleavage of the oxazolidinone proceeded 
efficiently with lithium hydroxide at room temperature, liberating the initial amino 
alcohol functionality with good yield (70% after purification). The methyl ester did not 
appear to be affected during the process, although partial hydrolysis of this moiety to the 
corresponding acid could account for the mass balance of the reaction. As the presumed 
acid however could not be detected, this remains only a speculation. 
 
Scheme 4.7 
 
 
 
 
 
 
 
 
Although the above result constituted a significant progress, we reasoned that this 
approach was not optimal, as it required the introduction of a temporary new 
functionality, lengthening in turn the overall synthetic sequence, for the sole purpose of 
removing a protecting group. We sought therefore to find efficient ways to trap the 
oxidized DMB species (vide supra) so that the deprotection could be performed on the 
“open” amino alcohol. We envisioned that using an excess of a nucleophilic additive in 
the reaction mixture could, in principle, sequester the departing aldehyde, or cleave the 
activated imide resulting from benzylic over-oxidation. 
The addition of 1,3-propanediol led to the isolation of the desired product 207 in 
approximately 50% yield along with a second, more polar product which by 1H NMR and 
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MS analysis was identified as diester 208, and which seemed to be consistent with the 
mechanistic considerations presented in Scheme 4.5. Namely, the DMB 
methoxycarbenium intermediate (generated after single electron transfer) reacts with 
water (or the oxygen nucleophile additive), and either eliminates DMB aldehyde 
(observed in the crude 1H NMR) leading to the formation of the desired product, or 
intramolecularly acylates the pendant alcohol generating 208 (Figure 4.2). This 
assessment seems to be supported also by the isolation of mixed acetal 209 when 
methanol was substituted for water and no additive was used.  
 
 
 
 
 
 
Figure 4.2.  Byproducts of the DMB removal on the unprotected amino alcohol. 
 
Surprisingly, the use of ethanolamine (expected to mimic the amino alcohol 
moiety) as additive under the same reaction conditions led to complete recovery of 
unaltered starting material even after prolonged reaction time and increased temperature. 
 
4.2 Synthesis of the Angular Aza-Triquinane Core of the Axinellamines 
With small amounts of newly generated des-DMB amino alcohol in hand we 
decided to explore the intramolecular cyclization that would deliver the tricyclic core of 
the axinellamines. We reasoned based on molecular model analysis, that given the close 
proximity of the hydantoin free nitrogen to the carbinol carbon C6, oxidation of the 
alcohol to the corresponding aldehyde would provide a convenient electrophile that 
could, in turn, potentially trigger the desired cyclization in situ. As anticipated, treatment 
with DMP pleasingly led to the isolation of a modest yield (~38%) of tricyclic aminal 
210 as confirmed by the appearance in the 1H NMR of aminal proton 6 at δ 5.89 ppm , 
and by the complete absence of any aldehyde signals in the crude 1H NMR. The tentative 
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assignment of the stereochemistry at C6 was made on the basis of coupling constants and 
model analysis.  
Scheme 4.8 
 
 
 
 
 
 
Isolation of 210 attested to the predicted ease of cyclization of the hydantoin 
nitrogen in the presence of an adequate electrophilic moiety. This result prompted us to 
explore an alternative, more direct approach to arrive at carbinolamine 210, and it was 
envisioned that inverting the order of events could deliver the desired outcome. Thus, 
oxidation of the DMB protected amino alcohol with DMP cleanly generated a stable 
aldehyde, which was carried on to the next step without purification. Treatment of the 
crude material with CAN then, under the established conditions, led to the isolation of a 
modest yield of a product that was spectroscopically identical to aminal 210, along with a 
major byproduct that could not, in the early trials, be unambiguously identified.    
 
Scheme 4.9 
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Much later, further experimentation provided strong indirect evidence that the 
major byproduct of the CAN reaction was the over-oxidized benzoate derivative 210b. 
Following literature precedents then,67 this material was briefly exposed to typical 
hydrolysis conditions (LiOH THF/H2O at ambient temperature for 10 minutes) cleanly 
generating additional aminal 210, in modest yield for the overall, 3-step process. Aminal 
210 featured the completely functionalized tricyclic core of the axinellamines 
(highlighted in Scheme 4.9), and it was deemed to be a suitable precursor for the 
completion of the synthesis of the target natural products. Investigations in this direction 
were however brief, as our efforts were geared toward the development of a potentially 
biomimetic approach to the PIA’s (discussed in Chapter V), and eventually this 
admittedly abiotic strategy was abandoned.  
As discussed above, the stereochemistry of the carbinolamine center (C6) could not 
be unambiguously established, but it was assumed to be trans to the sulfonamide at C10 
based on model, and stereoelectronic considerations. Our first efforts therefore, were 
aimed at inverting the configuration of this center with a nitrogen nucleophile in order to 
generate a syn diamine 212, which could then be annulated using triphosgene (or 
analogs), closing the D ring thereby delivering the complete carbon framework of the 
axinellamine core 213 (Scheme 4.10).     
 
Scheme 4.10 
 
 
 
 
 
 
 
 
Thus, treatment of aminal 210, with tosylethylamine at 50ºC (no reaction was 
observed between 0ºC and 23ºC), resulted in clean and complete conversion to bis-amine 
214 (Scheme 4.11; confirmed by 1 and 2D 1H NMR, and mass data) with up to 64% yield 
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after purification. Based on coupling constant analysis this product seemed to have 
retained the original C6/C10 trans relative stereochemistry, indicating that the 
transformation could proceed via an acyliminium Ia and/or an aziridinium transient 
intermediate IIa (Scheme 4.11).  
 
Scheme 4.11 
 
 
 
 
 
 
 
 
 
 
 
 
In addition a pathway that involves the aldehyde tautomer of the starting material 
Ib undergoing imine formation followed by intramolecular ring closure IIb is also a 
viable option. Even though the acyliminium and the imine transient intermediate could 
potentially give rise to mixtures of C6 epimers, it is plausible to assume (as a single 
product was consistently isolated) that under the reaction conditions they would 
equilibrate converging to the thermodynamically favored trans species. In the case of the 
aziridinium intermediate IIa it would be reasonable to expect a mixture of regioisomers, 
with the amine nucleophile attacking either C6 or C10. As this outcome was however not 
observed we inferred that an aziridinium intermediate was either not formed or was never 
present in significant concentration to interact with the incoming nucleophile (i.e. the 
indicated equilibrium lies far to the left). 
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In an attempt to investigate the reactivity of diamine 214 we envisioned that 
treatment with triphosgene as projected (vide supra), could potentially provide either an 
advanced intermediate viable to complete the synthesis of the target product (imidazolone 
215a in Scheme 4.12), or at least, indirect evidence to support the stereochemical 
assignment of C6.  
Scheme 4.12 
 
 
 
 
 
 
 
 
The fact that no reaction occurred under standard conditions between 0 ºC and 20 
ºC seemed to be a clear indication that the two amine functionalities lied on opposite 
faces of the core pyrrolidine ring and could therefore not be simultaneously engaged by 
the electrophile. Use of more forcing conditions (50 ºC for 4.5 h) on the crude recovered 
starting material led to complete conversion to a new product, which based on NMR and 
mass spectrometry data was assigned as carbamoyl chloride 215b. Constructs like 215b, 
which may be expected to be significantly labile, have in fact been reported to be 
remarkably stable, 68 and in some cases, amenable to silica gel purification.   
Having gathered abundant evidence that the substitution reaction at C6 was under 
thermodynamic control, we tried to overcome this bias using Mitsunobu conditions, 
which typically involve SN2 displacement of an activated alcohol. Unfortunately using 
diphenyl phosphoryl azide (DPPA) at 0 ºC did not result in any appreciable reaction, but 
led to complete conversion upon increasing the temperature to ambient level. Once again, 
based on coupling constant analysis, the newly formed azide 216 appeared to have 
retained the original configuration, seemingly deriving from thermodynamically 
controlled nucleophilic addition to a transient acyliminium species (see Ia in Scheme 
4.11). 
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Scheme 4.13 
 
 
 
 
 
 
As anticipated, our main focus was to develop a biomimetic, unified route to 
axinellamine and palau’amine, therefore the abiotic efforts described above were 
eventually abandoned, and the investigations toward the synthesis of a common late-stage 
precursor (discussed in Chapter V) that were performed concomitantly, regained priority.   
 
4.3 Synthesis of the Trans-azabicyclo[3.3.0]octane Core of Palau’amine 
In our unified strategy toward palau’ amine and axinellamine, spirohydantoin 123 
was to be the point of divergence (see Chapter II) as this tricyclic structure featured the 
completely functionalized ABC core of palau’amine (2), but required an inversion of 
configuration at C12 to match the stereochemical relationships found in axinellamine (3) 
(vide supra). 
While our studies on the epimerization of C12 were ongoing, the structural revision 
of palau’amine (see Chapter II)3 appeared in the literature, presenting convincing 
evidence that the original assignment of the relative stereochemistry of key centers in the 
chlorocylopentane substructure was incorrect. The revised configuration of C12 and C17 
revealed that the spirocyclic cores of axinellamine and palau’amine were in fact identical, 
supporting a common biosynthetic origin. 
Having identified efficient conditions to invert the C12 configuration (see Chapter 
III) we reasoned that intermediate ester 177, already shown to be a suitable precursor to 
the azatriquinane core of axinellamine 210 (vide supra), could in principle lead also to 
the construction of the revised ABC substructure of palau’amine. To this end we 
envisioned that nucleophilic attack of the sulfonamide onto an adequate electrophile at 
C13 would regenerate the pyrrolidine substructure of the natural product. At first analysis 
(Scheme 4.14) however, and based on previous results (see Chapter III) it appeared that 
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the two reacting termini, lying on opposite faces of the chlorocyclopentane core, would 
either not be properly oriented to interact constructively or would lead to regeneration of 
the starting substrate 217a via thermodynamic equilibration to relieve the strain of the 
trans [3.3.0] bicyclic system 217b.      
Scheme 4.14 
 
 
 
 
 
 
Upon examination of molecular models however, we reasoned that in the presumed 
thermodynamically preferred conformation of methyl ester 177, in which all the 
substituents around the chlorocyclopentane core adopt a pseudo-equatorial arrangement, 
it seemed that the sulfonamide and C13 could be in close enough proximity to react 
efficiently. In addition, to overcome the issue of possible equilibrating tautomers 
(Scheme 4.14) we envisioned an SN2 pathway, in which the loss of an adequate leaving 
group from C13 in 219 would render the process irreversible, generating a double 
envelope structure that appeared not to be as highly strained as originally assumed.   
 
Scheme 4.15 
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After a brief survey of the literature we were pleased to find that sulfonamides 
often act as nucleophiles under Mitsunobu conditions (a fact supported also by our 
findings on related systems discussed in Chapter VI), thus reduction of the methyl ester 
to the corresponding primary alcohol would provide a substrate suitable for the projected 
intra-molecular displacement, leading to the target trans bicyclic system.   
At the onset of our investigation in this direction we reasoned that protection of the 
primary alcohol at C6 would be necessary to eliminate any potential regioselectivity 
issues arising from competing cylization of the sulfonamide resulting in the formation of 
an aziridine. It was decided that use of a triisopropylsilyl (TIPS) ether would be 
convenient, as it would facilitate the comparison of spectroscopic data with similar 
intermediates generated in our previous studies toward the original structure of 
palau’amine (see Chapter I). 
The reduction of the ester moiety in the protected amino alcohol 220 using DIBAL 
under standard conditions was unexpectedly sluggish resulting in the formation of a 
mixture of the desired primary alcohol 221 and the corresponding aldehyde (not shown). 
It is plausible that coordination of the aluminum reagent with the basic sulfonamide was 
the reason for the reduced reactivity that led to the observed partial reduction. Attempts 
to drive the reaction to completion by increasing the temperature resulted in the 
formation of complex, intractable mixtures of unidentified products. However, brief 
exposure of the crude mixture obtained after shortened treatment with DIBAL at low 
temprature to sodium borohydride at ambient temperature quickly completed the 
reduction leading to the isolation of synthetically useful yields of target alcohol.   
 
Scheme 4.16 
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The synthesis of alcohol 221 set the stage for the projected intramolecular ring 
closure and we were delighted to find that under standard Mitsunobu conditions at 
ambient temperature the desired cyclization occurred efficiently, generating consistently 
good yields of trans-azabicyclo [3.3.0] octane 222. 
 
Scheme 4.17 
 
 
 
 
 
 
 
 
Evidence for the stereochemistry of this bicyclic intermediate was garnered by 
comparison of the coupling constants of several key protons of pyrrolidine 222 with those 
reported for palau’amine by Quinn3b (Table 4.1).  The coupling constants indeed 
correlated well further confirming the revised stereochemistry of palau’amine i.e. the 
trans-azabicyclo[3.3.0]octane core.   
 
Table 4.1.  Coupling constant comparison between 222 and natural palau’amine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
proton palau’amineb  mult (J)c 222  mult (J)c 
11 d (14.4)  dd (14.5. 10.0) 
12 dddd (14.6, 10.2, 9.0, 7.2) dddd (14.5, 11.0, 10.5, 6.5)_ 
13 α dd (10.2, 7.2)  dd (11.0, 6.5) 
13 β  t (10.2)  t (11.0) 
17  d (9.0)  d (10.5) 
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In addition, selected nOe enhancements for tricycle 222 also corroborated the 
relative stereochemistry and the conformation of this rather rigid, spirotricyclic system 
(Figure 4.3). 
 
 
 
 
 
 
 
Figure 4.3.  Selected nOe enhancements in tricycle 222. 
 
Once the structure of tricycle 222 had been convincingly established we became 
interested in assessing whether the aziridine mode of cyclization that we had sought to 
prevent (vide supra) was indeed a viable avenue of reaction for methyl ester 177, and if 
so, to what extent as compared to the ring closure leading to the desired pyrrolidine. As 
we had correctly anticipated, exposure of methyl ester 177 to the established Mitsunobu 
condition provided the aziridine 223 deriving from nucleophilic displacement of the 
activated alcohol at C6 from the adjacent sulfonamide. It is noteworthy that this reaction 
required the use of excess reagent and prolonged time but nonetheless generated the 
expected product in good yields. Having determined that aziridine cyclization was, in fact 
possible we endeavored to assess how competitive this alternative reaction manifold was 
with the desired pyrrolidine annulation, and we envisioned that aminodiol 224 would 
provide us with a quick insight into the relative reactivity at C6 and C13 Reduction of the 
ester moiety in 177 with DIBAL was once again rather sluggish, and as before we 
ascribed the reduced reactivity of the aluminum reagent to the abundance of Lewis basic 
sites in the substrate. In this particular instance only partial conversion to the desired 
product was observed, with only traces of the half-reduced aldehyde. Resubjecting the 
crude material to the reaction conditions for prolonged time completed the conversion, 
generating however only modest yields of the target diol 224.  
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Scheme 4.18 
 
 
 
 
 
 
 
 
 
 
 
 
Under the established Mitsunobu conditions this diol generated virtually equal 
amounts of pyrrolidine 225 and aziridine 226 (by comparison of key signals in the crude 
1H NMR spectrum), confirming that the two modes of intra molecular cyclization were 
indeed competitive. It is noteworthy that under standard conditions the relative rate of a 
5-exo-tet ring closure is several orders of magnitude higher than a 3-exo-tet annulation69 
however, the result of our competition experiment revealed that in our setting, likely due 
to the inherent strain of the trans conformation of the nascent bicyclic system, the rate of 
5-membered ring formation was greatly slowed.  
The structures of both pyrrolidine 225 and aziridine 226, were assigned by NMR 
and mass data, and the former could further be confirmed by comparison of spectroscopic 
data with the product deriving from selective TIPS deprotection of tricyclic system 222 
(Scheme 4.17), using TBAF as previously discussed (see Chapter II). Conversely, 
attempts to corroborate the structure of 226 by similar comparison with the 1H NMR 
spectrum of the product derived from reduction of the ester functionality in aziridine 223, 
were thwarted by the unexpected reactivity of this substrate (Scheme 4.19).  
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Scheme 4.19 
 
 
 
 
 
 
 
 
Using either DIBAL or lithium borohydride, in fact, the reaction led to the 
generation of excellent yields of C20 aminal 227 as indicated by the appearance of a new 
signal in the 1H NMR at δ = 5.45 ppm which is consistent with a carbinolamine proton. In 
addition, this signal correlated (HMQC analysis) to a carbon at δ = 89 ppm, also 
consistent with a carbinolamine carbon. Disappearance of the lactam carbonyl signal 
from the 13C NMR (δ = 173 ppm) and mass spectrometric analysis (M+H, M+Na and 
M+K all matching) further corroborated the structural assignment. Designation of the 
relative stereochemistry at C20 however, remained unfortunately elusive.  
It must be underlined at this point that reaction at C20 was not observed, under a 
variety of conditions in virtually any other synthetic intermediates that were generated in 
this, and other studies. Given that all the targeted PIA’s feature a guanidine hemiaminal 
moiety, and considered that preliminary (but admittedly not exhaustive) investigations in 
our projected approach returned no satisfactory conditions to adjust the oxidation level of 
this key center, we envisioned this unforeseen carbinolamine to be a potentially viable 
precursor to the synthesis of the natural products of interest. Further investigations in this 
direction however (discussed in Chapter VII), revealed that the newly generated free 
hydroxy functionality of the C20 carbinolamine was significantly reactive, resulting in 
undesired outcomes and veritable synthetic dead-ends, suggesting that the originally 
planned late-stage reduction would be the preferred course of action. 
A “three-way” competition experiment with aminotriol 228, obtained in low yields 
from global silyl deprotection of alcohol 221 (TBAF/AcOH), resulted in a very sluggish 
and inconclusive outcome. Although complete loss of starting material was observed, 
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because of the small scale of the reaction none of the potential, expected products 229a-c 
could be isolated and unambiguously characterized.       
 
Scheme 4.20 
 
 
 
 
 
 
4.4 Conclusions 
The asymmetric synthesis of the angular azatriquinane core of the axinellamines 
and the trans-azabicyclo[3.3.0]octane core of palau’amine from a common cyclization 
precursor was described. In the course of these investigations, suitable conditions for the 
efficient cleavage of the DMB protection were identified and significant insight into the 
stereoelectronic factor governing the key projected intra molecular cyclizations was 
obtained. Although our interest lied in developing a potentially biomimetic strategy for 
the synthesis of the selected PIA’s the synthetic intermediates discussed above remain 
viable precursor for an admittedly abiotic approach.  
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CHAPTER V 
 
STUDIES TOWARD THE CONSTRUCTION OF THE D RING OF THE 
AXINELLAMINES 
 
5.1 Original Late Stage C12 Epimerization Approach to Axinellamine 
As previously discussed (Chapter II), at the time of my initial involvement with the 
synthesis of the PIA’s, the working strategy toward axinellamine involved a late stage 
C12 epimerization, focusing instead on the establishment of the tetracyclic core. 
Pioneering work by Dr. Dransfield had generated relatively large amounts of advanced 
intermediate 139, and preliminary studies had shown that under microwave irradiation 
and acid catalysis the urea would cyclize onto the dimethyl acetal delivering the 
corresponding imidazolone 140, thereby introducing the precursor to the D ring of the 
axinellamines (Scheme 5.1 inset). 
 
Scheme 5.1 
  
 
 
 
 
 
 
 
 
 
The reaction conditions however had not been optimized and varying amounts of 
undesired carbinolamine 141 were consistently detected in the crude reaction mixture, 
with extreme instances in which 141 was the only product isolated. In addition, scale up 
above 20 mg of starting material proved not to be straightforward resulting in 
inconsistent, and irreproducible outcomes. Furthermore, carbinolamine 141 appeared to 
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be resistant to ulterior manipulations, in attempts to dehydrate it to the desired 
imidazolone, returning unaltered starting material under a variety of conditions. 
After preliminary attempts to reproduce Dr. Dransfield’s results, aimed at preparing 
synthetically useful amounts of imidazolone 140 in order to further study the advanced 
steps in our original projected strategy (vide infra), I endeavored to optimize the reaction 
conditions of this key transformation. At first analysis it appeared that the solvent 
mixture, and in particular the amount of water used, might play a crucial role in the 
outcome of the reaction and indeed investigations in this direction, summarized in table 
5.1, seemed to support this assessment.  
 
Table 5.1. Investigations of the imidazolone cyclization reaction conditions. 
 
Entry Scale MeOH/H2O Rxn Time (min) Heat Outcome 
1 12 mg 1/0a 20+20 µW, 90 ºC NRb 
2 10 mg 0.5ml/1drop 20+20+20+20 µW, 90 ºC Mostly 141 + Xc 
3 10 mg 0/1 20 µW, 100 ºC 1:1 140:139 (no 
141) 
4 20 mg 1/3 40+ 20 µW, 90 ºC 3:1 (140 :141) 
43% Yd 
5 21 mg 1/5 20 µW, 100 ºC 140 65% Yd 
6 44 mg 1/5 20+20 µW, 100 ºC 140 48% Y (2 
steps)e 
7 52 mg 1/5 40+30 µW, 100 ºC 4:1 (140 :141) 
50% Cf 
8 49 mg 1/5 20+20 µW, 100 ºC 10:1 (140 :141) 
60% C 
9 52 mg 1/5 20+10 µW, 100 ºC 140+traces 141 
70% C 
10 167 mg 1/7 210 95 ºCg 140+ traces 139 
a = 3 Å Molecular sieves also used; b = No Reaction; c = Unidentified product; d = Refers to isolated yield; 
e = Refers to isolated yield after tosylation of the imidazolone nitrogen; f = Refers to conversion as 
determined by comparison of key signals in the crude 1H NMR spectrum; g = Conventional heating in an 
oil bath. Unmeasured catalytic amounts of p-TSA were used in all reactions. 
 
 
 
When only methanol in presumed anhydrous conditions (entry 1) was used, no 
reaction was observed even after resubjecting the reaction mixture to further heating. The 
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use of “catalytic” amount of water led to a very slow conversion to a mixture of aminal 
141 and an unidentified product X, with no traces of desired imidazolone 140 detected. 
With only water as solvent and an increased operating temperature (entry 3) partial 
conversion to the desired product was observed, with no discernible formation of aminal 
141 or any other undesired products. Reasoning that the partial conversion could be due 
to the poor solubility of the starting material in aqueous media we opted to use small 
amounts of methanol co-solvent (entry 4-10), and this, along with small adjustments in 
the reaction time and operating temperature led to markedly improved results. In a 1:3 
MeOH/H2O solvent system at 90 ºC for 40 consecutive minutes minimal reaction 
occurred, but after resubjecting the crude material to increased temperature (100 ºC) a 
modest yield of a ~3:1 mixture of desired imidazolone 140 to aminal 141 was formed. 
When a 1:5 (MeOH/H2O) mixture of solvents was used at 100 ºC for 20 minutes (entry 5) 
a 65% yield of desired product was isolated and no traces of aminal 141 and unreacted 
starting material could be detected. With promising conditions in hand we next attempted 
to double the reaction scale (entries 6-9) and eventually up to 70% conversion to the 
desired imidazolone with minimal formation of aminal by product could be obtained. 
Comparable results could be obtained on a much larger scale (entry 10) under 
conventional heating in an oil bath resulting in the generation of synthetically useful 
yields of desired product, albeit requiring a significantly longer reaction time.  
No other solvent system were investigated but in retrospect, it seems evident that 
the use of methanol in the presence of a dimethyl acetal was a poor strategic choice, and 
that other solvents (i.e. acetone, see Chapter VII) could have provided better results. 
It must be mentioned at this point that although TLC analysis and mass 
spectrometry data were indicative of a single product, the 1H NMR of imidazolone 140 
was not very pristine, even after several rounds of careful purification. We reasoned that 
partial tautomerism (140a/140b) in the imidazolone ring, driven by the formation of an 
aromatic hydroxyimidazole system (Figure 5.1) could account for the observed lack of 
definition. In addition, potential hindered rotation around the C11-C10 bond could give 
rise to rotamers (140c/140d), and the presence of multiple species in solution could also 
lead to a poorly resolved 1H NMR, however, variable temperature NMR experiments to 
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assess this possibility were not performed. The presence of an unidentified byproduct 
having a similar Rf value to the target product could also not be excluded a priori. 
 
 
 
 
 
 
 
 
Figure 5.1. Possible tautomers and/or rotamers of imidazolone 140 
 
. 
Interestingly, after treatment with tosyc anhydride, the 1H NMR spectrum of the 
resulting protected imidazolone 230 was very neat and well resolved. Therefore, after the 
first attempts to purify the precursor did not returned spectroscopically pristine product, 
the crude material was carried on to the protection step and purified afterwards.   
 
Scheme 5.2 
 
 
 
 
 
 
 
 
The selective tosylation of the imidazolone could be easily confirmed as the 
chemical shift of the two free nitrogen protons of 140 were significantly different and 
clearly identifiable in the 1H NMR spectrum. In addition, under the same reaction 
conditions urea cyclization precursor 139 remained unaltered, suggesting that the lactam 
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nitrogen was inert toward tosylation. On the other hand, treatment with Boc anhydride 
proceeded smoothly to deliver the corresponding carbamate protection on the lactam 
nitrogen.  
 
Scheme 5.3 
 
 
 
 
 
 
 
 
 
A further tosylation reaction however, provided puzzling results that potentially did 
not support the above assessment. When the crude material from the conventional heating 
reaction (table 1, entry 10) was subjected to the established reaction conditions in fact, a 
very slow conversion was observed, and although the expected tosylimidazolone was the 
major product isolated, significant amounts of another material were obtained as well. 
Based on 1H NMR data comparison with the desired product (partial spectra shown in 
Figure 5.2) this unexpected material was tentatively assigned as tosylamine 232, which 
could be generated by reaction of the tosylating reagent at the lactam nitrogen site, 
followed by intramolecular ring opening by the adjacent imidazolone free nitrogen. Full 
characterization of this compound was not achieved and assignment of the indicated 
structure remains purely speculative. 
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Figure 5.2. Spectral comparison of tosylimdazolone 230 and presumed tosylamine 232. 
 
 
 Treatment of tosyl imidazolone 230 with Boc anhydride cleanly delivered, as 
expected, good yields o the fully protected product 233. Remarkably, when imidazolone 
140, was treated with Boc anhydride the bis-carbamate resulting from reaction at both 
nitrogen sites was the only product isolated in modest yield (not shown). 
 
Scheme 5.4 
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5.2 Further Studies Along The Original Route Toward Axinellamine  
Imidazolone 140 featured the complete carbon framework of the core of 
axinellamine (3), and we anticipated that the projected intramolecular oxidative 
cyclization of the spirohydantoin “lactam” nitrogen would establish the C ring of the 
tetracyclic scaffold of the natural product (Scheme 5.5). In our initial approach we 
envisioned that under the reaction conditions required for the oxidation of the 
imidazolone unsaturation, the DMB protecting group could be cleaved triggering the 
desired intramolecular ring closure in situ.  Treatment of imidazolone 140 with freshly 
prepared dimethyldioxirane (DMDO), however, led to the slow formation of several 
products, the major of which was tentatively assigned as diol 235 by 1H NMR analysis 
after purification. The desired tetracycle 234 was not detected. 
 
 
Scheme 5.5 
 
 
 
 
 
 
 
 
In light of these first results it became apparent that it was necessary to identify 
conditions for the efficient removal of the DMB protecting group to increase the 
reactivity of the hydantoin nitrogen and to trigger the desired cyclization. Once again, we 
envisioned that under the acidic conditions required for the formation of the imidazolone, 
this cyclization might happen in situ, therefore we initiated our DMB cleavage 
investigations on the imidazolone precursor 139, using ceric ammonium nitrate (CAN).70 
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Table 5.2. Attempted DMB cleavage on urea 139. 
 
 
 
 
 
 
Entry Scale Solvents CANa Temp/Time Outcome 
1 2.4 mg MeCN/H2O (3:1) 3 equiv. 23 0C/1 h Mixb + 199 
2 1 mg MeCN/H2O (4:1) 1.9 equiv. 23 0C/24 h Mix b + 199 
3 1 mg MeCN/pH 7 buffer (4:1) 1.9 equiv. 23 0C/24 h Mix b + 199 
4 2 mg MeCN/H2O (9:1) 2 equiv. 0 0C/1.5 h Mix b + 199 
a = the reagent was added as a solution in the indicated solvent mixture; b = multiple products were 
detected’ separation was not attempted  
 
 
 
In all cases (see Table 5.2), analysis of the crude 1H NMR revealed discernible 
signals ascribable to dimethoxy benzaldehyde 199, which is consistent with the expected 
oxidative cleavage of the DMB group, on the other hand however very sluggish outcomes 
were obtained in all cases. Multiple products appeared to have formed, and given the 
small scale of these reactions, separation and characterization was not attempted. Equally 
inconclusive results, with sluggish reactions were obtained under the same conditions 
with imidazolone 140 and tosylimidazolone 230 (not shown) and resolution of the 
complex mixtures of products was not attempted. 
With fully protected imidazolone 233 in hand I attempted to expand on the 
preliminary results obtained by Dr. Dransfield aimed at inverting the stereochemistry at 
C12 via equilibration of the aldehyde tautomer of the carbinolamine obtained by selective 
reduction of the Boc lactam. This carbinolamine proved not to be extremely stable and 
significant loss of material occurred by decomposition. Furthermore, as already discussed 
in Chapter II, these investigations returned no positive results, and the original route was 
abandoned, and a new strategy featuring an early C12 epimerization (discussed in 
Chapter III) was developed and implemented.  
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5.3 New Early C12 Epimerization Approach to Axinellamine 
With the structure of amino alcohol 177 still not unambiguously assigned (see 
Chapter III), we carried on assuming that the C12 configuration had been inverted, and 
we refocused our efforts toward the construction of the imidazolone precursor to the D 
ring of the axinellamines. Unequivocal confirmation of the reversal of configuration at 
C12 was achieved during the course of these preliminary advanced investigations and a 
detailed account is described in Chapter III. In our initial approach to this endeavor we 
reasoned that proceeding through the cyclization of a pendant urea onto an exposed or 
masked aldehyde (i.e. a dimethyl acetal) would be the best course of action, as most of 
the chemistry involved had already been studied and optimized (Scheme 5.6).    
 
Scheme 5.6 
 
 
 
 
 
 
 
 
 
 
Initial attempts to oxidize the free primary alcohol of methyl ester 177 using Dess 
Martin periodinane (DMP) as before (see Chapter II) were rather sluggish but provided 
nonetheless small amounts of desired aldehyde 211 that could be utilized crude in the 
following steps. Thus treatment with trimethyl orthoformate in methanol under acid 
catalysis, as anticipated generated modest yields of dimethyl acetal 178. 
In a first attempt to access the target imidazolone annulation we treated crude 
aldehyde 211 with previously generated tosylethyl isocyanate 238, following a 
methodology recently reported by Trost71. Unfortunately, with our substrate the reaction 
proved to be extremely untidy, and no significant products were isolated.    
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Scheme 5.7 
 
 
 
 
 
 
 
In a second run, starting material and Tse(CO)N3 were heated together in PhH at 
80ºC. Formation of TseNCO 238 was observed by TLC, but the aldehyde seemed not to 
react. After cooling to room temperature Cs2CO3 was added resulting in the formation of 
new products. The major product isolated did not show any aldehyde or methyl ester 
signals, but could not be unambiguously assigned. In a third run TseNCO 238 (freshly 
prepared) was added over 30 min to a solution of starting material and Cs2CO3 at 0ºC 
then the mixture was allowed to reach room temperature and stirred for ~15h. After 
column purification a mixture (~1:1) of products was isolated which promisingly showed 
extra tosyl signals and no aldehydes. Attempts to isolate and characterize the potential 
products however met with no success. 
Reasoning that the sluggish reaction obtained thus far could be due to the low 
purity of the aldehyde obtained by DMP oxidation we decided to explore alternative 
protocols in order to improve the yield and the quality of this key intermediate. 
Disappointingly however, under a variety of conditions (SO3•Py in DMSO/CH2Cl2, 
pyridinium chlorochromate in CH2Cl2, and stoichiometric tetrapropylammonium 
perruthenate in CH2Cl2) no improvement could be obtained. In the end use of DMP for 
prolonged reaction times (up to 48 h) provided the best results and the crude material 
could be taken on to the acetal formation delivering satisfactory yields (up to 75% for the 
two steps) of desired product. With sizeable amounts of dimethyl acetal 178 in hand we 
then tried to introduce a pendant urea by reaction of the sulfonamide with Tse isocyanate 
238. As before, addition of freshly prepared reagent to the reaction mixture and 
prolonged heating (12 hours) only led to partial recovery of the starting material with no 
desired product formed. When the isocyanate was generated in situ however (by heating a 
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mixture of starting material and tosylethyl acyl azide in a sealed tube) partial conversion 
to a mixture of two products was observed.  The two products refused to be separated by 
column chromatography (one spot by TLC) and based on analysis of the 1H NMR of the 
purified mixture they appeared to be a pair of diastereomers, which however could not be 
confirmed as the desired urea 239.      
 
Scheme 5.8 
 
 
 
 
 
 
 
 
A stepwise approach involving the generation of a carbamoyl chloride intermediate 
240, which would then further react with a nitrogen source to deliver the target urea 
resulted in an intractable mixture, and no significant products could be discerned. Tse 
amine was chosen as the nucleophile to facilitate the characterization of new products by 
spectroscopic comparison with similar substrates previously obtained. Attempts to isolate 
the potentially stable carbamoyl chloride intermediate (see Chapter IV) also met with no 
success.   
Scheme 5.9 
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We reasoned at this point that the decreased nucleophilicity of the sulfonamide was 
hindering the interaction with the electrophile, and we also considered that the methyl 
ester functionality might be somehow interfering, offering a potential alternative 
manifold of reaction leading to unidentified products. As this functionality required to be 
removed anyway to allow for installation of the pyrrole carboxamide side chain of the 
natural product, this task took priority in our investigation. We envisioned that reduction 
to the corresponding primary alcohol and protection as the same silyl ether (TBDPS) as 
the C18 chain would be the most convenient course of action as it would eventually allow 
for efficient, simultaneous manipulation of both side chains. 
Initial attempts to effect the reduction using DIBAL, were rather sluggish, with 
minimal reaction observed at the standard operating temperature, and with undesired side 
reaction occurring at higher temperatures, leading to poor isolated yield of not very 
pristine target alcohol after purification. The semi pure material could however taken on 
to the protection step generating modest yields of bis-silyl ether 197. It was soon 
discovered however (as already discussed in Chapter IV, although this was 
chronologically the first instance) that treatment of the starting material with DIBAL at 
low temperature for a shorter time, followed by brief exposure of the crude mixture to 
methanolic sodium borohydride at 0 ºC, provided the desired primary alcohol in 
sufficient purity to be advanced to the next step, without the need for further purification. 
Etherification under the condition discussed above then, afforded synthetically useful 
amounts of the target bis-silyl ether in greatly improved yields (up to 65% for the three 
steps).   
 
Scheme 5.10 
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We were also pleased to find that under the CAN conditions described above 
cleavage of the DMB protecting group was cleanly affected on this advanced 
intermediate, albeit seemingly requiring a significantly longer reaction time (~ 40 hours).  
 
Scheme 5.11 
 
 
 
 
 
 
 
This result was significant in that it demonstrated that although the developed 
conditions were suitable for the removal of the key DMB protection, this transformation 
was however rather capricious and apparently highly substrate-dependent.  
With perceived significant progress made on several fronts, we returned to the still 
unresolved issue of the construction of the imidazolone ring required for the pivotal intra 
molecular cyclization projected to deliver the tetracyclic core of the axinellamines (3). As 
our initial investigations aimed at emulating the successes obtained in previous endeavors 
had returned discouraging results (vide supra) we sought alternative approaches.  
 
Scheme 5.12 
 
 
 
 
 
 
 
We reasoned that if using the sulfonamide to append the required urea was in fact 
problematic (A Scheme 5.12), a plausible alternative course of action would be to reverse 
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the order of events, introducing a carboxamide electrophile on the alcohol terminus and 
force the poorly nucleophilic sulfonamide to cyclize onto it, in a stepwise or potentially 
concerted fashion (B Scheme 5.12).  
Thus, treatment of aldehyde 211 with TseNH2 72 led to complete conversion to a 
new product (which was assumed to be the desired imine 244) in 2 hours at 0ºC. Once 
again Tse amine was chosen for the ease of comparison with previously obtained similar 
compounds. The crude product was azeotroped and treated with triphosgene at ambient 
temperature with overnight stirring. After purification the 1H NMR spectrum was 
consistent with the desired product 185 (appearance of vinyl imidazolone proton signal at 
δ = 6.70 ppm; consistent with previous observations) and the 13C NMR spectrum showed 
a new signal at δ ~ 151 ppm, ascribable to a urea carbonyl. Mass spectrometric analysis 
also seemed to confirm formation of the target product (observed M+Na; M+K values 
matched the calculated mass). Soon afterwards the reaction was repeated on a slightly 
larger scale (~40 mg of crude aldehyde) leading to a ~30% isolated yield (two steps) of 
the desired product. It is noteworthy that starting from the aminoalcohol precursor of 
aldehyde 211 the desired imidazolone 185 product can be obtained in three steps 
requiring only one purification. 
 
Scheme 5.13 
 
 
 
 
 
 
 
Two facts must be highlighted at this point. Firstly, this new approach to the 
construction of the key imidazolone significantly shortened the synthetic route, as 
compared to the original strategy (vide supra). Starting from spirotricyclic intermediate 
132 (Chapter III), in fact, nine steps and seven column chromatography purifications 
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were necessary to arrive at tosylimidazolone 230. With the newly developed approach on 
the other hand, only four transformation and two column chromatography purifications 
were required to access imidazolone 185 from the same starting point. In addition 
imidazolone 185 featured the correct configuration at C12, matching the relative 
stereochemistry of the target natural product, an issue that had proved problematic to 
address with tosylimidazolone 230 (see Chapter II).   
 
Scheme 5.14 
 
 
 
 
 
 
  
Secondly, it must be underlined that although this new approach appears in other 
documents,62 which preceded the present manuscript in publication, it was therein not 
properly credited. The original work is described in Scheme 5.13 and additional studies 
and optimizations will be further expanded upon below.  
After this first exhilarating breakthrough we encountered unforeseen difficulties in 
obtaining reproducible results. After meticulous investigation it was discovered that the 
lack of consistency could be ascribed to the solvent source, which puzzlingly however 
seemed to have no discernible deleterious effects on most other reactions. A detailed 
account of these investigations serves no purpose in this context, and it will suffice to say 
that as a result we opted to use tetrahydrofuran as solvent in place of dichloromethane. 
With this change, consistently better and reproducible result could be obtained leading to 
the isolation of up to 57% yield of the desired imidazolone after overnight reaction at 
ambient temperature. Initial attempts to increase the operating temperature (to 50 ºC) 
seemed to have no effect (by TLC analysis) on the outcome, however it was later found 
that the reaction time could be greatly reduced (to just a few hours) and the yields seemed 
to be consistently better (vide infra) when the transformation was run at 60 ºC. It seems 
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reasonable to envision that the reaction could proceed through the formation of a bis-
enamine intermediate 245 generated after deprotonation at C10. The acidity of this site 
could be enhanced by initial non-bonded interaction of the imine nitrogen with a 
phosgene equivalent. The termini of the bis-enamine could be in a syn arrangement with 
respect to the double bond thereby placing the electrophilic carbamoyl chloride in close 
proximity to the sulfonamide leading to ring closure. If, on the other hand the termini are 
in an anti arrangement, constructive interaction of the sulfonamide with the presumed 
carbamoyl chloride cannot occur, and this fleeting intermediate could be hydrolyzed upon 
work-up leading to a decrease yield. Alternatively, equilibration of the two geometric 
isomers could result in increased productive interactions, boosting the formation of the 
desired product. It is easy to see in this scenario how increased operating temperatures 
would facilitate this equilibration, reducing the reaction time and ultimately increasing 
the yield. 
 
Scheme 5.15 
 
 
 
 
 
 
  
 
 
Use of a different carbonyl source, namely carbonyl diimidazole (CDI), led only to 
partial recovery of the starting material, even after prolonged reaction time (15 hours) at 
65 ºC. An attempt to condense imine formation and imidazolone cyclization in a “one-
pot” transformation resulted in an extremely sluggish reaction with no significant product 
isolated or starting material recovered.  
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Eventually, through refinement of the reaction conditions the three-step synthesis of 
imidazolone 185 from amino alcohol 177 could be run on a 100 mg scale consistently 
obtaining synthetically useful yields (up to 50 % for the three steps) of desired product. 
 
Scheme 5.16 
 
 
 
 
 
 
 
The first two reactions appear to be quantitative, as both crude 1H NMR are pristine 
and are tainted only by residual reagents that seem however, not to interfere with the 
following transformations. For the reasons presented above I believe that the cause for 
the decrease in the overall efficiency of the sequence lies solely in the third step, but with 
sizeable amounts of imidazolone 185 consistently generated in good purity, and in the 
interest of moving the project forward, further optimization was not pursued.      
 
5.4 Further Improvement: Synthesis of an Azide Imidazolone  
More recently, in light of the structural revision of palau’amine we realized that our 
original unified approach to the synthesis of selected PIA’s could be modified to delay 
the point of divergence to a much later common intermediate in the synthetic route 
(discussed below). We reasoned also that the early introduction of a nitrogen “handle” on 
the C18 side chain would improve the overall efficiency, decreasing the number of steps, 
and minimizing deceivingly trivial, but potentially costly manipulations on advanced 
precious intermediates. It was decided that introduction of an azide at C19 would provide 
a convenient masked amine functionality that could be easily liberated (for palau’amine 
(2)), and acylated (for axinellamine (3) and konbu’acidin (5)) in the later stages of the 
synthesis. 
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Thanks to the excellent work by Dr. Yonggang Wang, my collaborator on the 
project, the desired modification was promptly achieved. It must be made clear that 
although I have personally performed all the reactions described below (Scheme 5.17), 
credit for the adjustment of the original reaction conditions to suit our new needs and 
optimization of the related experimental procedures goes entirely to Dr. Wang. 
 
Scheme 5.17 
 
 
 
 
 
 
 
   
 
 
Thus, treatment of Diels Alder adduct 121 with freshly prepared hydrazoic acid 
under typical Mitsunobu conditions led to only partial conversion to the desired product 
with large amounts of unreacted starting material recovered after a long and tedious 
purification process. Alternatively, two-step activation of the free alcohol as the 
corresponding tosylate followed by displacement with sodium azide generated the target 
material in good yields, in gram-scale reactions. Azide 246 was then exposed to freshly 
prepared DMDO as before, and the crude intermediate stable allylic alcohol (see Chapter 
II) was treated with N-chlorosuccinimide in the presence of propylene oxide and 
cyclohexene generating modest yields of the desired chlorinated spirohydantoin 247. Use 
of chloramine-T, as previously reported, led in this instance to sluggish reactions and 
lowered yields. In addition, due to the problematic preparation of large amounts of 
DMDO, this two-step sequence was only suitable for relatively small (in these early 
stages of the synthesis) reaction scales (only few hundred milligrams). In order to 
streamline the synthesis we sought alternative oxidation protocols, and Dr, Wang found 
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that the use of readily available oxaziridnium reagent 248 (inset in Scheme 5.17) allowed 
to process up to six grams of azide 246 at a time, providing comparable yields of 
spirotricycle 247 in synthetically useful amounts.  
The silyl protection cleavage and subsequent lactam opening with concomitant 
reversal of configuration at C12 under the established conditions proceeded smoothly, 
consistently providing excellent yields of methyl ester 250.  
 
Scheme 5.18 
 
 
 
 
 
 
 
First attempts to construct the imidazolone substructure from amino alcohol 250 
under the conditions previously identified (vide supra) seemed not to present any 
problems and the desired product 251 (Scheme 5.19) could be isolated in modest yields, 
that were however comparable with previous results. 
 
Scheme 5.19 
 
 
 
 
 
 
 
Further confirmation of the structural assignment of the newly generated product 
was obtained by manipulation of the C18 side chain of imidazolone 185. Cleavage of the 
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TBDPS silyl ether, followed by activation of the free alcohol and displacement with 
sodium azide under standard conditions returned a material that was spectroscopically 
identical to the compound obtained via the three-step imidazolone annulation protocol.    
Further runs of the cyclization sequence however, led to the isolation of significant 
amounts of over-oxidized enone 252 (Scheme 5.20) along with the desired product, with 
extreme cases in which 252 was the only material generated. 
 
Scheme 5.20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dr. Wang proposed that residual Dess Martin reagent and/or related byproducts 
present (254 Scheme 5.20) in the crude aldehyde material could interact with the 
intermediate presumed imine 235a leading to oxidation of the sulfonamide. Abstraction 
of the proton α to the methyl ester II (much more accessible in this species than in the 
highly congested TBDPS analog) would generate an extended enolate III. Reprotonation 
and tautomerization would then regenerate the amino-imine 235b, which would proceed 
to ring closure with triphosgene as before. Dr. Wang postulated that removal of the DMP 
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byproducts prior to imine formation, which would in turn be run under buffered 
conditions, could reduce the potential for this undesired reaction manifold. Thus, washing 
the crude aldehyde material with a saturated solution of sodium thiosulfate (Na2S2O3), 
followed by imine formation in the presence of potassium phosphate monobasic 
(KH2PO4) provided a material that upon treatment with triphosgene, under unmodified 
conditions, led to the consistent isolation of markedly improved yields (up to 60% for the 
three steps on a 200 mg scale) of the desired imidazolone 251 with no discernible 
detection of the over-oxidized enone. 
 
Scheme 5.21 
 
 
 
 
 
 
 
Two attempts to generate a semi-protected imdazolone 256 reacting aldehyde 255 
with either potassium isocyanate or urethane 257 at high temperatures led to extremely 
sluggish reactions with no significant products detected. 
 
Scheme 5.22 
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5.5 Synthesis of an Amino-Imidazole D Ring Analog 
As already discussed (Chapter II) in our original strategy we had projected delaying 
the introduction of the amino-imidazole moieties to the final stages of the synthesis 
envisioning a simultaneous transformation of the northern urea and the southern 
hydantoin. During the course of the investigations described above we realized that an 
installation of the northern aminoimidazole could prove beneficial for the advanced 
stages of the synthesis, as it would more closely mimic the species involved in the 
presumed biogenetic key oxidative cyclizations. We anticipated that the established 
imidazolone cyclization protocol (vide supra) could readily be modified with the use of a 
nitrogen-containing “phosgene analog” which would, upon interaction with the reported 
amino-imine, deliver the desired cyclic guanidine.  
One such phosgene analog could be easily prepared from commercially available 
bis-methylthio methylenetosylsulfonamide 258, by heating with sulfuryl chloride in a 
chloroform solution. Interestingly, after brief reaction at room temperature the mono-
chloride species 259 was readily obtained but prolonged heating was required for 
displacement of the second thiomethyl group.   
 
 
Scheme 5.23 
 
 
 
 
 
 
Before experimenting on the real system imine dichloride 260 was tested on 
propane diamine 261, and after a few hours complete loss of starting material was 
observed. Although spectroscopic data of the purified product were unclear and 
inconclusive, mass spectrometric analysis seemed to suggest formation of the indicated 
cyclic guanidine 262.  
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Scheme 5.24 
  
 
 
 
 
 
Pleasingly, the first attempts to use imine dichloride 260 in lieu of triphosgene in 
our established cyclization protocol delivered modest yields (up to 37% for the three 
steps) of the target per-tosylated cyclic guanidine 263. 
 
Scheme 5.25 
 
 
 
 
 
 
 
Use of toluene as solvent led to minimal reaction after several hours at 80 ºC, and 
resubjecting the crude material using Hünig’s base in place of triethylamine seemed not 
to result in any significant improvements. When the reaction was run in acetonitrile in the 
presence of Hünig’s base better yields of semi-pure (the material did not appear pristine 
by NMR analysis even after multiple rounds of purification) desired product could be 
isolated after prolonged time at ambient temperature, requiring however multiple 
resubjections of the crude mixture to the reaction conditions. Increasing the temperature 
in these instances seemed to have no effect on the rate of conversion.  
Having accumulated enough material for further studies we began to investigate the 
cleavage of selected protecting groups in order to arrive at a suitable substrate to explore 
the key oxidative cyclization to the tetracyclic core of axinellamine (3).  
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It was encouraging to find that under the established conditions, oxidative cleavage 
of the DMB protection proceeded relatively well.  
 
Scheme 5.26 
 
 
 
 
 
 
 
Treatment of the advanced per-tosylated guanidine 263 with 5 equivalents of at 
CAN at 0 ºC in fact, gave a fast, and for the most part, clean conversion to a new product 
which was consistent by mass with the desired de-benzylated target 264. D2O wash 
revealed the presence of an exchangeable proton at δ = 6.57 ppm (consistent with the 
lactam nitrogen proton), and a signal ascribable to the vinyl proton of the cyclic 
guanidine (δ = 6.6 ppm) was also present. 
Initial attempts to test the reactivity of the double bond of the cyclic guanidine 263 
seemed to suggest that the presence of the tosyl group rendered this functionality, 
virtually inert. Attempted oxidations under NCS or m-CPBA activation, did not lead to 
any significant reaction (by crude 1H NMR analysis), and given the small scale of these 
studies, recovery of the starting material was not attempted. 
 
Scheme 5.27 
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To increase the reactivity of the cyclic guanidine toward oxidation we attempted 
the removal of all the sulfone protecting groups using freshly prepared sodium 
naphthalenide. Given the small scale of the reaction, the greatly reduced molecular 
weight of the potential product and its unknown polarity, these endeavors were mostly 
inconclusive.  
Scheme 5.28 
 
 
 
 
 
 
 
Selective removal of one tosyl group could be achieved using commercially 
available samarium diiodide in THF solution. It is reasonable to assume that the tosyl 
group was removed from the imidazole ring nitrogen as this would lead, trough 
tautomerization, to the establishment of an aromatic protected amino-imidazole 267b. 
 
Scheme 5.29 
 
 
 
 
 
 
 
 
Treatment of the newly generated product with NCS in MeOH under the same 
conditions described in Scheme 5.27 resulted in the formation of a new product (as 
confirmed by the disappearance of the very diagnostic vinyl proton signal), which 
however could not be unequivocally assigned. This result was however significant in that 
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our reasoning that removal of the tosyl group from the amino-imidazole would render the 
desired double bond more prone to oxidation appeared to have been correct. Further 
confirmation of our reasoning came from the attempted oxidation of the desired double 
bond in the DMB-deprotected, fully tosylated analogue 264 no reaction was observed by 
TLC analysis, and only starting material was recovered. When this same intermediate 
however was exposed to excess amounts (~ 20 equiv.) of samarium diiodide, complete 
conversion to a new product containing only three tosyl groups was observed.  
 
Scheme 5.30 
 
 
 
 
 
 
 
 
The mass was consistent with the expected amino-imidazole 268a but the absence 
in the 1H NMR spectrum of the very diagnostic signals for the vinyl proton and the 
hydantoin lactam proton suggested formation of the tetracyclic structure 268b, deriving 
from intramolecular cyclization. Unfortunately, only a sub-milligram amount of 268b 
could be isolated so unambiguous confirmation of its structure as well as assignment of 
the relative stereochemistry at C10 and C6 was not possible. 
These encouraging results provided the impetus to continue our investigations, 
disappointingly however, further attempts to generate more per-tosylated cyclic 
guanidine 263 to expand on these initial promising findings proved to be fruitless. Even 
utilizing conditions that had previously been successful in providing modest amounts of 
desired product, only sluggish reactions with inconsistent and irreproducible results and 
no recovery of starting material were obtained. 
Alternative approaches to the construction of related aminoimidazole surrogates 
were equally dismal. Attempted reaction of aldehyde 211 with imido chloride 269 
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prepared from isothiourea 270 (readily available in turn, from commercially available 
bis-methylthio methylenetosylsulfonamide 250) was extremely sluggish and no 
significant products or starting material could be detected in the crude 1H NMR. It must 
be clarified that, although isothiourea 270 could easily be confirmed by NMR and mass 
data, assignment of 269 could not be unequivocally secured. In a separate experiment, 
use of isothiourea 270 directly on aldehyde 211, led to the recovery of the starting 
material.    
 
Scheme 5.31 
 
 
 
 
  
 
 
 
 
A few attempts to use commercially available cyanamide on aldehyde 211 or 
dimethyl acetal 197 to directly introduce the amino-imidazole ring, resulted in partial 
recovery of the starting materials even after heating up to 70 ºC. Reasoning, as before that 
the presence of the tosyl group was significantly decreasing the nucleophilicity of the 
amine we tried to identify conditions to remove the sulfone protecting group. Several 
trials in this direction using a variety of conditions were unsuccessful, but utilizing a two-
step protocol developed in our group by Dr. Ziad Moussa73 appeared to provide 
promising results. Thus treatment of aldehyde 211 with trifluoroacetic anhydride, 
followed by exposure of the crude material to samarium diiodide returned a product that 
was consistent by preliminary NMR observations with the desired trifluoroacetamide 
273. Upon further detailed 1 and 2D NMR analysis however (and confirmation by mass 
spectrometry data), the product was identified as des-amino aldehyde 274.   
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Scheme 5.32 
 
 
 
 
 
 
 
In a final attempt to make use of this unexpected substrate and garner further 
insight into the reactivity of these systems we envisioned that introduction of a halogen to 
the open α position of the aldehyde would provide yet another viable starting material for 
a one-step amino-imidazole synthesis. A brief survey of the literature in fact, showed that 
α-halo carbonyl compounds readily react with acetylguanidines to deliver the 
corresponding cyclic guanidines (Scheme 5.33). α-bromination of aldehydes is also 
widely reported. In our specific instance however, treatment of aldehyde 211 with 
bromine under common conditions74 led only to the generation of a modest yield of 
aldehyde 275 clearly deriving from electrophilic aromatic substitution on the highly 
electron-rich DMB ring. Substitution at the 6 position of the aromatic ring was confirmed 
by appearance in the 1H NMR spectrum of two singlets at δ = 6.92 ppm and δ = 7.01 
ppm, in place of the typical DMB pattern (d-dd-d).  
 
Scheme 5.33 
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Although certainly disappointing, though in hindsight not entirely unexpected, this 
result may seem, it is important to note here that it exposed avenues of reactivity that we 
had not previously considered and it also set a precedent that quickly provided great 
insight into the outcomes of later investigations.   
In light of these results, further investigations toward the direct construction of the 
northern amino-imidazole ring were not pursued, and our efforts were refocused on the 
original approach involving a late-stage bis-guanidinylation.    
 
5.6 Conclusions 
Efficient methodologies for the construction of an imidazolone precursor to the D 
ring of the axinellamines featuring the correct C12 configuration were developed and 
later optimized in collaboration with Dr. Yonggang Wang. The new approach (4 steps) 
significantly shortened the existing synthetic route (9 steps), also requiring far less 
purification of the intermediates.  Preliminary investigations toward the direct synthesis 
of the northern amino imidazole ring of the target natural product returned promising, 
albeit inconsistent results. Further exploration of these reactivity avenues I believe is 
warranted.  
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CHAPTER VI 
 
BIOINSPIRED STRATEGIES TOWARD AXINELLAMINE, KONBU’ACIDIN 
AND PALAU’AMINE  
 
6.1 Initial Studies Toward Axinellamine 
After the first successful, though yet unoptimized syntheses of the imidazolone 
precursor to the D ring of the axinellamines, in order to move the project forward we 
endeavored to investigate the key cyclization that would deliver the tetracyclic core of the 
target natural product. As before (see Scheme 5.6 and related text), we projected that 
reduction of the ester moiety and protection of the resulting primary alcohol as the same 
silyl ether as the one already present at C19 would provide a convenient way to 
simultaneously manipulate both side chains in the late stages of the synthesis, once the 
core had been established. 
 
Scheme 6.1 
 
 
 
 
 
 
 
 
 
 
 
 
We were pleased to find that treatment of methyl ester 185 with DIBAL under 
standard reaction conditions quickly and cleanly generated the desired primary alcohol 
281 with no intermediate aldehyde 282 observed. It appeared that our previous 
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assessment (Scheme 5.9 and related text) that the proximity of a Lewis basic site (namely 
a sulfonamide), would hinder the reactivity of the aluminum reagent was correct.   
 
Scheme 6.2 
 
 
 
 
 
 
 
When crude alcohol 281 was exposed to TBDPS chloride however, no reaction was 
observed by TLC analysis even after prolonged reaction time (19 hours) and indeed after 
column chromatography purification, unaltered starting material was recovered almost 
entirely. Considering that perhaps unknown impurities in the crude starting material had 
compromised the reactivity of the reagents, the procedure was repeated on the recovered 
purified material only to arrive at the same outcome.  
As this reaction had worked before on dimethyl acetal 178 (Scheme 5.10), we 
reasoned that in imidazolone 281 the C13 alcohol might lie in a rather congested region 
of space and we postulated that a smaller protecting group might be required. Indeed, 
when the smaller, and more reactive triisopropyl silyl triflate was used etherification of 
the free alcohol occurred readily. The protection step could eventually be run on the 
crude alcohol, generating modest yields of the desired product (54 % for the two steps).  
 
Scheme 6.3 
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With small amounts of bis-silylether 283 in hand we proceeded to try and find 
suitable conditions to cleave the DMB protecting group in order to liberate the 
spirohydantoin “lactam” nitrogen for the projected intra molecular cyclization that would 
deliver the core of axinellamine. Several runs using ceric ammonium nitrate (CAN) did 
not provide any reaction at ambient temperature even after prolonged time (up to 40 
hours). Increasing the operating temperature seemed to result in minimal reaction, as 
traces of the diagnostic signals of the aldehyde byproduct (199 see Chapter IV) began to 
appear in the crude 1H NMR, however no significant products could be isolated after 
column chromatography. It is important to note that these studies were performed early 
on, and the optimized conditions described in Chapter IV had not been identified yet.    
 
Scheme 6.4 
 
 
 
 
 
 
An interesting result was however obtained, albeit entirely serendipitously, in the 
course of these investigations when methyl ester 185 was subjected to the tested reaction 
conditions.  
 
Scheme 6.5 
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Treatment of the DMB-protected imidazolone 185 with CAN (5 equiv.) for 1 hour 
at 0 ºC in fact, led to the isolation of a stable (purified by column) intermediate which 
still contained a “DMB” moiety. This unidentified intermediate was unintentionally left 
in CDCl3 solution and very slowly (followed by 1H NMR) released DMBCHO and was 
completely and cleanly converted to a new product. After re-purification of the mixture 
the isolated product was consistent by 1H and 2D NMR as well as MS data with either 
bis-hydantoin 285a or tetracycle 285b. A 2D heteronuclear NMR investigation (HMBC) 
was not conclusive due to the minute amount of material, however 13C NMR revealed the 
appearance of a new signal at δ = 170 ppm, which is consistent with a lactam carbonyl. 
This appeared to indicate that the correct structure was bis-hydantoin 285a and several 
literature precedents confirmed that similar oxidations are not uncommon. 
Concomitant early attempts to test the reactivity of the imidazolone double bond 
toward oxidation provided sluggish reactions and inconclusive results, and our focus 
shifted to the direct synthesis of an amino-imidazole precursor to the D ring of 
axinellamine (see Chapter V). 
 
Scheme 6.6 
 
 
 
 
 
 
 
 
6.2 First Generation Synthesis of a Mono-Pyrrole Precursor to Palau’amine 
As our studies toward the synthesis of axinellamine (3) (see Chapter V and 6.1 
above) were well underway, the structural revision of palau’amine (2) appeared,3 
unifying these two natural products from a relative stereochemistry standpoint. We 
realized that the chlorocyclopentane core of our newly synthesized imidazolone 185 
possessed all the correct stereochemical relationships found in both alkaloids and we 
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envisioned that introduction of a pyrrole carboxamide functionality on the C12 side chain 
(Scheme 6.7) would readily give us an opportunity to investigate a presumed biomimetic 
bis-cyclization2 eading to the hexacyclic core of palau’amine. We projected that trivial 
manipulations, namely reduction of the ester moiety, introduction of an azide on the 
resulting primary alcohol followed by reduction and acylation of the corresponding 
primary amine would quickly deliver the required cyclization precursor 287. 
 
Scheme 6.7 
  
 
 
 
 
. 
 
Initial attempts to introduce the azide directly on the free primary alcohol under 
Mitsunobu conditions met with no success, whereas the typical two-step protocol 
involving activation with tosyl chloride followed by displacement with sodium azide 
consistently provided good yields of the desired product 290. Eventually the tosylation 
reaction could be run on the crude alcohol obtained after DIBAL reduction improving the 
overall efficiency of the sequence. 
 
Scheme 6.8 
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At this point following precedents set by Dr. Shaohui Wang in his pioneering 
studies62 on this project we attempted to effect a simultaneous azide reduction and tosyl 
deprotection using samarium diiodide. The removal of the tosyl group from the 
imidazolone under these conditions, though expected was at the onset deemed 
inconsequential, however later findings (discussed in Chapter V) demonstrated that this 
was in fact necessary to activate the imidazolone toward oxidation. It is noteworthy that 
contrary to what reported by Dr. Wang, in my hands this manipulation proved to be 
surprisingly problematic, and in most instances, treatment of azide 290 with either 
commercially available, or freshly prepared samarium diiodide led only to cleavage of 
the sulfone leaving the azide unaltered.  
 
Scheme 6.9 
 
 
 
 
 
 
 
Resubjecting the crude or purified detosylated azide 291 to the reaction conditions 
even using large excesses (up to 15 equivalents) of reagent at ambient temperature for 
prolonged time only led to recovery of the starting material. Similarly, treatment with 
phosphines in a THF/H2O solvent mixture for up to 17 hours only returned unaltered 
azide 291. Under the latter conditions tosylated azide 290 underwent a very sluggish 
reaction and 1H NMR analysis of the crude material revealed formation of several 
products. Mass spectrometry data showed peaks consistent with the desired amine 293 
(M+H, M+Na and M+K), with phosphinamine 294 along with others that could not be 
reconciled with any plausible products.   
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Scheme 6.10 
 
 
 
 
 
 
 
When triphenylphospine was used instead only partial conversion was observed at 
room temperature after overnight stirring. This appeared to be an indication that perhaps 
the target azide in 290 was significantly hindered. Heating to 50ºC for a few hours led to 
nearly complete conversion, but the isolated product in this case was different than before 
and could not be unequivocally assigned. Use of the less sterically demanding 
triethylphosphine, which had provided excellent results on simple azides (not shown) 
either trying to arrive at the free amine or to the target pyrrole, led to the isolation of a 
product that was consistent (confirmed by mass) with phosphine-imine 296.  
 
 
Scheme 6.11 
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Apparently after formation of this intermediate hydrolysis to the amine did not 
occur, and consequently the desired acylation did not take place. Several literature 
precedents confirmed that trialkyl phosphinimine (even primary ones) can indeed be 
quite stable and resistant to hydrolysis. Attempts to hydrolize phosphinimine 296 by 
prolonged exposure to water with heating, and under basic (Cs2CO3) or acidic conditions 
(2M HCl) were fruitless. 
Alternative reduction protocols, such as hydrogenation in the presence of a 
palladium catalyst resulted in extremely sluggish reactions with no significant products 
being detected. At this point it was decided to explore different approaches to install the 
amine functionality at C13 that did not require the intermediacy of an azide. We 
envisioned that displacement of the tosylate precursor by ammonia (or an analog thereof) 
could be a suitable strategy, which would also remove one step from the overall 
sequence. Although this procedure finds ample precedent in the literature, in our case 
stirring a solution of 289 in MeOH saturated with gaseous ammonia in a sealed vial for 
15 h resulted in the complete conversion to de-tosylated imidazolone 297b (confirmed by 
mass).  
 
Scheme 6.12 
 
 
 
 
 
 
 
 
Resubjecting this crude material to the reaction conditions but increasing the 
temperature to 70ºC resulted in the cleavage of the S-O bond of the tosylate generating 
alcohol 297c with only traces of the desired amine 297a detected by mass spectrometric 
analysis. When the reaction was run in THF under the same conditions75 no reaction was 
detected even after prolonged reaction time. 
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Having gathered evidence that seemed to indicate that the C13 position of our 
substrate was unexpectedly but significantly hindered, we reasoned that removal of the 
bulky TBDPS protecting group from the C19 alcohol could in principle decongest the 
space around the desired reacting site allowing for easier approach of potential 
nucleophiles. In a first run, treatment of azide 290 with excess TBAF led to the complete 
cleavage of the imidazolone Tse group. This outcome was rationalized considering that 
the mild acidity of the sulfone α protons (see Chapter III) could be in this setting greatly 
enhanced by conjugation through the imidazolone unsaturation with the electron-
withdrawing tosyl moiety.  
 
 
Scheme 6.13 
 
 
 
 
 
 
 
 
In addition, the formation upon removal of the Tse group, of an aromatic hydroxy 
imidazole tautomer (see Scheme 5.29) could provide a significant driving force for this 
reaction manifold. The use of buffered conditions seemed to be an appropriate course of 
action at this juncture, and indeed addition of quantitative amounts of acetic acid to the 
reaction mixture (Scheme 6.13) completely reversed the chemoselectivity leading to the 
isolation of the desired desilylated alcohol 299 in up to 72% yield.   
With free alcohol 299 in hand we were pleased to confirm that our assessment (vide 
supra) was correct. Without the hindrance of the TBDPS group the azide reduction 
proceeded efficiently using phosphines, and after some experimentation the crude amine 
could directly be acylated with commercially available trichloroacetylpyrrole generating 
modest yields (~ 40 % for the 2 steps) of cyclization precursor 300.   
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Scheme 6.14 
 
 
 
 
 
 
 
This material featured the complete carbon framework of palau’amine (2) however, 
oxidative cyclization experiments to generate the hexacyclic core of the target natural 
product (see Scheme 6.7) were never performed on this substrate. 
 
6.3 Bis-Pyrrole Cyclization Precursor Toward Axinellamine and Konbu’acidin 
One of the recently isolated new PIA’s that called into question the original 
structural assignment of palau’amine was konbu’acidin B3a (5, see Chapter I). This 
alkaloid attracted our interest as it featured the hexacyclic core of palau’amine (2) but the 
level of bromination of the axinellamines (3), Indeed, the two natural products share a 
virtually identical framework and differ only in connectivities. Consistent with the 
proposal by Al Mourabit and Potier in fact, these two metabolites could derive from a 
common biogenetic precursor. Intrigued by their similarities we set out to emulate the 
presumed biosynthetic pathway by synthesizing one such precursor, namely bis-pyrrole 
155, which could lead in one step, via different modes of intra molecular cyclization, to 
either (or both) cores of the target alkaloids (Scheme 6.15). We had previously 
demonstrated that the spirohydantoin “lactam” nitrogen could in fact interact with a 
pendant electrophile, cyclizing to the ABC core of axinellamine (see Chapter III), and we 
envisioned that in this complex scenario the DMB protecting group would be the 
controlling element that would allow to select the desired mode of intramolecular 
cyclization. In the presence of this blocking group the anticipated facile hydantoin 
cyclization onto the pendant imidazolone would be precluded, and pyrrole carboxamide 
bis-cyclization should be favored. By contrast, after removal of the DMB the 
axinellamine pathway was expected to take precedence. It is also plausible that the two 
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reaction avenues might be in competition leading to the formation of mixture of the two 
products, which would support a common biogenetic origin.  
 
Scheme 6.15 
 
 
 
 
 
 
 
 
 
Initial manipulation of the C12 and C18 side chains of imidazolone 185 proved to 
be trivial and proceeded uneventfully using conditions that we had previously identified, 
to generate modest yields (up to 58% for the two steps) of diol 301.   
 
Scheme 6.16 
 
 
 
 
 
 
 
At this point we envisioned that direct installation of azide functionalities on the 
free alcohol side chains under Mitsunobu conditions would be the most efficient way to 
proceed, even though previous experimentation on analog diol 302 had given unexpected 
results (Scheme 6.17) leading to the isolation of what was originally thought to be 
spirotricyclic mono-azide 304, deriving from intramolecular nucleophilic attack of the 
sulfonamide on the activated alcohol at C19. It was discovered only recently however 
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that intramolecular cyclization occurs in fact via displacement of the C13 alcohol 
generating trans-azabicyclo octane 349 (discussed in Chapter VII).  
 
Scheme 6.17 
 
 
 
 
 
 
In this case, we reasoned that the absence of the internal nucleophile (i.e. the 
sulfonamide) should prevent similar undesired reactions. The fact that imidazolone 301 
provided no discernible reaction under the same reaction conditions attests that the 
reactivity of these two substrates was indeed profoundly dissimilar.    
We therefore resorted once again to a two-step procedure involving treatment of the 
free alcohols with mesyl chloride, followed by displacement of the activated mesylates 
by sodium azide under standard conditions. This immediately provided satisfactory 
results leading to the consistent isolation of good yields of bis-azide 305 (70-74% for the 
two steps). 
 
Scheme 6.18 
 
 
 
 
 
 
 
In later trials starting from azide imidazolone 251 (discussed in Chapter V) bis-
azide 305 could be obtained through similar transformations with overall good efficiency 
(52-59% for the three steps). In addition we envisioned that the intermediate alcohol 306 
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and mesylate 307 along this route could be convenient point of divergence in pursuit of 
the synthesis of palau’amine (discussed in the section 6.4 below).  
 
Scheme 6.19 
 
 
 
 
 
 
 
 
With a robust synthetic sequence to access bis-azide 305 in hand we projected that 
under single-electron-transfer conditions, namely using sodium naphthalenide, a global 
deprotection of the sulfone protecting group and concomitant reduction of the azide 
functionalities could occur delivering, after selective acylation of the primary amine 
moieties, the cyclization precursor that we had set out to synthesize (vide supra). 
Although not resulting in the desired outcome, preliminary studies in this direction were 
not entirely discouraging. In a first run 305 was treated with excess of freshly pre-
prepared reagent (13 equiv.) and stirred at –78ºC for 3 hours. The mixture was then 
quenched with t-BuOH and the solvents were evaporated. After prep TLC the only 
product isolated (~25 % yield) was mono-deprotected imidazolone 308.  
 
Scheme 6.20 
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In a second run of the reaction a sub-stoichiometric amount of naphthalene and 
excess sodium were directly added to a THF solution of the starting material and the 
resulting mixture was stirred at 0ºC for 6 hours and then at ambient temperature 
overnight. After aqueous workup and column purification a 69% yield of 308 was 
isolated. Subjecting the isolated 308 to the above conditions led to the generation of 
mono-tosylated imidazolone 309 in ~ 80% yield).  
Treatment of bis-azide 305 with freshly prepared samarium diiodide led, as before 
(Scheme 6.9) only to the selective cleavage of the imidazolone tosyl group (68% yield 
obtained consistently in multiple runs) leaving the azide functionalities unaltered.  
 
Scheme 6.21 
 
 
 
 
 
 
A few other efforts to arrive at a complete detosylation either from 309 or from 305 
met with no success, therefore it was decided that imidazolone 310 (already shown to be 
activated toward oxidation) would be advanced to the investigation of the key oxidative 
cyclization, delaying the removal of the Tse groups to the later stages of the synthesis. 
Several attempt to reduce the azide functionalities under a variety of conditions such as 
Mg in MeOH under sonication76 and hydrogenation in the presence of palladium of 
platinum catalysts led only to partial recovery of unaltered starting material. Once again, 
the use of phosphines provided far superior results generating after acylation of the crude 
bis-amine intermediate with dibromo-trichloroacylpyrrole 311, useful yields (up to 50% 
for the two steps) of the target bis-pyrrole cyclizaton precursor (Scheme 6.22). After 
some experimentation, using the detosylation conditions fortuitously discovered in earlier 
studies (vide supra) we could run the three-step sequence shown in Scheme 6.22 in one 
pot without any work-up of the intermediates. A single column chromatography 
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purification at the end of the three steps afforded bis-pyrrole 312, featuring the complete 
carbon framework of both axinellamine and konbu’acidin, in overall good yields.    
 
Scheme 6.22 
 
      
 
 
 
 
 
 
Investigations of the projected, presumed biomimetic oxidative cyclization of this 
material leading to the hexacyclic core of konbu’acidin B (5b) are discussed in section 
6.5 below. 
 
6.4 Second Generation Synthesis of a Mono-Pyrrole Precursor Toward Palau’amine 
As anticipated above, in our unified strategy we envisioned mesylate 307 and 
alcohol 306 (Scheme 6.19) as potential points of divergence toward the synthesis of the 
non-brominated palau’amine (2). Our first efforts in this direction were inspired by work 
done in the Shair group at Harvard77 involving direct installation of acylpyrrole 
precursors 314 onto a primary alcohol under Mitsunobu conditions, followed by mild 
basic hydrolysis to liberate the carboxamide functionality. 
 
Scheme 6.23 
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Having found the reported syntheses of pyrrole hydantoin 314 not to be 
satisfactory, we developed a new approach and after brief optimization the target reagent 
could readily be synthesized from commercially available trichloroacetylpyrrole. 
Although the last step was usually low-yielding (not accurately determined), the entire 
sequence could be run in a few hours furnishing synthetically useful amounts of pure, 
crystalline reagent.   
 
Scheme 6.24 
 
 
 
 
 
While our investigation was in progress a publication by Lovely16h appeared 
demonstrating the utility of this reagent in the total synthesis of nagelamide D.  
Disappointingly however, in our setting no reaction was detected with alcohol 306 
resulting in complete recovery of unaltered starting material even after prolonged time at 
higher temperatures (50 ºC). It appeared that the space surrounding the C13 center was 
still too congested (see Scheme 6.11 and related text), and would either not accommodate 
a bulky activating agent (such as triphenylphosphine) and/or not allow the approach of a 
large nucleophile.  
 
Scheme 6.25 
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Further studies of this procedure were not performed and it was decided at this 
point that mesylate 307 would provide better opportunities for the differentiation of the 
C12 and C18 side chains. 
Initial attempts to use ammonia as the nitrogen source to displace the activated 
alcohol led only to complete, clean cleavage of the imidazolone tosyl group without 
affecting the mesylate. By contrast, treatment with commercially available diformylimide 
320 in DMF, generated a virtually equimolar mixture of mono- and bis-formylated 
amines 321 (as expected per literature precedent)78 Under strong acidic conditions the 
crude mixture converged to amine 322 (detected only by TLC analysis), and subsequent 
acylation of this presumed material provided modest amounts of mono-pyrrole 323. 
 
Scheme 6.26 
 
 
 
 
 
 
 
 
 
 
   
 
Although the procedure in the literature precedent was reported to be highly 
efficient (granted on much less complex substrates), and was eventually optimized to a 
one-pot protocol, the sequence in Scheme 6.26 was extremely sluggish (mainly due to the 
acid hydrolysis step) and could not be improved, prompting us to seek alternatives. 
 Use of potassium phthalimide 324 immediately provided far better results and after 
brief adjustment of the reaction conditions consistently led to the isolation of good yields 
(65-73%) of the desired product. Interestingly, when the reaction was run at slightly 
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higher temperature (60 ºC vs. 45 ºC) only minor amounts of the desired phthalimide 325a 
were detected, with a mono-detosylated analog being the major product being isolated. 
The undesired product was identified as 325b directly by 1H NMR and mass data, and 
indirectly by the concomitant isolation of tosylethylphthalimide 327. We have already 
discussed how the enhanced acidity of the α proton of the sulfone renders this group 
unusually labile (vide supra). Thus it is plausible to envision that phthalimide could act as 
a base, liberating a vinyl sulfone 326, which is in turn trapped via conjugate addition by a 
second equivalent of phthalimide.  
 
Scheme 6.27 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loss of this Tse moiety was not desirable at this juncture as it was later proven to 
hinder the removal of the tosyl protection necessary for activation of the imidazolone 
toward oxidation; therefore lowering the operating temperature from 60 to 45 ºC 
minimized this unwanted side reaction.  
The phthalimide moiety in 325a was readily cleaved using hydrazine under 
standard conditions liberating the corresponding amine. It was noticed that in the process 
concomitant partial detosylation occurred and mass data confirmed that, in this instance it 
was the imidazolone tosyl group that was being cleaved. As this suited our needs (vide 
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supra) we tried to maximize this detosylation by increasing the reaction time from two to 
twelve hours. After this time increased, though not complete tosyl cleavage was obtained, 
and the crude mixture of amines 328a/b was advanced to the acylation step, leading to 
the isolation of the expected mono-pyrrole carboxamides 329, along with some unreacted 
amine precursors. These were resubjected to the reaction conditions generating additional 
desired products for an overall yield of 81% (2 steps).    
   
 
Scheme 6.28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In a later experiment pyrrole 329a could be efficiently converted to the detosylated 
analog 329b, using the conditions indicated in Scheme 6.28. In this instance however, the 
two products, which were easily separated by column chromatography, proved to be 
useful for preliminary, comparative studies of the projected oxidative cyclization 
(discussed below), as both featured the complete carbon framework of palau’amine.  
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6.5 Oxidative Cyclization Studies 
In our initial investigation of the presumed biomimetic intramolecular bis-
cyclization that generates the hexacyclic core of palau’amine and konbu’acidin (study of 
the axinellamine mode of cyclization was postponed) we opted to monitor our reactions 
via LC/MS. This analytical technique would not only provide mass data and valuable 
information on the neatness of the reactions but it would also allow us to operate at a sub-
milligram level, minimizing the use of precious advanced synthetic intermediates. In 
addition the presence of multiple bromine atoms in our substrates, which give rise to very 
characteristic isotopic patterns in the mass spectra (Figure 6.1), would allow us to 
identify significant products even in very sluggish reactions, as these patterns can be 
easily and accurately predicted.79 
  
 
 
 
 
 
 
 
    
 
 
 
 
 
Figure 6.1. a) HPLC trace for bis-pyrrole 312. b) observed and c) predicted79 
M+Na cluster for bis-pyrrole 312. 
 
 Literature precedents for the desired oxidative cyclization were quite encouraging, 
as in several instances polycyclic alkaloids of the PIA family were obtained from linear 
precursors through intramolecular ring closures triggered by a variety of activating 
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agents. Namely, the pioneering work by Büchi,80 later emulated by Horne13c and more 
recent reports by Chen18b and Al Mourabit29 provided us with promising starting points in 
our endeavors. Preliminary results along these guidelines however, quickly demonstrated 
that in our complex setting, the desired transformations would not be trivial. Intractable 
mixtures of unidentifiable materials were in fact obtained when bis-dibromopyrrole 312 
was exposed to excess amounts of N-bromosuccinimide (NBS), and no significant insight 
could be garnered at this point. Equally dismal outcomes resulted from the use of a 
hypervalent iodine reagent (PhI(OAc)2) and no noteworthy information could be derived 
from LC/MS data analysis. In yet another run using NBS in an acidic medium (TFA) the 
only significant LC/MS data could not be reconciled to any plausible outcomes, and an 
experiment using N-chlorosuccinimide (NCS) as the activating agent inexplicably 
seemed to result in complete decomposition.  
In all the above experiments, given the exceedingly small scale of the reactions 
(0.25-1.5 mg range) no work-up was performed to prevent loss of material and after 
evaporation of the solvents the crude residues were subjected to LC/MS analysis. The 
realization that this might have had in fact, a significant impact on the outcome provided 
the first potential breakthrough. In a subsequent run with NBS as the activating agent in a 
THF solution, despite the small scale, the reaction mixture was quenched with a saturated 
solution of sodium thiosulfate (Na2S2O3), diluted with ethyl acetate, dried and 
concentrated. Although the HPLC trace was not remarkably neat the major cluster in the 
mass spectrum and its isotopic pattern were clearly consistent with the addition of two 
bromine atoms and the loss of four hydrogens, which was highly indicative of an 
oxidation. Identification of the product remained at this point elusive, and a tentative 
assignment was advanced only after meticulous investigations (vide infra).  
Also, if on one hand the result was encouraging, on the other hand it exposed 
potential reactivity avenues that we had not previously considered, namely the competing 
bromination in our substrate of moieties other than the target imidazolone. Recalling that 
electrophilic aromatic substitution of the DMB ring had previously been observed (see 
Chapter V), we set out to systematically investigate the reactivity of our substrates toward 
halogenation.  
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When azide imidazolone 251 was treated with an excess of NBS, a slow reaction 
was observed by TLC and the only product isolated was shown to be monobrominated 
derivative 330 (Scheme 6.29) by the change in the 1H NMR spectrum of the very 
diagnostic DMB aromatic signals (Figure 6.2).  
 
Scheme 6.29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2. Spectroscopic comparison of the aromatic region of the 1H NMR 
spectra of a) azide imidazolone 251 and b) brominated derivative 330. 
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Incorporation of a bromine atom was confirmed by the isotopic pattern of the M+H, 
M+Na and M+K clusters in the mass spectrum. Exposure of this material to a large 
excess (> 150 equiv.) of NBS reagent led to no further reaction even after several hours.    
This study clearly showed that incorporation of halogens in the very electron-rich 
DMB ring was quite facile although not remarkably fast. In addition, presumably because 
of steric hindrance this system can only accommodate one bromine atom even in the 
presence of a large excess of reagent. Lastly, but perhaps most importantly, as observed 
in many previous instances the tosyl-protected imidazolone was confirmed to be 
completely inert toward oxidation, as the diagnostic vinyl proton signal remained 
virtually unchanged in the 1H NMR spectrum (Figure 6.2). Monobromination of the 
DMB ring was also clearly confirmed in bis-azide 305, leaving the imidazolone 
unaltered, while a completely different outcome was observed once the tosyl group was 
removed. 
When detosylated bis-azide 331 was subjected to the same reaction conditions in 
fact (Scheme 6.29), a much more sluggish reaction occurred, though a major product was 
observed in the crude 1H NMR spectrum. After several rounds of careful purification 
analysis of the spectroscopic data of this compound revealed some very interesting 
features. ALL three DMB aromatic signals were clearly visible whereas the imidazolone 
vinyl proton was missing.  
Scheme 6.30 
 
 
 
 
 
 
 
 
The NH signal on the imidazolone was also clearly visible, and all protecting 
groups were still present. In addition, the H17 coupling constant was a perfect match for 
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palau’amine (9.0 Hz) suggesting the formation of the strained trans-bicyclic system, and 
finally the isotopic pattern of the mass peaks indicated that no bromine atom had been 
incorporated, which seemed to suggest that it did indeed activate the imidazolone and 
was subsequently extruded (which was the kind of reactivity we had sought to obtain). In 
light of these observations the product was tentatively assign as aziridine 333. 
Later bromination experiments on substrates featuring free or protected amines on 
the side chains returned mostly inconclusive results, and coupling constant analysis of the 
only usable data obtained seemed to suggest that the “palau’amine cyclization” had not 
occurred. 
Continuing on our systematic investigation, we became aware of several reports in 
the literature81 indicating that pyrroles were prone to extensive halogenation, which 
prompted us to explore this unexpected reaction manifold on our substrates. Indeed, 
under the established reaction conditions model carboxamide 334 quickly incorporated a 
bromine atom in the available position of the pyrrole, and toslylated imidazolone 329a 
reacted equally promptly delivering a single product. Analysis of the 1H NMR spectrum 
of the purified material revealed that all aromatic pyrrole signals had disappeared and the 
isotopic pattern in the salient mass peaks confirmed the presence of three bromines. It is 
also noteworthy that in this instance, the DMB ring was not affected, suggesting that 
incorporation of bromine on the pyrrole was much faster. 
 
 
Scheme 6.31 
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On the basis of the results of the investigations described above we could advance a 
tentative assignment of the structure of the product detected by LC/MS in the only 
significant oxidative cyclization experiment we performed (vide supra). As discussed, 
mass data suggested the incorporation of two bromine atoms and a possible oxidation, 
which appeared to be consistent with hexabrominated hexacyclic compound 337 (Scheme 
6.31). This assessment was, of course, extremely promising because if confirmed, 
compound 337 would feature the completely functionalized carbon skeleton of 
konbu’acidin B ((5b)inset in Scheme 6.31).  
 
Scheme 6.32 
 
 
 
 
 
 
 
 
Extremely dishearteningly however, all attempts to scale up this reaction in order to 
obtain adequate amounts of product for a complete spectroscopic characterization 
resulted in sluggish, inconsistent outcomes that provided only unintelligible or 
inconclusive data. In addition analysis of the coupling constants of key signals in the only 
significant 1H NMR spectra obtained seemed to suggest that the desired oxidative 
cyclization had not occurred. Use of different solvents (MeCN, MeOH, CD3OD and 
CH2Cl2) and different activating agents (NCS) were fruitless, and a better insight in the 
inner workings of this transformation had to await further experimentation.  
Reasoning that the established competitive halogenation of the pyrroles was 
hindering our understanding of the reactivity of the imidazolone we sought alternatives 
means of oxidation.  
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Scheme 6.33 
 
 
 
 
 
 
 
 
 
 
 
Treatment of both bis-dibromopyrrole 312 and mono-pyrrole 329b with either m-
CPBA or DMDO immediately resulted in much cleaner reactions leading to complete 
conversions to what appeared to be single products by TLC analysis. In most instances 
however, crude 1H NMR analysis revealed the presence or two or more species. After 
careful purification the major products could be separated and spectroscopic data clearly 
showed that only the imidazolone had reacted. It was equally evident on the other hand 
that no cyclization had occurred as confirmed by the presence in the 1H NMR spectrum 
of the N-H signals of the pyrrole carboxamide. Based on incomplete mass and NMR data 
the products were tentatively assigned either as bis-hydantoins 338a or allylic 
carbinolamines 338b (Scheme 6.33). No further experiments in this direction were 
performed.   
Our final investigations on the oxidative cyclization of mono-pyrrole 329b 
provided another deceiving breakthrough. Treatment of this substrate with a carefully 
measured stoichiometric amount of N-iodosuccinimide (NIS) in MeCN solution at 0 ºC 
quickly led to complete loss of starting material. LC/MS analysis of the crude material 
revealed that the mass of the major species present was consistent with the desired 
product 339 (Scheme 6.34). The compound could be isolated and the mass was 
reconfirmed, but due to the scarcity of the material however, the 1H NMR spectrum 
remained inconclusive. 
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Scheme 6.34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pleasingly, although only partial conversion was observed, the result could be 
reproduced, furnishing an adequate amount of product for a detailed 1H NMR analysis. 
Disappointingly, examination of the coupling constants of key signals and the presence of 
the pyrrole N-H signal were not consistent with hexacycle 339, and based on the 
available data the product of the above reaction was tentatively assigned as piperidine 
derivative 340 (Scheme 6.34). Interestingly this material was cleanly converted into a 
new species upon resting in a DMSO-d6 solution for several days. The new product 
remains unfortunately unidentified.   
In light of all the evidence gathered in the investigations discussed above some 
speculations could be made on the factors governing these reactions, and a plausible 
mechanistic rationale could be advanced. In particular it seems reasonable to ascribe the 
failure to attain the desired reactivity to the inherent ring strain of key presumed 
intermediates, the inadequate nucleophilicity of the pyrrole nitrogens and the abundance 
of competing reaction manifolds, which could potentially lead to the formation of 
deceiving structural isomers. These ruminations, relative to both the bis- and mono-
pyrrole substrates, are summarized in Scheme 6.35.       
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In the presence of an activating agent (generalized as X), acyliminium Ia (path A) 
could arise. This species could be potentially engaged by either the amide nitrogen, or the 
pyrrole nitrogen of the C12 side chain. Given the established low nucleophilicity of the 
pyrrole nitrogen, coupled with the formation of an 8-membered ring, the former appears 
to be the more likely possibility. The pyrrolidine intermediate IIa thus formed, due to the 
strain generated by the trans fusion with the core chlorocyclopentane, would revert to the 
initial acyliminium Ia extremely faster than if could proceed to the hexacyclic species 
339 by nucleophilic attack of the pyrrole nitrogen at C6. Acyliminium Ia could then 
equilibrate, via “onium” intermediate Ic to isomeric acyliminium Ib. The generation of 
this species directly from the starting material (path B) also, cannot be excluded a priori. 
Acyliminium Ib, could then be engaged by the C12 side chain in the same fashion as 
before. Once again, formation of a 9-membered ring by attack of the pyrrole nitrogen at 
C6 appears improbable, and the 6-membered ring piperidine 340 would be generated 
instead. The ring strain in this system would be far smaller than in spirocyclic 
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intermediate IIa, allowing for elimination of “HX” delivering acyl imine 340a. Although 
these constructs are reported to be, in some instances, relatively stable, tautomerization 
would quickly re-establish the pseudo-aromatic imidazolone. These species and 
hexacycle 339 are structural isomers and in the absence of detailed, pristine spectroscopic 
data could easily be misassigned. 
After a few fruitless attempts to remove all the sulfone protecting groups in order to 
further explore the desired oxidative cyclization, this presumed biomimetic strategy was 
abandoned.        
 
6.6 Conclusions 
Two mono-pyrrole carboxamides featuring the complete carbon framework of 
palau’amine and a bis-dibromopyrrole imidazolone featuring the complete carbon 
frameworks of the axinellamines and konbu’acidin B were synthesized. Extensive, though 
not exhaustive investigations of the presumed biomimetic modes of intra-molecular 
oxidative cyclization generating the polycyclic cores of the natural products however, did 
not provide the desired outcomes. Considering the insight obtained in our studies, we 
ascribe the failure of this strategy to the inherent ring strain of key intermediates leading 
to the targets, the inadequate nucleophilicity of the pyrrole nitrogens, and several 
competing reaction manifolds often resulting in the generation of deceiving structural 
isomers.  
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CHAPTER VII 
 
ABIOTIC STRATEGIES TOWARD PALAU’AMINE AND STYLOGUANIDINE 
 
7.1 Second Generation Synthesis of the Trans-azabicyclo[3.3.0]octane Core of 
Palau’amine  
Given the disheartening results obtained in our bioinspired strategy aimed at 
emulating the presumed biosynthetic intra-molecular oxidative cyclization generating 
several PIA’s it was decided to return to the admittedly abiotic approach pioneered by Dr. 
Shaohui Wang (see Chapter II), which had been abandoned shortly after the structural 
revision of palau’amine.3 As discussed above (Chapter III) in the course of our 
investigations toward the synthesis of the axinellamines we had identified conditions to 
effect the key reversal of stereochemistry at C12 of the chlorocyclopentane core shared 
by all these metabolites. These studies had culminated in the synthesis of the peculiar 
trans-azabicyclo[3.3.0]octane core of  the revised palau’amine (Chapter IV) and we 
envisioned that this material could be elaborated to the target natural product following 
the original route, and anticipating only minor refinements.   
 
Scheme 7.1 
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We set out therefore to prepare an analog of 222 using our newly synthesized azide 
methyl ester 250 (Chapter V). In earlier, unrelated studies we already discovered that the 
intra-molecular cyclization of the sulfonamide in ester 250, onto the adjacent primary 
alcohol generating the corresponding aziridine 342, which had been achieved on the 
TBDPS analog under Mitsunobu conditions (Chapter IV), could easily be triggered by 
simple treatment with mesyl chloride. We reasonably anticipated that similar conditions 
could be applied toward the synthesis of the pyrrolidine.  
 
Scheme 7.2 
 
 
 
 
 
 
Use of the procedures that had been successful in our previous studies immediately 
provided gratifying results. Both protection of the free primary alcohol as the TIPS ether, 
and reduction of the ester moiety proceeded uneventfully generating good yields of 
cyclization precursor 343.    
 
Scheme 7.3 
 
 
 
 
 
 
 
Not expecting the cyclization to the trans-azabicyclo[3.3.0]octane system to be 
quite as facile as the generation of the aziridine (Scheme 7.2), we anticipated to isolate a 
stable intermediate mesylate, and then in a separate experiment induce the desired 
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intramolecular ring closure. Indeed, after treatment with mesyl chloride and aqueous 
work up, the crude material could be purified by preparative TLC, affording a modest 
yield (not quantified) of mesylate 344. We were then pleased to find that stirring the 
activated alcohol in a methanol solution in the presence of potassium carbonate (K2CO3) 
cleanly promoted the projected cyclization providing tricyclic system 345, as confirmed 
by mass spectrometry data and analysis of the coupling constants of diagnostic signals in 
the 1H NMR spectrum. 
 
Scheme 7.4 
 
 
 
 
 
 
This early success prompted us to refine the overall approach, and in particular we 
sought to circumvent the cumbersome reprotection of the C6 alcohol, which had however 
been useful in the early stages of our investigations (Chapter IV), for spectroscopic 
comparison purposes.       
 
7.2 Third Generation Synthesis of the Trans-azabicyclo[3.3.0]octane Core of 
Palau’amine  
In the original approach to the core of palau’amine (2) (see Scheme 2.10) the C6 
alcohol was carried on to the late stages of the synthesis as the silyl ether, until it was 
conveniently liberated and oxidized to the corresponding aldehyde. This moiety was then 
engaged by a pendant pyrrole to generate a stable carbinolamine, thus establishing the D 
ring of the natural product. Committed to these guidelines we reasoned that in the revised 
approach, an early oxidation of the C6 to the required aldehyde, would be the most 
efficient course of action. We envisioned that masking the aldehyde as the corresponding 
acetal would afford a stable surrogate that could be safely advanced through several 
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chemical operations in the early stages of the synthesis, while in turn providing an 
adequate electrophile for the projected key ring closure. 
Once again the use of established procedures allowed us to quickly and efficiently 
generate sizeable amounts of the required cyclization precursor 347 (Scheme 7.5).   
 
Scheme 7.5 
 
 
 
 
 
 
 
With alcohol 347 in hand the stage was set for the key ring closure, and as expected 
under the previously devised conditions (Scheme 7.4) modest yields of the desired trans 
system 349 were obtained. Suspecting that the intra-molecular cyclization in this setting 
might be in fact, more facile that we had originally predicted we reasoned that increasing 
the operating temperature could promote the process. Indeed we were pleased to find that 
after formation of mesylate 348 at 0 ºC, allowing the reaction mixture to warm to ambient 
temperature led to the clean generation of the target product, which could eventually be 
isolated in markedly improved yields. 
 
Scheme 7.6 
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 It is reasonable to envision that under the previous conditions, the unanticipated 
partial formation of the cyclized product 349, which was unknowingly discarded after 
purification of the desired intermediate, could account for the lower efficiency of the 
initial runs.   
 
7.3 Synthesis of the D Ring Cyclization Precursor 
Having devised a robust protocol for the synthesis of the pivotal trans-
azabicyclo[3.3.0]octane system establishing the key sterochemical relationships in the 
core of the revised structure of palau’amine we focused on the projected construction of 
the D ring (vide supra). Installation of the necessary pendant pyrrole moiety required the 
prior removal of the tosyl protecting group from the pyrrolidine nitrogen. 
This transformation had previously been accomplished using an excess of freshly 
prepared sodium naphthalenide, and indeed this proved eventually to be the most 
efficient method to arrive at the target cyclization precursor. Initial investigations in this 
direction however exposed some key issues that required small but significant 
adjustments of the original procedure. 
Treatment of a THF solution of tricyclce 349 and naphthalene with sodium metal or 
addition of a large excess of a 0.1 molar solution of pre-prepared sodium naphthalenide 
to a THF solution of the starting material provided no reaction at 0 ºC. After overnight 
stirring at ambient temperature on the other hand, clean cleavage of the Tse group was 
observed without affecting the pyrrolidine tosylate (product 351, Scheme 7.7).  
 
Scheme 7.7 
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Use of a 1 molar solution of freshly prepared sodium naphthalenide however 
resulted in greatly increased reactivity and complete detosylation, along with reduction of 
the azide functionality to the corresponding primary amine 350 was obtained in minutes 
at –78 ºC. Although potentially useful, isolation of detosylated tricycle 350, either 
directly or after acylation of the primary amine proved to be rather problematic. In 
addition, in some instances deceivingly fast reactions were observed that led to the 
formation of only partially detosylated amines. We reasoned that better results could be 
obtained after preemptive reduction and acylation of the interfering azide, and in fact, 
deprotection of carbamate 352 proceeded smoothly under the optimized conditions 
leading to the isolation of good yields of pyrrolidine 353.  
 
 
Scheme 7.8 
 
 
 
 
 
 
 
 
As anticipated above, alternative procedure that were tested for the cleavage of the 
tosyl group gave unsatisfactory outcomes. In particular treatment of azide 349 with 
magnesium metal in methanol solution under sonication did not provide any discernible 
reaction and unaltered starting material was recovered even after extended reaction time 
(> 30 h). At the opposite extreme, dissolving metal (Li or Na) conditions (Scheme 7.9) 
led to indiscriminate extensive reduction, annihilating several functionalities effectively 
resulting in a synthetic dead end (354). 
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Scheme 7.9 
 
 
 
 
 
 
 
With tricycle 353 in hand, installation of an acyl pyrrole on the pyrrolidine nitrogen 
delivered the pivotal cyclization precursors for the construction of the D ring of 
palau’amine. Following once again the guidelines set forth by Dr. Wang’s previous 
studies, use of freshly prepared acyl chlorides (148 and 357) provided fast reactions at 
ambient temperature, compared to acylations using commercially available 
trichloroketone analogs, which require higher temperatures and extended reaction times. 
The target pyrrole cyclization precursor 355 was isolated, under these conditions in good 
yield and purity, whereas dibrominated analog 356 was not pristine by 1H NMR analysis 
and an accurate yield could not be determined. The reasons that prompted the synthesis 
of this modified cyclization precursor are discussed below. 
 
 
Scheme 7.10 
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7.4 Studies Toward the Construction of the D ring of Palau’amine 
In our early exploration of reported procedures suitable for the late stages of our 
projected synthesis we became intrigued by a methodology for the generation of cyclic 
guanidines developed by Al Mourabit82 in his synthetic approach to 
dibromoagelaspongine (inset in Scheme 7.10).   
 
Scheme 7.11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It was reported therein that enamine 363 could be activated with N-iodosuccinimide 
(NIS) to promote the inter-molecular addition of a guanidine surrogate such as the 2-
aminopirymidine 365, or alternatively a protected guanidine (such as 361), to deliver the 
a 2-aminoimidazole ring system 364. At this juncture we considered that following Dr. 
Wang’s original procedures would take us from dimethyl acetal 355, through 5 or 6 steps 
to generate a pendant guanidine 359 set up for a late stage cyclization triggered by 
activation of the C10 C-H bond (see Chapter II). We reasoned that if the expected 
carbinolamine 358, obtained by acid promoted cyclization of the pyrrole onto the 
dimethyl acetal could be forced to eliminate water (perhaps under the same acidic 
conditions), we could arrive at system 360, which is suitable for this procedure, removing 
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several steps from the overall sequence. Although the loss of the C10 stereocenter could 
potentially translate into a poor facial selectivity, we were confident that the inherent 
conformational bias of the substrate would work to our advantage. Molecular model 
analysis in fact (not shown), seemed to indicate that the approach of the activating agent 
would occur from the most exposed β face, necessarily guiding the guanidine nucleophile 
to attack at the α face, thereby establishing the stereochemical relationships found in 
palau’amine (362 in Scheme 7.11). 
If on one hand we were pleased to find that treatment of dimethyl acetal 355 with 
para-toluenesulfonic acid (p-TSA) in an acetone solution at 50 ºC had triggered the kind 
of reactivity that we had hoped for, on the other hand we had not anticipated where it 
would lead us. 
Scheme 7.12 
 
 
 
 
 
 
 
 
Analysis of the 1H NMR (CDCl3) spectrum of the purified product in fact, revealed 
the absence of the signals relative to the acetal and the appearance of a new signal at δ = 
6.1 ppm ascribable to the vinyl proton at C6, which suggested formation of the desired 
enamine 360 (Scheme 7.12). In addition, LC/MS data of the crude material and mass 
spectrometry analysis of the purified product provided values consistent with the 
expected outcome. However, the presence in the 1H NMR spectrum of the very 
diagnostic pyrrole N-H signal (δ = 9.4 ppm) and the significant change in the multiplicity 
of the C4 and C5 pyrrole signals provided strong evidence for a C3 mode of cyclization 
that had generated the pentacyclic core of the styloguanidines 366 (Chapter I). 
Different modes of pyrrole cyclization had been previously reported by Al 
Mourabit,83 and in retrospect this result was not entirely unexpected. In particular, in early 
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synthetic efforts toward dibromophakellin and ugibohlin, al Mourabit had discovered that 
in a non-brominated pyrrole the C3 mode of cyclization was preferred under acidic 
conditions, whereas the N1 cyclization was selected in a neutral medium. By contrast, 
bromination of the C4 and C5 position of the pyrrole rendered the N1 cyclization the 
exclusive avenue of reactivity under either set of conditions resulting in the formation of 
a stable carbinolamine.  
As mentioned above, these observations prompted us to explore the reactivity of the 
dibromopyrrole advanced intermediate 356 (Scheme 7.13), and under the same acidic 
conditions as before, only partial (~50%) conversion was detected after several hours. 
Despite very similar polarities, the only product formed and the starting material could be 
separated via preparative TLC (60% EtOAc/Hexanes, 6 elutions; Rf product ~ 0.6, Rf 
SM ~ 0.5). 
 
Scheme 7.13 
 
 
 
 
 
 
 
 
 
Analysis of the 1H NMR spectrum of the new material revealed the absence of the 
diagnostic signals of the dimethyl acetal and the pyrrole N-H. In addition, the pyrrole C3 
singlet was clearly visible and no traces of aldehyde signals could be detected. 
Furthermore LC/MS data of the purified material confirmed a single product, and the 
isotopic pattern of the significant mass cluster was consistent with carbinolamine 367. 
The stereochemical assignment of the C6 center was advanced solely on the basis of 
thermodynamic considerations and upon spectroscopic comparison with similar materials 
provided by a colleague (Dr. Chunxiao Xu). Although the evidence gathered strongly 
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supports the indicated structural assignment, the minute amount of product obtained 
prevented an exhaustive spectroscopic characterization and this assessment must be 
considered tentative. Finally, the partial conversion even after extended reaction time 
seemed to attest to the low nucleophilicity of the pyrrole nitrogen that had however 
apparently been enhanced by the effect of the bromine substituents, which could also be 
responsible for the complete inhibition of the C3 cyclization manifold. 
 
7.5 Guanidinylation Studies 
With the small amounts of enamine 366 generated only few attempts to generate 
the final ring of the styloguanidine skeleton using the methodology reported by Al 
Mourabit (Scheme 7.11) could be endeavored. The results however, were significant and 
although our investigation ultimately did not lead to the synthesis of the target products, 
valuable insight on the reactivity of these systems was obtained.   
In a first experiment, drop-wise addition of a solution of NIS to a cold (-40 ºC) 
MeCN solution of the starting material and excess bis-Boc-guanidine 369 resulted in 
complete loss of the starting material in 2 hours. As the progress of the reaction proved 
impossible to monitor by TLC, the indicated time was arbitrarily chosen.  
LC/MS analysis of the crude material indicated the formation of two major 
products containing one and two iodine atoms respectively. After preparative TLC 
purification, the mono-iodinated product 370 was separated and the 1H NMR spectrum 
clearly showed substitution at the C4 pyrrole position, as attested by the disappearance of 
the relative signal and the change in the multiplicity of the remaining pyrrole signal from 
a doublet to a singlet.  
 
Scheme 7.14 
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The diiodinated product, apparently present only in significantly smaller quantity, 
could not be isolated. Further iodination at C5 on the pyrrole or substitution of the C6 
vinyl proton are plausible reaction avenues that might have led to the generation of this 
material. 
A brief model study performed on the simplified substrate 371, (kindly provided by 
Dr. Xu) featuring the N1 mode of cyclization, led to further insight on the reactivity of 
these peculiar ring systems.  
 
Scheme 7.15 
 
 
 
 
 
 
 
 
Under the same condition as before, treatment with a stoichiometric amount of NIS 
resulted in the formation of a nearly equimolar mixture of inseparable mono-iodinated 
regioisomers 372a and 372b, whereas in the presence of excess reagent at higher 
temperature complete diiodination (373, Scheme 7.15) was confirmed by mass and 1H 
NMR data. In both cases the enamine appeared to remain unaltered.  
Two further experiments on sub-milligram amounts of enamine 366 were 
performed, and the results therefore only analyzed by LC/MS. Using chloramine-T (a 
commercially available source of electrophilic chlorine) the formation of a mono-
chlorinated product, presumably arising by substitution at C4 as seen before, was 
detected. Treatment with m-CPBA in the presence of an excess bis-Boc guanidine 
reagent provided inconclusive results. 
Interestingly, later theoretical calculations (performed by Mikail Abbasov) revealed 
interesting features of enamine 366. According to the data, the C6-C10 unsaturation was 
part of an extended conjugation with the pyrrole ring, suggesting that, as observed 
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experimentally, it would not behave as an isolated double bond. In addition, it was found 
that while the C6 vinyl carbon had the highest HOMO coefficient, the C4 on the pyrrole 
held the highest negative natural charge making it, as observed, the most prone to be 
engaged by an electrophile. Lastly in the molecule’s lowest energy conformation (global 
minimum) the DMB aromatic ring was shown to lie parallel to the DE ring system, 
presumably because of π-π interactions with the pyrrole ring. In this scenario the 
projected approach of a guanidine nucleophile from the α face (vide supra) would be 
unfeasible, therefore we set out to remove this hindrance by attempting to cleave the 
DMB protecting group under the conditions previously identified (Chapter IV). 
Unfortunately, this resulted in an extremely sluggish reaction on the last available 
material, thus ending our investigations on this substrate.  
Having failed to generate any significant amount of carbinolamine 367 we resorted 
to study model system 374 (once again generously provided by Dr. Xu) to garner some 
initial information about the potential reactivity of this substrate. Treatment with 
pseudothiourea 375 under typical Mitsunobu conditions led to the formation of the 
elimination product 376 as the overwhelmingly major one, with only minimal amounts of 
the desired target 377 detected by 1H NMR, and confirmed by LC/MS data. 
 
Scheme 7.16 
 
 
 
 
 
 
 
 
Although far from satisfactory this procedure has potential for optimization, and it 
could provide a more efficient entry into the projected urea cyclization precursor 
(Scheme 7.10) for the synthesis of dibromopalau’amine. An attempt to activate 
carbinolamine 374 with mesyl chloride in the presence of pseudothiourea 375, resulted 
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only in partial conversion to the elimination product 376. Finally carbinolamine 374 
proved to be remarkably stable under acidic conditions (p-TSA) with the starting material 
being recovered unaltered even after prolonged stirring at 80 ºC.    
 
7.6 Other Salient Studies 
As anticipated in Chapter IV the required reduction of the C20 lactam to the aminal 
functionality found in several PIA’s (including palau’amine and axinellamine) could not 
be achieved under a variety of conditions in any of our synthetic intermediates with the 
exception of aziridine 223 (Scheme 4.19) We thought that this serendipitous but 
significant result warranted more investigation, and having recently synthesized azide 
aziridine 342 (Scheme 7.2) we saw a convenient opportunity to further explore the 
possibility of using this intermediate as a precursor to the synthesis of the natural 
products of interest. 
Using the established reduction conditions excellent results were immediately 
obtained and the desired carbinolamine 378 was isolated in good yield with remarkable 
diastereoselectivity, although the configuration at C20 was not unambiguously 
established.  
 
Scheme 7.17 
 
 
 
 
 
 
 
 
Unexpectedly however, when crude starting material was subjected to the same 
conditions the peculiar spirotricyclic system 379 was exclusively generated. This product 
presumably arises from activation of the C13 alcohol by residual mesyl chloride from the 
previous reaction (Scheme 7.2) followed by intramolecular displacement by the newly 
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generated C20 hydroxy moiety, and examination of molecular models confirmed that this 
functionality was in fact, in close proximity to C13. 
Further studies seemed to show that this carbinolamine provided competitive 
reaction manifolds in other settings as well (not shown), however this could not be 
unequivocally established. Although I believe that this system remains a worthy 
candidate for the development of an efficient approach to key functionalities found in the 
PIA’s, it appears that the originally planned late-stage reduction would be the preferred 
course of action. 
 
7.7 Conclusions 
A robust protocol for the synthesis of the pivotal trans-azabicyclo[3.3.0]octane core 
of the revised structure of palau’amine was devised. Investigations on the projected 
crucial intra-molecular pyrrole cyclization provided significant insight into the key 
factors governing this transformation. In particular, introduction of bromine substituents 
at C4 and C5 of the pyrrole ring appeared to increase the nucleophilicity of the nitrogen, 
promoting the desired interaction with the pendant electrophile, delivering the 
pentacyclic core of dibromopalau’amine. By contrast, under similar operating conditions 
a C3 cyclization manifold was preferred in a non-brominated pyrrole, resulting in the 
formation of a styloguanidine potential precursor.  
 
 140 
CHAPTER VIII 
 
CONCLUSIONS 
 
The pyrrole-imidazole alkaloids are an ever-growing family of marine metabolites 
that already features well over one hundred members and new congeners continue to be 
detected and characterized. Efforts in this field have proliferated in recent years leading 
to the development of a wealth of remarkable synthetic strategies, which have often 
culminated in exquisite total syntheses. Our approach to the synthesis of selected 
members of this family of alkaloids, premised on the biosynthetic proposals by Kinnel 
and Scheuer and Al Mourabit and Potier involves a Diels Ader cycloaddition followed by 
and oxidative ring contraction to generate a pivotal spirocyclic common precursor.   
With this intermediate as a starting point, a chlorocyclopentane methyl ester 
featuring the stereochemical relationships found in the cores of several related natural 
products, was synthesized and its structure was secured by extensive NMR experiments 
and X-ray crystallographic analysis. The viability of this key intermediate to generate 
diverse molecular constructs via various mode of intra-molecular cyclization was 
demonstrated by the synthesis of the angular azatriquinane core of axinellamine and the 
trans-azabicyclo[3.3.0]octane core of the recently revised structure of palau’amine. In 
addition, studies on the amino alcohol functionality of this pivotal intermediate led to the 
construction of an imidazolone ring precursor to the northern amino-imidazole of 
palau’amine, axinellamine, styloguanidine, konbu’acidin and massadine. This approach 
significantly shortened the previously established route to a comparable analog.  
Further elaboration of this system produced a bis-dibromopyrrole advanced 
intermediate featuring the complete carbon framework of the axinellamines and 
konbu’acidin B, and two mono-pyrrole analogs both featuring the complete carbon 
framework of palau’amine and styloguanidine. Attempts to emulate the presumed 
biomimetic intra-molecular modes of oxidative cyclization leading to the cores of the  
indicated natural products were not successful, presumably because of the inherent ring 
strain of key reactive intermediates, the inadequate nucleophilicity of the pyrrole 
nitrogens and the abundance of competitive reaction manifolds. 
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Starting from an analog of the pivotal chlorocyclopentane methyl ester described 
above, prepared in collaboration with Dr. Yonggang Wang, a robust route to a new trans-
azabicyclo[3.3.0]octane system was devised. This served as the starting point for the 
development of an abiotic strategy toward palau’amine premised on the pioneering work 
in our group by Dr. Shaohui Wang, resulting in the synthesis of a pyrrole cyclization 
precursor and a dibrominated analog. Investigations on the reactivity of these substrates 
aimed at the construction of the piperazine ring of palau’amine revealed different modes 
of ring closure. A pyrrole C3 cyclization led to the construction of a pentacyclic enamine 
precursor to styloguanidine, while an alternative N1 annulation ensued in the 
dibrominated congener generating a stable carbinolamine suitable for the completion of 
palau’amine. The assignment of the latter though strongly supported by spectroscopic 
evidence remained tentative. Finally, attempts to construct the northern amino-imidazole 
ring of styloguanidine by direct guanidinylation of the enamine precursor failed 
presumably because of the unexpected conjugation of the enamine double bond with the 
pyrrole effectively reducing its propensity for oxidation.     
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EXPERIMENTAL PROCEDURES 
 
 
 
General Procedures: All non-aqueous reactions were carried out under nitrogen 
atmosphere in oven-dried (120 ºC) glassware. Dichloromethane (CH2Cl2), acetonitrile 
(MeCN) and toluene (PhMe) were obtained from a MBraun solvent system passing 
HPLC grade solvents through activated alumina. Tetrahydrofuran (THF) was distilled 
from a sodium/benzophenone ketyl. Triethylamine (99% Acros) was distilled from 
calcium hydride. Methanol (MeOH), ethyl acetate (EtOAc), hexanes, acetone and 
chloroform were used without purification. Other chemicals were purchased from 
Aldrich or Acros and used as received without further purification. Analytical thin layer 
chromatography (TLC) was performed using aluminum-backed silica gel 60F254 (Merck, 
250 µm thickness). Plates were visualized under UV light (at 254 nm) and/or by staining 
with ceric ammonium molybdate followed by heating. Deuterated solvents were 
purchased from either Aldrich or Cambridge Isotopes and used as received. Flash column 
chromatography was performed using 60Å Silica Gel (Baker, 230-400 mesh) as a 
stationary phase.  
1H NMR chemical shifts are reported as δ values in ppm relative to CDCl3 (7.27 ppm), 
benzene-d6 (7.16 ppm), CD3OD (3.31 ppm), acetone-d6 (2.05 ppm) or DMSO-d6 (2.50 
ppm). 1H NMR coupling constants (J) are reported in Hertz (Hz) and multiplicity is 
indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br s 
(broad singlet), dd (doublet of doublets), dt (doublet of triplets), dq (doublet of quartets), 
ddd (doublet of doublets of doublets). Deuteriobenzene (benzene-d6), deuteriochloroform 
(CDCl3), CD3OD, or DMSO-d6 served as internal standard (128.30 ppm, 77.23 ppm, 
49.00 ppm, or 39.50 ppm  respectively) for all 13C spectra. Mass spectra were obtained at 
the Center for Chemical Characterization and Analysis at TAMU. Infrared spectra were 
obtained as thin film on NaCl plates. Optical rotations were recorded at 589 nm using a 
250 µL cell.  
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Alcohol 132: To a solution of chlorocyclopentane 123 (200 mg, 0.169 mmol) in 20 mL 
of anhydrous THF at -45 °C was added TBAF (1.0 M in THF, 180 µL, 0.180 mmol). The 
reaction mixture was stirred for 2 h while allowing to reach -20 °C. It was then quenched 
with 10 mL of pH 7 buffer, allowed to reach 20 ºC and extracted with EtOAc (3 x 15 mL). 
The combined organic phase was dried over MgSO4 and concentrated in vacuo. 
Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (60:40) gave 
138 mg (79%) of alcohol 132 as a white foam: Rf = 0.59 (60% EtOAc/Hexanes); [α]D23 = 
-26.1 (c = 1.70, CH2Cl2); IR (thin film): 3063, 2932, 2856, 1717, 1652, 1518, 1457, 1144, 
1113 cm-1; 1H NMR (500 MHz, benzene-d6): δ 8.14 (d, J = 8.0 Hz, 2H), 7.91 (m, 2H), 
7.85 (d, J = 8.0 Hz, 2H), 7.80 (m, 2H), 7.46 (d, J = 2.0 Hz, 1H), 7.38 (dd, J = 8.0, 2.0 Hz, 
1H), 7.21-7.29 (m, 6H), 6.81 (d, J = 8.0 Hz, 2H), 6.71 (d, J = 8.0 Hz, 2H), 6.37 (d, J = 
8.0 Hz, 1H), 5.80 (d, J = 15.5 Hz, 1H), 4.79 (s, 1H), 4.71 (d, J = 16.0 Hz, 1H), 4.54 (d, J 
= 12.5 Hz, 1H), 4.47 (dd, J = 8.5, 10.5 Hz, 1H), 4.14 (dd, J = 4.0, 10.5 Hz, 1H), 3.93-3.96 
(m, 1H), 3.73 (d, J = 11.5 Hz, 1H), 3.65-3.70 (m, 1H), 3.64 (s, 3H), 3.54-3.61 (m, 1H), 
3.50 (d, J = 8.5 Hz, 1H), 3.40-3.46 (m, 2H), 3.29 (s, 3H), 3.19-3.24 (m, 1H), 2.94-2.99 
(m, 1H), 1.86 (s, 3H), 1.76 (s, 3H), 1.17 (s, 9H), 0.99 (bs, 1H); 13C NMR (125 MHz, 
benzene-d6): δ 173.2, 171.9, 156.9, 150.3, 149.9, 145.1, 145.0, 136.3, 136.2, 136.0, 135.8, 
134.1, 133.8, 130.1, 130.0, 129.9, 129.8, 129.5, 129.3, 129.0, 128.3, 121.6, 113.0, 112.1, 
76.7, 63.8, 60.7, 60.6, 60.2, 55.8, 55.4, 50.8, 48.9, 48.1, 46.8, 46.0, 33.3, 27.2, 21.2, 19.6; 
MS (MALDI) calcd for C52H58ClN3O11S2Si [M+H]+: 1028, [M+Na]+: 1050, [M+K]+: 
1066; found  [M+H]+: 1028, [M+Na]+: 1050, [M+K]+: 1066. 
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Ester 177. To a stirred solution of alcohol 132 (250 mg, 0.243 mmol) in 30 mL MeOH at 
room temperature was added 3.2 mL of a freshly prepared solution of NaOMe in MeOH 
(0.23 M, 0.729 mmol), and after stirring at ambient temperature for 25 min, the mixture 
was heated to 65oC and stirred for 18 h. The reaction mixture was then cooled to 20 ºC 
and quenched with 20 mL of a saturated solution of NH4Cl. Water (20 mL) was then 
added, the mixture was extracted with EtOAc (3 x 45 mL) and the combined organic 
phase was dried over MgSO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on SiO2 eluting with hexanes/EtOAc (60:40  40:60) gave 197 mg 
(76%) of ester 177 as a colorless foam: Rf = 0.46 (60% EtOAc/Hexanes); [α]D19.7 26.0 (c 
2.20, CH2Cl2); IR (thin film) 3511, 3271, 2934, 2857, 1776, 1717, 1596, 1516, 1453, 
1149, 814, 704 cm-1; 1H NMR (500 MHz, benzene-d6) δ 7.85 (d, J = 7.0 Hz, 2H), 7.83-
7.81 (m, 4H), 7.55 (d, J = 8.0 Hz, 2H), 7.35 (app t, J = 8.0 Hz, 2H), 7.30 (app. t, J = 8.0 
Hz, 2H), 7.27-7.24 (m, 3H), 7.05 (dd, J = 1.5, 8.0 Hz, 1H), 6.84 (d, J = 8.0 Hz, 2H), 6.76 
(d, J = 8.5 Hz, 2H), 6.41 (d, J = 8.5 Hz, 1H), 5.62 (d, J = 9.5 Hz, 1H), 5.15 (d, J = 11.5 
Hz, 1H), 4.93 (d, J = 16.0 Hz, 1H), 4.86 (d, J = 16.0 Hz, 1H), 4.18 (dd, J = 11.5, 11.5 Hz, 
1H), 3.94 (dd, J = 11.5, 11.5 Hz, 1H), 3.82 (dd, J = 11.0, 2.0 Hz, 1H), 3.74 (s, 3H), 3.72-
3.69 (m, 4H), 3.63 (s, 3H), 3.60 (dd, J = 12.0, 2.5 Hz, 1H), 3.38-3.34 (m, 2H), 3.33 (s, 
3H), 3.05 (dd, J = 12.0, 4.0 Hz, 1H), 2.78 (app. dd, J = 11.5, 11.5 Hz, 1H), 1.91 (s, 3H), 
1.84 (s, 3H), 1.25 (s, 9H); 13C NMR (125 MHz, benzene-d6) δ 175.0, 173.6, 157.7, 150.7, 
150.0, 145.2, 143.2, 140.0, 136.5, 136.4, 136.0, 134.3, 133.5, 130.6, 130.5, 130.4, 130.2, 
129.32, 129.28, 128.7, 128.6, 128.5, 128.3, 127.4, 120.8, 112.6, 112.1, 74.8, 62.2, 60.8, 
58.4, 56.0, 55.6, 55.3, 52.85, 52.79, 49.8, 48.7, 46.9, 46.6, 33.9, 30.6, 27.7, 21.5, 20.1; 
MS (MALDI) calcd for C53H62ClN3O12S2Si [M+Na]+: 1082, [M+K]+: 1098; found 
[M+Na]+: 1082, [M+K]+: 1098. 
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Dimethyl Acetal 178.To a stirred solution of alcohol 132 (123 mg, 0.116 mmol) in 10 
mL CH2Cl2 at 20 ºC was was added Dess Martin periodinane (82 mg, 0.193 mmol) in one 
portion. The mixture was stirred at 23ºC for 4 h then it was diluted with Et2O (~ 20 mL) 
and filtered through a thick pad of Celite. The solvent was removed in vacuo affording a 
white foam. This crude material (211) was dissolved in 4.5 mL of MeOH and 3.0 mL of 
trimethylorthoformate was added at 20 ºC. The resulting mixture was heated to 65 ºC and 
stirred for 16 h, then cooled to 20 ºC, and about half of the solvents were removed in 
vacuo. pH 7 buffer solution was then added (~ 10 mL) and the mixture was extracted 
with EtOAc (3 X 10 mL) and the combined organic phase was dried over MgSO4, filtered 
and concentrated in vacuo. Purification by flash chromatography on SiO2 eluting with 
hexanes/EtOAc (60:40) gave 46 mg (63%) of dimethyl acetal 178 as a colorless foam: Rf 
= 0.62 (80% EtOAc/Hexanes); 1H NMR (500 MHz, benzene-d6) δ 7.82 (d, J = 8.0 Hz, 
2H), 7.78 (d, J = 8.5 Hz, 2H), 7.68 (app d, J = 8.0 Hz, 4H), 7.39 (d, J = 1.5 Hz, 1H), 7.34 
(app t, J = 7.0 Hz, 2H), 7.29 (app t, J = 8.0 Hz, 2H), 7.24 (app t, J = 7.5 Hz, 2H), 7.00 (dd, 
J = 8.0, 1.5 Hz, 1H), 6.77 (d, J = 8.5 Hz, 2H), 6.75 (d, J = 8.0 Hz, 2H), 6.27 (d, J = 8.5 
Hz, 1H), 5.46 (d, J = 16.5 Hz, 1H), 5.40 (d, J = 9.0 Hz, 1H), 5.00 (d, J = 11.5 Hz, 1H), 
4.86 (d, J = 16.5 Hz, 1H), 4.09-3.93 (m, 5H), 3.84 (td, J = 8.5, 4.0 Hz, 1H), 3.73 (dd, J = 
11.0, 1.5 Hz, 1H), 3.66 (s, 3H), 3.64 (s, 3H), 3.50 (dd, J = 11.5, 7.0 Hz, 2H), 3.24 (s, 3H), 
2.87 (s, 3H), 2.86 (s, 3H), 2.59 (app dd, J = 11.5, 11.5 Hz, 1H), 1.90 (s, 3H), 1.84 (s, 3H), 
1.18 (s, 9H); 13C NMR (125 MHz, benzene-d6) δ = 174.6, 173.6, 157.3, 150.9, 150.0, 
144.9, 143.3, 139.2, 136.8, 136.42, 136.41, 134.6, 133.5, 130.5, 130.4, 129.9, 129.6, 
129.1, 128.7, 128.6, 128.5, 128.1, 128.0, 120.5, 112.5, 112.0, 105.9, 74.8, 61.1, 58.2, 56.7, 
56.4, 56.1, 55.6, 54.5, 53.6, 52.5, 50.0, 48.7, 46.7, 46.1, 34.0, 30.5, 27.6, 21.51, 21.47 
20.0. 
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Bis-silylether 197: To a stirred solution of dimethyl acetal 178 (11.6 mg, 0.0105 mmol) 
in 1.0 mL of CH2Cl2 cooled to –78 ºC was added DIBAL-H (xs) dropwise. The mixture 
was stirred at to –78 ºC for 30 minutes then it was quenched by the addition of MeOH 
(0.8 mL). The mixture was then allowed to warm to 20 ºC, and a solution of saturated 
Rochelle’s salt was added (~ 2 mL). The resulting mixture was stirred vigorously for 2 h, 
and then it was extracted with EtOAc (3 X 10 mL). The combined organic phase was 
dried over MgSO4, filtered and concentrated in vacuo. The crude mixture was dissolved 
in MeOH (1.0 mL), cooled to 0 ºC and treated directly with an excess of NaBH4. After 10 
minutes H2O was added (~ 1 mL) and the mixture was allowed to warm to 20 ºC then it 
was extracted with EtOAc (3 X 10 mL). The combined organic phase was washed with 
brine (1 X 10 mL) then it was dried over MgSO4, filtered and concentrated in vacuo. The 
crude material was dissolved in CH2Cl2 (2 mL) and TBDPSCl (xs) was added at 20 ºC, 
followed by Et3N (~ 0.15 mL, xs) and a small crystal of DMAP. The mixture was stirred 
at 20 ºC for 9 h then it was concentrated in vacuo. Purification of the residue by flash 
chromatography on SiO2 eluting with hexanes/EtOAc (70:30  50:50) gave bis-
silylether 178 as a colorless foam (9 mg, 65% overall yield). Rf = 0.71 (60% 
EtOAc/Hexanes); 1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8.0 Hz, 2H), 7.69 (app d, J 
= 8.0 Hz, 2H), 7.64 (d, J = 8.0 Hz, 2H), 7.63 (app d, J = 6.5 Hz, 2H), 7.49 (app d, J = 8.0 
Hz, 2H), 7.44 (app d, J = 7.5 Hz, 2H), 7.41-7.32 (m, 12H), 7.26-7.23 (m, 4H) 7.00 (d, J = 
2.0 Hz, 1H), 6.71 (dd, J = 8.0, 2.0 Hz, 1H), 6.28 (d, J = 8.5 Hz, 1H), 5.85 (d, J = 9.5 Hz, 
1H), 5.16 (d, J = 16.0 Hz, 1H), 4.61 (d, J = 16.0 Hz, 1H), 4.53 (d, J = 12.0 Hz, 1H), 4.02 
(dd, J = 10.5, 3.0 Hz, 1H), 3.91-3.88 (m, 2H), 3.79 (s, 3H), 3.71 (d, J = 9.0 Hz, 1H), 3.61 
(s, 3H), 3.61-3.56 (m, 2H), 3.48-3.43 (m, 3H), 3.38 (dd, J = 11.0, 2.0 Hz, 1H), 3.13 (dd, J 
= 11.0, 7.5 Hz, 1H), 3.05 (s, 3H), 2.97 (s, 3H), 3.0-2.9 (m, 1H), 2.46 (s, 3H), 2.42 (s, 3H), 
2.18 (app. t, J = 11.5 Hz, 1H), 1.10 (s, 9H), 0.99 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 
173.8, 156.7, 149.1, 148.5, 145.4, 143.4, 138.6, 135.96, 135.93, 135.77, 135.71 133.7, 
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132.8, 132.72, 132.66, 130.3, 130.2, 130.1, 130.0, 129.8, 129.5, 129.1, 128.5, 128.1, 
128.0, 127.8, 127.4, 120.1, 110.97, 110.91, 106.6, 75.7, 64.8, 60.3, 57.6, 56.9, 56.4, 56.0, 
55.7, 53.3, 53.2, 46.9, 46.8, 46.0, 40.6, 33.15, 29.9, 27.22, 27.20 21.9, 21.7, 19.53, 19.45; 
MS (MALDI) calcd for C70H84ClN3O12S2Si2 [M+Na]+: 1336, [M+K]+: 1352; found 
[M+Na]+: 1336, [M+K]+: 1352. 
 
 
 
 
 
 
 
Oxazolidinone 206: To a stirred solution of 177 (9.8 mg, 0.00924 mmol) in 0.9 mL of 
THF cooled to 0 ºC was added triethylamine (xs), followed by a few crystals of 
triphosgene, and the mixture was stirred at 0 ºC for 1 h. The reaction was then quenched 
at 0 ºC by the addition of a saturated solution of NaHCO3, and the organic solvent was 
evaporated under reduced pressure. The aqueous residue was extracted with EtOAc (3 X 
10 mL) and the combined organic phase was dried over MgSO4, filtered and concentrated 
in vacuo to afford a white crystalline solid. This crude material was dissolved in 1.0 mL 
of MeCN/H2O (3:1) and the solution was cooled to 0ºC. Ceric ammonium nitrate (25.4 
mg; 0.0463 mmol) was then added in one portion and the resulting mixture was stirred at 
0ºC for 1 h, The mixture was then diluted with EtOAc (~ 10 mL) and washed with brine 
(3 X 10 mL). The organic phase was dried over MgSO4, filtered and concentrated in 
vacuo. Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (70:30 
 50:50) gave oxazolidinone 206 as a colorless foam (6.9 mg, 80% overall yield of 206 
for the 2 steps). Rf = 0.48 (50% EtOAc/Hexanes); IR (thin film) 1786, 1723, 1447, 1172, 
1146 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 8.5 Hz, 2H), 7.80 (d, J = 8.5 Hz, 
2H), 7.75 (app dd, J = 8.0, 2.0 Hz, 2H), 7.72 (app dd, J = 8.0, 1.5 Hz, 2H), 7.45-7.39 (m, 
10H), 6.57 (br s, 1H), 4.81 (ddd, J = 9.5, 5.0, 1.5 Hz, 1H), 4.59 (d, J = 12.0 Hz, 1H), 4.51 
(dd, J = 9.5, 9.5 Hz, 1H), 4.15 (dd, J = 9.5, 5.0 Hz, 1H), 3.99-3.81 (m, 4H), 3.76 (dd, J = 
11.0, 11.0 Hz, 1H), 3.73 (s, 3H), 3.61 (ddd, J = 15.0, 9.5, 4.0 Hz, 1H), 3.42 (ddd, J = 14.5, 
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6.5, 3.5 Hz, 1H), 3.36 (dd, J = 11.5, 1.5 Hz, 1H), 2.80 (dddd, J = 11.5, 11.5, 2.5, 2.5 Hz, 
1H), 2.48 (s, 3H), 2.47 (s, 3H), 1.10 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 174.2, 172.7, 
155.6, 152.7, 146.6, 145.8, 136.00, 135.98, 135.0, 133.8, 133.0, 130.43, 130.39, 129.97, 
129.95, 128.7, 127.94, 127.93, 71.1, 70.6, 62.3, 58.4, 55.3, 52.80, 52.79, 50.9, 48.3, 43.25, 
33.1, 29.9, 27.0, 26.9, 22.0, 21.9, 19.6; MS (MALDI) calcd for C45H50ClN3O11S2Si 
[M+Na]+: 958, [M+K]+: 974; found [M+Na]+: 958, [M+K]+: 974. 
 
 
 
 
 
 
 
Carbinolamine 210: To a stirred solution of 177 (12 mg, 0.011 mmol) in 1.5 mL of 
CH2Cl2 at 23ºC was added Dess-Martin periodinane (10 mg, 0.024 mmol) in one portion. 
The mixture was stirred at 20ºC for 5 h, then it was diluted with Et2O (~ 10 mL) and 
filtered through a thick pad of Celite. The solvent was removed in vacuo affording a 
white foam. This crude material (211) was dissolved in 1.5 mL of MeCN/H2O (3:1) and 
the solution was cooled to 0ºC. Ceric ammonium nitrate (30 mg; 0.056 mmol) was then 
added in one portion and the resulting mixture was stirred at 0ºC for 2 h, The mixture was 
then diluted with EtOAc (~ 15 mL) and washed with brine (~ 15 mL). The organic phase 
was dried over MgSO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on SiO2 eluting with hexanes/EtOAc (70:30  60:40  35:65) gave 
carbinolamine 210 (not quantified) along with benzoyl aldehyde 210b (not quantified). 
210b was dissolved in 0.8 mL of THF/H2O and LiOH•H2O was added at 23ºC. After 10 
min the reaction mixture was quenched with NH4Cl (~ 5 mL) and extracted with EtOAc 
(3 x 5 mL). The combined organic phase was dried over MgSO4, filtered and 
concentrated in vacuo. Purification by flash chromatography on SiO2 eluting with 
hexanes/EtOAc (70:30  60:40  35:65) gave carbinolamine 210 as a colorless foam 
(3.7 mg, 36% overall yield of 210 for the 3 steps). Rf = 0.43 (50% EtOAc/Hexanes); 
[α]D19.5 31.3 (c 0.0032, CHCl3);  IR (thin film) 3470, 3269, 2928, 2854, 1782, 1723, 1146 
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cm-1; 1H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 8.5 Hz, 2H), 7.77 (d, J = 8.5 Hz, 2H), 
7.61-7.63 (m, 4H), 7.35-7.43 (m, 8H), 7.31 (d, J = 8.5 Hz, 2H), 6.26 (d, J = 6.5 Hz, 1H), 
5.88 (d, J = 3.0 Hz, 1H), 4.72 (d, J = 12.0 Hz, 1H), 4.23 (ddd, J = 15.0, 10.0, 2.5 Hz, 1H), 
3.99 (d, J = 7.0 Hz, 1H), 3.86 (dd, J = 11.0, 2.0 Hz, 1H), 3.83 (dd, J = 11.0, 1.5 Hz, 1H), 
3.74 (ddd, J = 15.0, 6.0, 3.0 Hz, 1H), 3.63 (ddd, J = 15.0, 10.5, 3.0 Hz, 1H), 3.41 (s, 3H), 
3.32 (dd, J = 11.5, 10.0 Hz, 1H), 3.25 (ddd, J = 15.0, 6.0, 2.5 Hz, 1H), 3.05 (d, J = 10.5 
Hz, 1H), 3.03 (br s., 1H), 2.66 (app t, J = 11.5 Hz, 1H), 2.46 (s, 3H), 2.42 (s, 3H), 1.02 (s, 
9H); 13C NMR (125 MHz, CDCl3) δ 171.4, 170.9, 157.7, 145.9, 143.6, 137.7, 135.8, 
135.0, 133.07, 133.05, 130.4, 130.02, 129.96, 128.7, 127.9, 127.2, 92.4, 79.9, 65.3, 61.6, 
58.0, 54.6, 52.3, 51.7, 51.4, 45.4, 33.0, 27.0, 21.9, 21.8, 19.6; MS (MALDI) calcd for 
C44H50ClN3O10S2Si [M+Na]+: 930, [M+K]+: 946; found [M+Na]+: 930, [M+K]+: 946. 
 
 
 
 
 
 
 
Bis-amine 214: To a stirred solution of carbinolamine 210 (3.8 mg, 0.00418 mmol) in 0.6 
mL of CH2Cl2 at 23ºC was added MgSO4 (tip of a microspatula), followed by 
tosylethylamine (xs). The mixture was heated to 50 ºC for 4.5 h then cooled to 20 ºC, 
filtered through a fritted funnel and concentrated in vacuo, Due to minimal reaction (by 
1H NMR) the crude material was resubjected to the reaction conditions for 2 h achieving 
complete conversion. Purification by flash chromatography on SiO2 eluting with 
hexanes/EtOAc (70:30  50:50) gave bis-amine 214. Rf = 0.43 (50% EtOAc/Hexanes); 
1H NMR (500 MHz, CDCl3) δ 7.91 (d, J = 7.5 Hz, 2H), 7.81 (d, J = 7.5 Hz, 2H), 7.77 (d, 
J = 7.0 Hz, 2H), 7.64-7.60 (m, 4H), 7.44-7.37 (m, 10H), 7.33 (d, J = 7.5 Hz, 2H), 6.23 (d, 
J = 8.0 Hz, 1H), 5.07 (app. s 1H), 4.64 (d, J = 12.0 Hz, 1H), 4.19-4.11 (m, 1H), 3.86-3.78 
(m, 1H), 3.84 (d, J = 8.0 Hz, 1H), 3.74 (d, J = 8.0 Hz, 1H), 3.65-3.61 (m, 1H), 3.46 (s, 
3H), 3.43-3.38 (m, 1H), 3.25-3.04 (m, 4H), 3.22 (dd, J = 11.0, 11.0 Hz, 1H), 3.08 (d J = 
9.5 Hz, 1H), 2.71 (app t, J = 11.5 Hz, 1H), 2.47 (s, 6H), 2.44 (s, 3H), 2.26-2.22 (m, 1H), 
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1.05 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 171.47, 171.42, 158.9, 145.9, 145.2, 143.7, 
137.9, 136.15, 135.75, 135.1, 133.1, 133.0, 130.4, 130.3, 130.1, 128.7, 128.3, 128.0, 
127.2, 83.39, 83.34, 80.3, 66.3, 61.1, 58.3, 54.9, 53.85, 52.34, 52.31, 51.5, 51.1, 46.3, 
39.4, 33.15, 29.9, 27.0, 21.90, 21.89, 19.65; MS (MALDI) calcd for C53H61ClN4O11S3Si 
[M+H]+: 1089 [M+Na]+: 1111, [M+K]+: 1127; found [M+H]+: 1089 [M+Na]+: 1111, 
[M+K]+: 1127. 
 
 
 
 
 
 
TIPS-Ester 220: To a stirred solution of ester 177 (18 mg, 0.0170 mmol) in 1.8 mL of 
CH2Cl2 at 20 ºC was added Et3N (10 µL, 0.07 mmol), followed by TIPSOTf (6 µL, 0.04 
mmol). The reaction mixture was stirred for 1 h at 20 ºC and then it was diluted with 15 
mL of EtOAC and quenched with 10 mL of saturated NH4Cl solution. The mixture was 
washed once with brine (15 mL) and the organic phase was dried over MgSO4, filtered 
and concentrated in vacuo. Purification of the crude orange oil by flash chromatography 
on SiO2 eluting with hexanes/EtOAc (90:10  85:15  70:30) gave 19 mg (91%) of 
TIPS-ester 220 as a colorless foam: Rf = 0.52 (40% EtOAc/Hexanes); [α]D19.5 24.8 (c 
0.0105, CH2Cl2); IR (thin film) 3366, 2949, 2866, 1780, 1726, 1442, 1149 cm-1; 1H NMR 
(500 MHz, benzene-d6) δ 7.88 (d, J = 8.5 Hz, 2H), 7.86 (dd, J = 8.0, 1.0 Hz, 2H), 7.82 
(dd, J = 8.0, 1.0 Hz, 2H), 7.43 (d, J = 8.0 Hz, 2H),  7.24-7.36 (m, 7H), 7.06 (dd, J = 8.5, 
1.5 Hz, 1H) 6.83 (d, J = 8.5 Hz, 2H), 6.70 (d, J = 8.5 Hz, 2H), 6.50 (d, J = 8.5 Hz, 1H), 
5.29 (d, J = 9.5 Hz, 1H), 5.16 (d, J = 11.5 Hz, 1H), 5.00 (d, J = 16.0 Hz, 1H), 4.93 (d, J = 
16.5 Hz, 1H), 4.29 (dd, J = 12.0, 10.5 Hz, 1H), 3.93 (app t, , J = 11.5, Hz, 1H), 3.82-3.92 
(m, 2H), 3.67-3.77 (m, 4H), 3.69 (s, 3H), 3.61 (s, 3H) 3.55 (ddd, J = 14.5, 8.5, 6.0 Hz, 
1H), 3.34 (s, 3H), 3.28 (dd, J = 10.5, 3.5 Hz, 1H), 3.07 (dt, J = 14.5, 5.5 Hz, 1H), 2.64 
(app. t, J = 11.5 Hz, 1H), 1.91 (s, 3H), 1.81 (s, 3H), 1.26 (s, 9H), 1.02-1.07 (m, 21H); 13C 
NMR (125 MHz, benzene-d6) δ 173.5, 172.6, 157.4, 150.4, 149.4, 144.6, 143.0, 139.6, 
136.05, 135.9, 135.8, 133.8, 133.0, 130.1, 130.0, 129.9, 129.8, 129.0, 128.8, 128.2, 128.0, 
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127.8, 126.8, 119.8, 112.2, 111.0, 74.5, 63.1, 60.7, 57.8, 55.65, 55.25, 54.0, 52.5, 51.9, 
49.0, 46.7, 46.3, 46.1, 33.6, 27.2, 21.05, 20.99, 19.6, 18.10, 18.09, 12.1; MS (MALDI) 
calcd for C62H82ClN3O12S2Si2 [M+Na]+: 1238, [M+K]+: 1254; found [M+Na]+: 1238, 
[M+K]+: 1254 
 
 
 
 
 
 
 
TIPS-alcohol 221: To a stirred solution of 220 (19 mg, 0.016 mmol) in 2.5 mL of 
CH2Cl2 cooled to -78 ºC was added DIBAl-H (8.5 µL, 0.048 mmol) dropwise. The 
mixture was stirred at -78 ºC for 55 min. then quenched with 1.5 mL of MeOH, then 
allowed to warm to 20 ºC, Rochelle’s salt solution (~15 mL) was then added and the 
resulting cloudy mixture was stirred vigorously for 3.5 h. Water (~10 mL) was then 
added and the mixture was extracted with EtOAC (3 x 20 mL). The organic phase was 
dried over MgSO4, filtered and concentrated in vacuo. The crude material was dissolved 
in 2.5 mL of MeOH, cooled to 0ºC and treated directly with excess NaBH4. After 40 min. 
water (~10 mL) was added and the mixture was allowed to 20 ºC while stirring. The 
mixture was then extracted with EtOAC (3 x 15 mL), and the organic phase was dried 
over MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on 
SiO2 eluting with hexanes/EtOAc (80:20 70:30) gave 12 mg (67%) of TIPS-alcohol 
221 as a colorless foam: Rf = 0.43 (40% EtOAc/Hexanes); [α]D20.5 16.7 (c 0.012, CHCl3); 
IR (thin film) 3493, 2925, 2863, 1774, 1717, 1451, 1146 cm-1; 1H NMR (500 MHz, 
benzene-d6) δ 7.89 (d, J = 8.5 Hz, 2H), 7.79 (d, J = 6.5 Hz, 2H), 7.75 (d, J = 7.0 Hz, 2H), 
7.61 (d, J = 8.0 Hz, 2H), 7.32-7.37 (m, 4H), 7.26 (d, J = 1.5 Hz, 1H), 7.25 (app s, 1H), 
7.23 (d, J = 1.5 Hz, 1H), 7.09 (dd, J = 8.5, 2.0 Hz, 1H), 6.77 (d, J = 8.0 Hz, 2H), 6.74 (d, 
J = 8.5 Hz, 2H), 6.67 (d, J = 10.0 Hz, 1H), 6.46 (d, J = 8.5 Hz, 1H), 5.46 (d, J = 16.5 Hz, 
1H), 5.01 (d, J = 11.5 Hz, 1H), 4.96 (d, J = 16.5 Hz, 1H), 4.18-4.21 (m, 1H), 3.89 (dd, J 
= 10.5, 2.0 Hz, 1H), 3.84 (dd, J = 11.0, 2.0 Hz, 1H), 3.72-3.78 (m, 2H), 3.61-3.67 (m, 
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1H), 3.63 (s, 3H), 3.56 (dd, J = 11.0, 2.0 Hz, 1H), 3.55 (dd, J = 10.5, 3.0 Hz, 1H), 3.49 
(app t, J = 9.5 Hz, 1H), 3.46 (dd, J = 9.5, 3.5 Hz, 1H), 3.42 (dd, J = 8.5, 5.0 Hz, 1H), 3.33 
(m, 3H), 3.30 (dd, J = 11.5, 5.5 Hz, 1H), 3.16-3.23 (m, 1H), 3.06 (br. s, 1H), 3.00 (dt, J = 
10.0, 5.0 Hz, 1H), 2.32 (app t, J = 11.5 Hz, 1H), 1.88 (s, 3H), 1.81 (s, 3H), 1.23 (s, 9H), 
1.00-1.06 (m, 21H); 13C NMR (125 MHz, benzene-d6) δ 174.1, 157.4, 150.45, 149.5, 
144.7, 142.8, 140.7, 136.3, 136.1, 135.9, 133.9, 133.2, 130.4, 130.2, 130.0, 129.9, 129.8, 
129.3, 128.4, 128.2, 128.0, 127.05, 120.2, 112.2, 111.7, 76.4, 66.8, 65.45, 61.0, 58.8, 
55.75, 55.4, 53.1, 52.0, 50.0, 47.2, 46.7, 41.95, 33.7, 27.4, 21.2, 21.1, 19.65, 18.3, 18.2, 
12.1; MS (MALDI) calcd for C61H82ClN3O11S2Si2 [M+Na]+: 1210, [M+K]+: 1226; found 
[M+Na]+: 1210, [M+K]+: 1226. 
 
 
 
 
 
 
 
Azabicyclooctane 222: A mixture of TIPS-alcohol 221 (8.5 mg, 0.0072 mmol) and 
triphenyhlphosphine (4.0 mg, 0.015 mmol) was azeotroped with PhMe (300 µL) under 
vacuum for 4 h. PhMe (1.6 mL) was then added under N2 at 20 ºC, followed by DIAD (3 
µL, 0.015 mmol). The mixture was stirred at 20 ºC for 2.5 h and then it was concentrated 
in vacuo. Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc 
(90:10  70:30) provided a semi-pure material contaminated with DIAD byproduct. 
Further purification by flash chromatography on SiO2 eluting with CHCl3/acetone (100:0 
 99:1) gave 6.2 mg (74%) of azabicyclooctane 222 as a colorless foam: Rf = 0.30 (30% 
EtOAc/Hexanes); [α]D20.7 –29.0 (c 0.0062, CHCl3);  IR (thin film), 2940, 2863, 1774, 
1723, 1448, 1149 cm-1; 1H NMR (500 MHz, benzene-d6) δ 7.87 (d, J = 8.5 Hz, 2H), 7.84 
(d, J = 8.0 Hz, 2H), 7.61 (dd, J = 8.0, 1.5 Hz, 2H), 7.56 (dd, J = 7.5, 2.0 Hz, 2H), 7.20-
7.27 (m, 6H), 7.08 (d, J = 2.0 Hz, 1H), 6.82 (d, J = 8.5 Hz, 2H), 6.72 (d, J = 8.5 Hz, 2H), 
6.52 (dd, J = 8.0, 2.0 Hz, 1H), 6.47 (d, J = 8.0 Hz, 1H), 5.11 (d, J = 16.5 Hz, 1H), 4.43 (d, 
J = 9.5 Hz, 1H), 4.31 (dd, J = 10.5, 4.5 Hz, 1H), 4.15 (dd, J = 10.5, 2.0 Hz, 1H), 4.04 (dd, 
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J = 11.0, 5.5 Hz, 1H), 3.98 (ddd, J = 14.5, 7.5, 5.5 Hz, 1H), 3.80 (dt, J = 14.5, 6.0 Hz, 
1H), 3.72-3.76 (m, 1H), 3.69 (s, 3H), 3.64 (d, J = 16.5 Hz, 1H), 3.47 (dd, J = 14.5, 10.5 
Hz, 1H). 3.35-3.41 (m, 2H), 3.30 (s, 3H), 3.27 (dd, J = 11.0, 5.0 Hz, 1H), 3.20 (dt, J = 
14.5, 6.0 Hz, 1H), 3.01 (app t, J = 11.0 Hz, 1H), 1.91 (s, 3H), 1.85-1.95 (m, 2H), 1.81 (s, 
3H), 1.25-1.27 (m, 21H), 0.93 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 170.5, 155.45, 
150.1, 149.05, 145.4, 144.2, 135.63, 135.57, 135.5, 135.4, 132.9, 132.5, 130.32, 130.30, 
130.2, 128.7, 128.6, 128.14, 128.06, 127.8, 118.7, 110.95, 109.8, 70.3, 65.6, 64.1, 61.8, 
58.35, 56.3, 56.15, 56.0, 52.75, 51.4 50.0, 47.3, 44.9, 33.4, 26.9, 21.90, 21.88, 19.2, 18.16, 
18.15, 12.2; MS (MALDI) calcd for C61H80ClN3O10S2Si2 [M+H]+: 1170, [M+Na]+: 1192, 
[M+K]+: 1208; found [M+H]+: 1170, [M+Na]+: 1192, [M+K]+: 1208. 
 
 
 
 
 
 
 
Aziridine 223: A mixture of ester 177 (4.5 mg, 0.0042 mmol) and triphenyhlphosphine 
(2.3 mg, 0.0088 mmol) was azeotroped with PhMe (50 µL) under vacuum for 2 h. PhMe 
(1.0 mL) was then added under N2 at 20 ºC, followed by DIAD (2 µL, 0.010 mmol). The 
mixture was stirred at 20 ºC for 2 h and then it was concentrated in vacuo. Crude 1H 
NMR analysis showed a ~ 2:1 mixture of 177 and 223 (respectively). The crude material 
was resubjected to the reaction conditions, stirred for 3 h and concentrated in vacuo. 
Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (70:30  
60:40) gave 3.2 mg (73%) of aziridine 223 as a colorless foam: Rf = 0.48 (50% 
EtOAc/Hexanes); IR (thin film), 2954, 2860, 1774, 1725, 1451, 1146 cm-1; 1H NMR (500 
MHz, benzene-d6) δ 7.83 (d, J = 8.0 Hz, 2H), 7.82 (d, J = 7.0 Hz, 2H), 7.80 (d, J = 8.5 Hz, 
2H), 7.74 (d, J = 7.0 Hz, 2H), 7.39 (app t, J = 7.5 Hz, 2H), 7.34 (d, J = 2.0 Hz, 1H), 7.23-
7.31 (m, 4H), 6.89 (dd, J = 8.5, 2.0 Hz, 1H), 6.78 (d, J = 8.0 Hz, 2H), 6.67 (d, J = 8.0 Hz, 
2H), 6.36 (d, J = 8.5 Hz, 1H), 5.21 (d, J = 16.0 Hz, 1H), 5.01 (d, J = 11.5 Hz, 1H), 4.67 
(d, J = 15.5 Hz, 1H), 3.95 (dd, J = 11.0, 2.0 Hz, 1H), 3.85 (dd, J = 11.0, 2.0 Hz, 1H), 3.75 
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(dd, J = 10.5, 7.5 Hz, 1H), 3.64 (s, 3H), 3.49-3.60 (m, 3H), 3.39 (s, 3H), 3.29-3.34 (m, 
1H), 3.32 (s, 3H), 3.18-3.23 (m, 2H), 3.00 (ddd, J = 15.0, 7.0, 4.0 Hz, 1H), 2.38 (d, J = 
4.0 Hz, 1H), 2.30 (d, J = 6.5 Hz, 1H), 1.83 (s, 3H), 1.82 (s, 3H), 1.24 (s, 9H); 13C NMR 
(125 MHz, benzene-d6) δ 172.9, 172.35, 157.1, 150.8, 150.2, 144.7, 144.3, 136.4, 136.32, 
136.26, 134.5, 133.3, 130.52, 130.49, 130.15, 129.9, 129.7, 129.3, 121.1, 112.9, 112.3, 
75.2, 59.5, 59.4, 56.0, 55.6, 52.2, 51.3, 49.5, 49.2, 46.8, 46.4, 40.5, 35.1, 33.7, 27.7, 27.6, 
21.4, 20.0; MS (MALDI) calcd for C53H60ClN3O11S2Si [M+Na]+: 1064, [M+K]+: 1080; 
found [M+Na]+: 1064, [M+K]+: 1080. 
 
 
 
 
 
 
Azabicyclooctane 225: To a stirred solution of azabicyclooctane 222 (6.2 mg, 0.0053 
mmol) in 0.5 ml of THF cooled to –35 ºC was added TBAF (10 µL, 0.01 mmol) dropwise 
and the mixture was stirred at –20 ºC for 1.5 h. The reaction was then quenched with 1 ml 
of pH 7 buffer and the mixture was allowed to warm to 20 ºC. Brine (~0.5 mL) was then 
added and the mixture was extracted with EtOAc (3 x 7 mL). The combined organic 
phase was dried over MgSO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on SiO2 eluting with hexanes/EtOAc (90:10  70:30  50:50) gave 3.3 
mg (61%) of azabicyclooctane 225 as a colorless solid: Rf = 0.24 (50% EtOAc/Hexanes); 
IR (thin film), 3503, 2934, 2857, 1774, 1717, 1457, 1152 cm-1; 1H NMR (500 MHz, 
benzene-d6) δ 7.84 (d, J = 8.5 Hz, 2H), 7.82 (d, J = 8.5 Hz, 2H), 7.68 (dd, J = 8.0, 2.0 Hz, 
2H), 7.54 (dd, J = 8.0, 2.0 Hz, 2H), 7.20-7.25 (m, 6H), 6.98 (d, J = 2.5 Hz, 1H), 6.88 (d, J 
= 8.0 Hz, 2H), 6.74 (d, J = 8.0 Hz, 2H), 6.62 (dd, J = 8.0, 2.0 Hz, 1H), 6.53 (d, J = 8.5 Hz, 
1H), 5.06 (d, J = 16.5 Hz, 1H), 4.49 (d, J = 9.5 Hz, 1H), 4.45 (dd, J = 10.0, 4.5 Hz, 1H), 
3.93-3.98 (m, 1H), 3.81-3.89 (m, 2H), 3.72 (d, J = 16.5, 1H), 3.64-3.69 (m, 1H), 3.65 (s, 
3H), 3.45-3.41 (m, 3H), 3.38 (d, J = 3.5 Hz, 2H), 3.33 (s, 3H), 2.94 (dd, J = 14.0, 10.5 Hz, 
1H), 2.74 (app t, J = 10.5 Hz, 1H), 2.57 (br s., 1H), 1.92 (s, 3H), 1.78-1.90 (m, 2H), 1.82 
(s, 3H), 0.90 (s, 9H); 13C NMR (125 MHz, benzene-d6) δ 171.8, 156.5, 151.3, 150.2, 
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144.8, 143.8, 136.6, 136.3, 136.1, 135.95, 133.20, 133.15, 130.7, 130.56, 130.52, 130.3, 
129.8, 129.0, 118.9, 112.7, 111.0, 71.0, 66.7, 64.3, 61.1, 60.8, 58.4, 56.3, 55.9, 53.3, 51.3 
50.1, 45.85, 45.2, 33.9, 27.0, 21.5, 21.4, 19.4; MS (MALDI) calcd for 
C52H60ClN3O10S2Si [M+Na]+: 1036; found [M+Na]+: 1036. 
 
 
 
 
 
 
 
Aziridine 226: A mixture of diol 224 (3.5 mg, 0.0034 mmol) and triphenyhlphosphine 
(3.8 mg, 0.0145 mmol) was azeotroped with PhMe (50 µL) under vacuum for 1.5 h. 
PhMe (1.0 mL) was then added under N2 at 20 ºC, followed by DIAD (2 µL, 0.010 
mmol). The mixture was stirred at 20 ºC for 2 h and then it was concentrated in vacuo. 
Crude 1H NMR analysis showed a ~ 1:1 mixture of azabicyclooctane 225 and aziridine 
226. Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (70:30 
 60:40  50:50) gave ~2 mg (~55%) of a mixture of azabicyclooctane 225 and 
aziridine 226. The two products were separated by prep TLC eluting with hexanes/EtOAc 
(75:25, 30 elutions): Characterization for azabicyclooctane 225 is reported above. 
Aziridine 226: Rf = 0.24 (50% EtOAc/Hexanes); IR (thin film) 3532, 2928, 2854, 1771, 
1714, 1451, 1149 cm-1; 1H NMR (500 MHz, benzene-d6) δ 7.80 (dd, J = 8.0, 1.5 Hz, 2H), 
7.75-7.79 (m, 4H), 7.73 (d, J = 8.0, Hz, 2H), 7.38 (app t, J = 7.5, Hz, 2H), 7.34 (d, J = 2.0, 
Hz, 1H), 7.23-7.33 (m, 4H), 6.92 (dd, J = 8.0, 2.0 Hz, 1H), 6.74 (d, J = 8.0 Hz, 2H), 6.65 
(d, J = 8.0 Hz, 2H), 6.46 (d, J = 8.5 Hz, 1H), 5.00 (d, J = 11.5 Hz, 1H), 4.94 (d, J = 15.5 
Hz, 1H), 4.69 (d, J = 16.0 Hz, 1H), 3.99-4.03 (m, 1H), 3.86-3.89 (m, 1H), 3.85 (dd, J = 
10.5, 2.0 Hz, 1H), 3.78 (dd, J = 10.5, 2.0 Hz, 1H), 3.67 (s, 3H), 3.51-3.55 (m, 2H), 3.36 
(s, 3H), 3.12-3.21 (m, 2H), 2.93-3.00 (m, 2H), 2.83 (app t, J = 11.0 Hz, 1H), 2.62 (dd, J = 
10.0, 7.5 Hz, 1H), 2.43 (d, J = 5.0 Hz, 1H), 2.30 (m,1H), 2.16 (d, J = 6.5 Hz, 1H), 1.81 (s, 
3H), 1.80 (s, 3H), 1.23 (s, 9H); MS (MALDI) calcd for C52H60ClN3O10S2Si [M+Na]+: 
1036, [M+K]+: 1052;  found [M+Na]+: 1036, [M+K]+: 1052. 
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Carbinolamino alcohol 227: To a stirred solution of aziridine 223 (2.8 mg, 0.0027 mmol) 
in 0.6 mL THF cooled to 0 ºC was added a 2M solution of LiBH4 in THF (xs). After 1 h 
the mixture was allowed to warm to 20 ºC and stirred for an additional 5 h then it was 
quenched by the addition of a saturated solution of NH4Cl (~ 1 mL). After stirring 
vigorously for 15 minutes the mixture was extracted with EtOAc (3 X 5 mL) and the 
combined organic phase was dried over MgSO4, filtered and concentrated in vacuo. 
Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (70:30  
40:60  20:80) gave ~3 mg (~99%, ~3.6:1 dr at C20) of carbinolamino alcohol 227: Rf = 
0.35 (50% EtOAc/Hexanes); 1H NMR (500 MHz, benzene-d6) δ 7.89-7.86 (m, 4H), 7.81 
(d, J = 8.0, Hz, 2H), 7.69 (d, J = 8.0, Hz, 2H), 7.43 (d, J = 2.0 Hz, 1H), 7.36 (app td, J = 
7.5, 4.0, Hz, 4H), 7.29-7.26 (m, 1H), 7.27 (dd, J = 7.5, 3.0 Hz, 2H), 6.72 (d, J = 7.5 Hz, 
2H), 6.71 (d, J = 8.0 Hz, 2H), 6.68 (d, J = 8.0 Hz, 2H), 5.45 (d, J = 11.0 Hz, 1H) 5.05 (d, 
J = 12.0 Hz, 1H), 4.85 (d, J = 15.5 Hz, 1H), 4.65 (d, J = 15.5 Hz, 1H), 3.96 (dd, J = 11.0, 
3.0 Hz, 1H), 3.85 (ddd, J = 15.0, 7.0, 4.0 Hz, 1H), 3.75-3.70 (m, 1H),  3.69 (dd, J = 11.0, 
2.0 Hz, 1H), 3.65 (s, 3H), 3.52-3.44 (m, 1H), 3.48 (s, 3H), 3.17 (d, J = 11.0 Hz, 1H ), 
3.17-3.13 (m, 1H), 3.04 (ddd, J = 10.5, 6.5, 4.5 Hz, 1H), 2.89 (ddd, J = 14.5, 7.0, 4.5 Hz, 
1H), 2.76-2.72 (m, 1H), 2.54 (app dd, J = 11.0, 11.0 Hz, 1H), 2.27 (d, J = 4.5 Hz, 1H), 
2.22 (dd, J = 10.0, 5.0 Hz, 1H), 2.19 (d, J = 6.0 Hz, 1H), 2.13 (br. s, 1H) 1.82 (s, 6H), 
1.31 (s, 9H); 13C NMR (125 MHz, benzene-d6) δ 159.7, 150.6, 150.1, 144.6, 144.3, 137.3, 
136.54, 136.47, 136.4, 136.3, 134.1, 133.5, 132.7, 132.6, 132.1, 130.6, 130.5, 130.2, 
130.0, 121.9, 114.0, 112.5, 89.0, 70.9, 66.2, 59.7, 59.3, 56.1, 55.9, 54.4, 49.6, 46.65, 
45.45, 44.2, 43.35, 35.4, 34.9, 27.7, 21.44, 21.41, 20.0;  MS (MALDI) calcd for 
C52H62ClN3O10S2Si [M+Na]+: 1038, [M+K]+: 1054;  found [M+Na]+: 1038, [M+K]+: 
1054. 
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Aminotriol 228: To a stirred solution of alcohol 221 (6.1 mg, 0.0051 mmol) in 1.0 mL 
THF at 20 ºC was added AcOH (50 µL). The mixture was then cooled to 0 ºC and TBAF 
was added (xs). After 2 h the mixture was allowed to warm to 20 ºC and stirred for an 
additional 7 h then it was diluted with EtOAc (~ 5 mL) and washed with a saturated 
solution of NaHCO3 (~ 2 mL). The aqueous phase was back extracted with EtOAc (1 X 5 
mL) and the combined organics were dried over MgSO4, filtered and concentrated in 
vacuo. Having observed partial, non-selective desilylilation, the crude mixture was 
resubjected to the reaction conditions and stirred at 20 ºC for 12 h, then worked up as 
before. Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (50:50 
 30:70  20:80) gave ~1.5 mg (~25%) of aminotriol 228: Rf = 0.12 (60% 
EtOAc/Hexanes); IR (thin film): 3508, 3289, 2928, 2857, 1770, 1714, 1454, 1152 cm-1; 
1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8.5, Hz, 2H), 7.61 (d, J = 8.5, Hz, 2H), 7.41 (d, 
J = 8.5 Hz, 2H), 7.25 (d, J = 8.8, Hz, 2H), 7.05 (d, J = 1.5 Hz, 1H), 6.98 (dd, J = 8.0,1.5 
Hz, 1H), 6.78 (d, J = 8.0 Hz, 2H), 6.04 (br s, 1H), 4.81 (d, J = 16.5 Hz, 1H), 4.55 (d, J = 
16.0 Hz, 1H), 4.50 (d, J = 11.0 Hz, 1H), 3.97-3.80 (m, 5H), 3.88 (s, 3H), 3.87 (s, 3H), 
3.74 (dd, J = 11.5, 4.5 Hz, 1H), 3.56-3.44 (m, 3H),  3.37 (app d, J = 11.0 Hz, 1H), 2.96 
(dd, J = 11.5, 4.5 Hz, 1H), 2.79 (dd, J = 8.5, 8.5 Hz, 1H), 2.62-2.56 (m, 1H), 2.47 (s, 3H), 
2.46-2.43 (m, 1H), 2.41 (s, 3H), 13C NMR (125 MHz, CDCl3) δ 173.5, 157.0, 149.1, 
148.7, 145.9, 143.8, 138.65, 134.7, 130.4, 130.0, 128.9, 128.7, 126.8, 120.9, 111.8, 111.1, 
75.9, 65.3, 62.9, 59.6, 59.2, 56.15, 56.0, 54.0, 52.0, 47.6, 47.0, 46.3, 42.7, 33.2, 21.95, 
21.8;  MS (MALDI) calcd for C36H44ClN3O11S2 [M+Na]+: 816, [M+K]+: 832;  found 
[M+Na]+: 816, [M+K]+: 832. 
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Imidazolone 185. To a solution of ester 177 (109 mg, 0.103 mmol) in 10.0 mL of 
CH2Cl2 was added Dess Martin periodinane (72 mg, 0.170 mmol), and the resulting 
reaction mixture was stirred at 20 °C for 3.5 h. Upon completion of the reaction as 
indicated by TLC, anhydrous ether (Et2O, ~20 mL) was added and the mixture was 
filtered through a pad of Celite. Removal of solvents in vacuo afforded the desired 
aldehyde. The crude aldehyde 211 was dissolved in 10.0 mL of anhydrous CH2Cl2 and 
cooled to 0 °C. To the solution was added MgSO4 (~100 mg) and TseNH2 (23 mg, 0.115 
mmol) and the reaction mixture was stirred at 0 ºC for 1 h then warmed to 20 ºC. 
Removal of MgSO4 by filtration and concentration in vacuo yielded the Tse-imine 
intermediate 244, which was used directly without further purification. The Tse-imine 
was dissolved in 11.0 mL of anhydrous THF and cooled to 0 °C. To the solution was 
added Et3N (50 µL, 0.354 mmol) and triphosgene (30 mg, 0.101 mmol) sequentially. The 
reaction mixture was warmed to 20 ºC and stirred for 30 min, then it was sealed, heated 
to 60 °C and stirred for 4 h. A saturated NaHCO3 solution (20 mL) was then added and 
the resulting mixture was cooled to 20 ºC and partitioned between water (20 mL) and 
EtOAc (3 x 30 mL). The combined organic phase was washed with brine, dried over 
MgSO4 and concentrated in vacuo. Purification by flash chromatography on SiO2 eluting 
with hexanes/EtOAc (60:40  50:50  40:60) gave 65 mg (50% 3 steps) of imidazolone 
185 as a colorless solid: Rf = 0.63 (60% EtOAc/Hexanes); [α]D23 = -44.7 (c = 0.75, 
CH2Cl2); IR (thin film): 3100-3600, 2955, 2931, 1723, 1640, 1516, 1451, 1318, 1146, 
814, 705 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.90 (d, J = 8.0 Hz, 2H), 7.83 (d, J = 8.5 
Hz, 2H), 7.65 (d, J = 8.5 Hz, 2H), 7.61 (dd, J = 8.0, 1.5 Hz, 2H), 7.52 (dd, J = 8.0, 1.5 Hz, 
2H), 7.36-7.45 (m, 10H), 7.31 (d, J = 8.0 Hz, 2H), 7.04 (d, J = 2.0 Hz, 1H), 6.81 (dd, J = 
8.0, 2.0 Hz, 1H), 6.50 (d, J = 1.0 Hz, 1H), 6.37 (d, J = 8.0 Hz, 1H), 4.95 (d, J = 16.0 Hz, 
1H), 4.79 (dd, J = 10.5, 1.0 Hz, 1H), 4.49 (d, J = 11.5 Hz, 1H), 4.11 (d, J = 16.0 Hz, 1H), 
3.80-3.96 (m, 4H), 3.76 (s, 3H), 3.68 (s, 3H), 3.62 (s, 3H), 3.51-3.59 (m, 2H), 3.43 (t, J = 
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11.0 Hz, 1H), 3.36-3.40 (m, 1H), 3.14 (dt, J = 14.5, 5.0 Hz, 1H), 2.89 (app t, J = 11.5 Hz, 
1H), 2.44 (s, 9H), 1.07 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 173.3, 171.6, 156.6, 
150.7, 149.1, 148.4, 146.3, 145.7, 145.15, 136.1, 135.8, 135.71, 135.69, 133.9, 132.9, 
132.75, 130.4, 130.31, 130.25, 130.15, 129.9, 129.5, 129.05, 128.5, 128.04, 128.00, 
127.98, 120.2, 118.6, 115.1, 111.4, 110.7, 73.15, 59.2, 58.1, 56.0, 55.8, 54.3, 52.75, 52.74, 
46.6, 44.3, 43.6, 42.7, 38.05, 33.7, 27.2, 22.0, 21.89, 21.88, 19.6; MS (MALDI) calcd for 
C63H69ClN4O14S3Si [M+Na]+: 1287, [M+K]+: 1303; found [M+Na]+: 1287, [M+K]+: 
1303. HRMS (ESI) calcd for C63H69ClN4O14S3Si  [M+Li]+: 1271.3590; found: 1271.3604.  
 
 
 
 
 
 
Imidazolone azide 251: To a solution of imidazolone 185 (13 mg, 0.00103 mmol) in 3.6 
mL of THF was added AcOH (~ 50 µL, xs), followed by TBAF (~ 150 µL, xs) and the 
resulting mixture was stirred at 20 ºC for 8.5 h, adding additional TBAF every hour. The 
mixture was then diluted with EtOAc (~ 20 mL), washed with a saturated solution of 
NaHCO3 (~ 15 mL), dried over MgSO4, filtered and concentrated in vacuo. Purification 
by flash chromatography on SiO2 eluting with hexanes/EtOAc (50:50  40:60  0:100) 
gave 6 mg (57%) of the desired alcohol intermediate and 3.5 mg (27%) of starting 
imidazolone 185. The purified alcohol was dissolved in 2 mL of CH2Cl2 and cooled to 0 
ºC. Et3N was then added (~ 4 µL, xs), followed by MsCl (~ 2 µL, ~0.02 mmol), and the 
resulting mixture was stirred at 0 ºC for 1h. Water was then added (~ 4 mL) and the 
mixture was extracted with EtOAc (3 X 5 mL), and the combined organic phase was 
dried over MgSO4, filterd and concentrated in vacuo. The crude material was dissolved in 
1.3 mL of anhydrous DMF, and NaN3 (7.5 mg, 0.115 mmol) was added in one portion. 
The resulting mixture was heated to 50 ºC for 12 h then it was allowed to cool t0 20 ºC. 
Water (~20 mL) was added, the mixture was extracted with EtOAc (3 X 15 mL), and the 
combined organic phase was washed with water (1 X 10 mL) and brine (1 X 15 mL) then 
it was dried over MgSO4, filterd and concentrated in vacuo. Purification by flash 
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chromatography on SiO2 eluting with hexanes/EtOAc (60:40  40:60  30:70) gave 5 
mg (81% over the two steps) of imidazolone azide 251: Rf = 0.39 (60% EtOAc/Hexanes); 
IR (thin film): 2954, 2931, 2108, 1777, 1723, 1450, 1146 cm-1; 1H NMR (500 MHz, 
CDCl3): δ 7.90 (d, J = 8.5 Hz, 2H), 7.82 (d, J = 8.0 Hz, 2H), 7.61 (d, J = 8.5 Hz, 2H), 
7.359 (d, J = 8.0 Hz, 2H), 7.361 (d, J = 8.0 Hz, 2H) 7.30 (d, J = 8.5 Hz, 2H), 7.02 (d, J = 
2.0 Hz, 1H), 6.98 (dd, J = 8.5, 2.0 Hz, 1H), 6.77 (d, J = 8.5 Hz, 1H), 6.66 (d, J = 1.0 Hz, 
1H), 5.02 (d, J = 16.0 Hz, 1H),  4.73 (dd, J = 9.5, 1.0 Hz, 1H), 4.18 (d, J = 11.0 Hz, 1H), 
4.00-3.90 (m, 2H), 3.93 (d, J = 15.5 Hz, 1H), 3.83 (dd, J = 13.0, 2.5 Hz, 1H), 3.83 (s, 3H), 
3.80 (s, 3H), 3.79 (s, 3H), 3.66 (dd, J = 13.0, 2.5 Hz, 1H), 3.53 (tdd, J = 15.0, 14.0, 6.0 
Hz, 2H), 3.38 (ddd, J = 14.0, 9.0, 4.5 Hz, 1H),  3.14 (ddd, J = 14.5, 5.5, 3.5 Hz, 1H), 3.04 
(dd, J = 11.0, 11.0  Hz, 1H), 2.98 (app tt, J = 11.0, 2.5  Hz, 1H), 2.45 (s, 6H), 2.43 (s, 3H); 
13C NMR (125 MHz, CDCl3) δ 173.0, 171.1, 156.3, 150.7, 149.0, 148.7, 146.4, 145.85, 
145.2, 136.0, 135.7, 133.9, 130.45, 130.3, 130.0, 129.5, 129.0, 128.4, 127.9, 121.3, 118.3, 
115.4, 112.0, 111.0, 73.0, 59.4, 56.03, 55.98, 54.5, 53.15, 52.7, 48.4, 44.6, 44.3, 43.85, 
42.1, 37.9, 33.7, 22.0, 21.9; MS (MALDI) calcd for C47H50ClN7O13S3 [M+H]+: 1052, 
[M+Na]+: 1074, [M+K]+: 1090; found [M+H]+: 1052, [M+Na]+: 1074, [M+K]+: 1090. 
 
 
 
 
 
 
 
 
Guanidine 263. To a solution of ester 177 (10 mg, 0.0094 mmol) in 1.0 mL of CH2Cl2 
was added Dess Martin periodinane (6 mg, 0.0141 mmol), and the resulting reaction 
mixture was stirred at 20 °C for 4 h. Upon completion of the reaction as indicated by 
TLC, anhydrous ether (Et2O, ~5 mL) was added and the mixture was filtered through a 
pad of Celite. Removal of solvents in vacuo afforded the desired aldehyde. The crude 
aldehyde 211 was dissolved in 1.0 mL of anhydrous CH2Cl2 and cooled to 0 °C. To the 
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solution was added MgSO4 (tip of a microspatula) and TseNH2 (2.5 mg, 0.0125 mmol) 
and the reaction mixture was stirred for 1.5 h at 0 ºC. Removal of MgSO4 by filtration 
and concentration in vacuo yielded the Tse-imine intermediate 244, which was used 
directly without further purification. The Tse-imine (half the material from the previous 
reaction) was dissolved in 0.7 mL of anhydrous THF and to the solution was added Et3N 
(~4 µL, 0.028 mmol) and imine dichloride 260 (~3 mg, 0.012) sequentially. The resulting, 
reaction mixture was heated to 60 °C and stirred for 4 h, then allowed to cool to 20 ºC 
and quenched by the addition of a saturated NaHCO3 solution (5 mL). The organic 
solvent was evaporated in vacuo and the aqueous residue was extracted with EtOAc (3 X 
5 mL) and the combined organic phase dried over MgSO4, filtered and concentrated in 
vacuo. Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (60:40 
 50:50) gave 2.5 mg (~37% over the 3 steps) of guanidine 263 as a yellow oil: Rf = 
0.30 (50% EtOAc/Hexanes); 1H NMR (500 MHz, CDCl3): δ 7.82 (d, J = 8.5 Hz, 2H), 
7.79 (d, J = 8.0 Hz, 2H), 7.65 (d, J = 8.5 Hz, 2H), 7.63 (d, J = 8.5 Hz, 2H), 7.53 (d, J = 
7.0 Hz, 2H), 7.43-7.29 (m, 14H), 7.11 (app s, 1H), 7.02 (d, J = 8.5 Hz, 2H), 6.98 (s, 1H), 
6.88 (app d, J = 8.5 Hz, 1H), 6.41 (d, J = 8.5 Hz, 1H), 4.95 (d, J = 16.0 Hz, 1H), 4.88 (d, 
J = 11.5 Hz, 1H), 4.59 (d, J = 11.5 Hz, 1H), 4.48 (dd, J = 16.0, 7.0 Hz, 1H), 4.13 (d, J = 
16.5 Hz, 1H), 3.89-3.86 (m, 2H), 3.80 (s, 3H), 3.83-3.74 (m, 2H), 3.71 (s, 3H), 3.65 (s, 
3H), 3.53-3.46 (m, 3H), 3.49 (dd, J = 11.5, 11.5 Hz, 3H), 2.84 (app t, J = 11.5 Hz, 1H), 
2.50 (s, 3H), 2.43 (s, 6H), 2.38 (s, 3H) 1.09 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 
173.2, 171.4, 156.7, 149.2, 148.6, 146.5, 145.7, 145.2, 144.4, 142.8, 140.4, 136.1, 135.95, 
135.7, 133.0, 132.67, 132.64, 130.4, 130.3, 130.2, 130.0, 129.6, 129.5, 129.34, 129.26, 
128.4, 128.04, 128.02, 127.97, 126.7, 122.8, 120.25, 119.35, 111.6, 110.8, 73.2, 59.4, 
57.9, 56.1, 55.78, 55.75, 52.87, 52.84, 52.7, 46.8, 44.7, 44.4, 43.2, 41.85, 33.75, 29.9, 
27.2, 22.0, 21.9, 19.6; MS (MALDI) calcd for C70H76ClN5O15S4Si [M+H]+: 1418; found 
[M+H]+: 1418.  
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Azide 290: To a solution of imidazolone 185 (33 mg, 0.0261 mmol) in 5.0 mL of CH2Cl2 
at -78 °C was added DIBAl-H (~ 50 µL, 0.28 mmol) and the mixture was stirred for 30 
min, then quenched with 3 mL of MeOH, and allowed to warm to 20 ºC. Rochelle’s salt 
solution was then added (~ 5 mL) and the mixture was stirred vigorously for 4 h. The 
mixture was then transferred into a separatory funnel and partitioned between water (10 
mL) and EtOAc (4 X 25 mL). The combined organic phase was dried over MgSO4, 
filtered and concentrated in vacuo, To a mixture of crude alcohol 185b and TsCl (16 mg, 
0.082 mmol) in 4.5 mL of anhydrous CH2Cl2, was added triethylamine (40 µL, 0.32 
mmol) and a few crystals of DMAP. The reaction mixture was stirred vigorously at 20 ºC 
for 15 h then it was quenched with 5 mL of pH 7 buffer partitioned between water (10 
mL) and EtOAc (3 X 15 mL). The combined organic phase was dried over MgSO4, 
filtered and concentrated in vacuo. Purification by flash chromatography on SiO2 eluting 
with hexanes/EtOAc (60:40  50:50  40:60) gave 23 mg (64%) of tosylate 289 as a 
colorless foam. To the tosylate 289 in a dry flask was added NaN3 (11 mg, 0.17 mmol) 
and anhydrous DMF (2.4 mL). The flask was sealed and the reaction mixture was heated 
to 50 °C and stirred for 12.5 h. After cooling to 20 ºC then, the mixture was partitioned 
between water (20 mL) and EtOAc (3 X 15 mL), and the combined organic phase was 
washed with water and brine, then dried over MgSO4, filtered and concentrated in vacuo. 
Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (50:50) gave 
13 mg (62%) of azide 290 as a light yellow foam: Rf = 0.49 (60% EtOAc/Hexanes); 
[α]D23 = -12.8 (c = 1.20, CH2Cl2); IR (thin film): 2931, 2857, 2102, 1774, 1720, 1593, 
1516, 1454, 1318, 1149, 1025, 814, 702 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.86 (d, J = 
8.5 Hz, 2H), 7.82 (d, J = 8.0 Hz, 2H), 7.64 (d, J = 8.5 Hz, 2H), 7.63 (dd, J = 8.0, 1.5 Hz, 
2H), 7.53 (dd, J = 8.0, 1.5 Hz, 2H), 7.34-7.48 (m, 10H), 7.31 (d, J = 8.0 Hz, 2H), 7.00 (d, 
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J = 2.0 Hz, 1H), 6.80 (dd, J = 8.5, 2.0 Hz, 1H), 6.51 (d, J = 8.5 Hz, 1H), 6.40 (d, J = 1.5 
Hz, 1H), 4.84 (d, J = 16.0 Hz, 1H), 4.46 (d, J = 11.5 Hz, 1H), 4.12 (d, J = 8.5 Hz, 1H), 
4.10 (d, J = 16.5 Hz, 1H), 3.81-3.97 (m, 6H), 3.79 (s, 3H), 3.70 (s, 3H), 3.54 (ddd, J = 9.5, 
5.5, 4.0 Hz, 2H), 3.67 (dd, J = 12.5, 3.5 Hz, 1H), 3.25-3.28 (m, 2H), 3.15 (dt, J = 14.5, 
5.0 Hz, 1H), 2.53 (m, 2H), 2.44 (s, 9H), 1.11 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 
173.6, 156.8, 150.6, 149.0, 148.4, 146.4, 145.7, 145.2, 136.1, 135.8, 135.7, 134.2, 132.8, 
132.7, 130.5, 130.4, 130.33, 130.29, 130.0, 129.5, 128.8, 128.45, 128.3, 128.1, 128.0, 
120.3, 118.8, 114.95, 111.45, 110.8, 73.9, 59.1, 58.1, 56.1, 55.85, 54.3, 52.75, 52.3, 45.9, 
44.49, 44.43, 39.05, 37.9, 33.7, 29.9, 27.3, 22.0, 21.91, 21.89, 19.6; MS (MALDI) calcd 
for C62H68ClN7O12S3Si [M+Na]+: 1284, [M+K]+: 1300; found [M+Na]+: 1284, [M+K]+: 
1300. 
 
 
 
 
 
 
Azide 299: To a solution of azide 290 (13 mg, 0.010 mmol) in 3.0 mL of THF at 20 °C 
buffered with 0.5 mL AcOH, was added TBAF (~150 µL, 0.15 mmol) and the mixture 
was stirred for 5 hours during which, additional TBAF was added as needed to drive the 
reaction to completion. The reaction mixture was then diluted with EtOAc (20 mL) and 
washed with saturated NaHCO3 solution (2 x 15 mL). The organic phase was dried over 
MgSO4, filtered and concentrated in vacuo, Purification by flash chromatography on SiO2 
eluting with hexanes/EtOAc (40:60  20:80  0:100) gave 7.6 mg (72%) of azide 299 
as a colorless foam: Rf = 0.33 (80% EtOAc/Hexanes); IR (thin film): 3485, 2102, 1714, 
1455, 1146; 1H NMR (500 MHz, CDCl3): δ 7.87 (d, J = 8.5 Hz, 2H), 7.82 (d, J = 8.0 Hz, 
2H), 7.59 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 4H), 7.28 (d, J = 8.5 Hz, 2H), 6.96 (d, 
J = 2.0 Hz, 1H), 6.94 (dd, J = 8.5, 2.0 Hz, 1H), 6.75 (d, J = 8.5 Hz, 1H), 6.64 (app s, 1H), 
4.84 (d, J = 15.5 Hz, 1H), 4.38 (d, J = 11.0 Hz, 1H), 4.12 (d, J = 7.5 Hz, 1H), 4.03 (d, J = 
16.0 Hz, 1H), 3.90-3.96 (m, 3H), 3.82-3.86 (m, 3H), 3.82 (s, 3H), 3.78 (s, 3H), 3.61 (app 
d,  J = 5.5 Hz, 2H), 3.54 (m, 2H), 3.30 (ddd, J = 14.5, 5.0, 5.0 Hz, 1H), 3.15 (dt, J = 14.5, 
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5.0 Hz, 1H), 2.48-2.61 (m, 2H), 2.44 (s, 6H), 2.43 (s, 3H), 1.79 (br s. 1H); 13C NMR (125 
MHz, CDCl3): δ 173.45, 156.5, 150.6, 148.8, 148.4, 146.4, 145.8, 145.2, 135.9, 135.7, 
134.2, 130.4, 130.3, 130.0, 129.6, 128.8, 128.4, 127.9, 121.0, 118.7, 115.4, 111.9, 111.1, 
74.1, 58.9, 57.4, 56.1, 56.0, 54.4, 52.8, 52.7, 45.8, 44.4, 44.2, 39.6, 37.7, 33.6, 22.0, 21.9; 
MS (MALDI) calcd for C46H50ClN7O12S3 [M+H]+: 1024 [M+Na]+: 1046, [M+K]+: 1062; 
found [M+H]+: 1024 [M+Na]+: 1046, [M+K]+: 1062. 
 
 
 
 
 
 
Cyclopentyl Pyrrolo amide 300: To a solution of azide 299 (4.2 mg, 0.004 mmol) in 1.0 
mL of THF/H2O (3:2) at 20 °C, was added Me3P (1M solution in THF, ~20 µL, 0.02 
mmol) and the mixture was stirred for 5 hours. The solvents were then evaporated and the 
dry crude material was dissolved in 1.0 mL of MeCN. DIPEA (~3 µL, 0.016 mmol) was 
added at 20 °C, followed by 2-(trichloroacetyl)-pyrrole 51 (~ 3 mg, 0.014 mmol), the 
flask was sealed to avoid loss of solvent through evaporation and the reaction mixture 
was stirred at 20 ºC overnight. The solvent was then evaporated and the residue was 
purified by flash chromatography on SiO2 eluting with EtOAc/MeOH (100:0  95:5) 
affording 1.8 mg (40%) of amide pyrrole 300 as a colorless solid: Rf = 0.13 (5% 
MeOH/EtOAc); IR (thin film): 3378, 1717, 1454, 1146; 1H NMR (500 MHz, CDCl3): δ 
9.40 (br s, 1H), 7.83 (d, J = 8.5 Hz, 2H), 7.82 (d, J = 8.5 Hz, 2H), 7.61 (d, J = 8.5 Hz, 
2H), 7.36 (d, J = 8.0 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 6.94 (d, 
J = 2.0 Hz, 1H), 6.87-6.90 (m, 2H), 6.84 (t, J = 5.5 Hz, 1H),  6.71 (d, J = 8.0 Hz, 1H), 
6.69 (d, J = 1.5 Hz, 1H), 6.55-6.57 (m, 1H), 6.21 (dd, J = 6.5, 2.5 Hz, 1H), 4.84 (d, J = 
15.5 Hz, 1H), 4.23 (d, J = 11.5 Hz, 1H), 4.09 (dd, J = 10.0, 1.5 Hz, 1H), 4.01 (d, J = 15.5 
Hz, 1H), 3.92-3.97 (m, 2H), 3.80-3.88 (m, 2H), 3.81 (s, 3H), 3.78 (s, 3H), 3.71 (dd,  J = 
11.5, 4.0 Hz, 1H), 3.59 (app t, J = 5.5 Hz, 2H), 3.47-3.58 (m, 3H), 3.21-3.27 (m, 1H), 
3.09 (dt, J = 14.5, 5.5 Hz, 1H), 2.59-2.66 (m, 1H), 2.52-2.57 (m, 1H), 2.45 (s, 3H), 2.44 
(s, 3H), 2.42 (s, 3H), 2.07 (br s, 1H); MS (MALDI) calcd for C51H55ClN6O13S3 [M+H]+: 
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1091 [M+Na]+: 1113, [M+K]+: 1129; found [M+H]+: 1091 [M+Na]+: 1113, [M+K]+: 
1129. 
 
 
 
 
 
Diol 301. To a solution of imidazolone 185 (61 mg, 0.048 mmol) in 12.0 mL of 
anhydrous THF was added LiBH4 (200 µL, 0.4 mmol), and the resulting reaction mixture 
was stirred at 20 °C for 8 h, adding additional reagent in 50 µL portions to dirve the 
reaction to completion as monitored by TLC. A saturated solution of NH4Cl (~ 20 mL) 
was then added, and the mixture was extracted with EtOAc (3 X 25 mL), and the 
combined organic phase was dried over MgSO4, filtered and concentrated in vacuo 
affording a white foam. This crude material was dissolved in 12.0 mL of anhydrous THF 
and AcOH (300 µL) was added followed by TBAF (500 µL, 0.5 mmol). The resulting 
mixture was stirred at 20 ºC for 2 h, then diluted with EtOAc (~ 30 mL), and washed with 
a saturated solution of NaHCO3, then dried over MgSO4, filtered and concentrated in 
vacuo. Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (30:70 
 0:100) and MeOH/EtOAc (3:97) gave 28 mg (58% 2 steps) of diol 301 as an off-white 
foam: Rf = 0.09 (80% EtOAc/Hexanes); 1H NMR (500 MHz, CDCl3): δ 7.84 (d, J = 8.5 
Hz, 2H), 7.82 (d, J = 8.5 Hz, 2H), 7.60 (d, J = 8.5 Hz, 2H), 7.36 (d, J = 7.5 Hz, 2H), 7.35 
(d, J = 7.5 Hz, 2H), 7.30 (d, J = 8.5 Hz, 2H), 6.95 (d, J = 2.0 Hz, 1H), 6.92 (dd, J = 8.5, 
2.0 Hz, 1H), 6.76 (d, J = 8.5 Hz, 1H), 6.64 (d, J = 1.0 Hz, 1H), 4.84 (d, J = 15.5 Hz, 1H), 
4.18 (d, J = 12.0 Hz, 1H), 4.10 (d, J = 16.0 Hz, 1H), 4.05 (dd, J = 10.5, 1.0 Hz, 1H), 396-
3.91 (m, 4H), 387-3.82 (m, 4H), 3.83 (s, 3H), 3.78 (s, 3H), 3.78 (dd, J = 17.0, 12.0 Hz, 
1H), 3.71 (dd, J = 11.0, 4.0 Hz, 1H), 3.65 (dd, J = 11.0, 5.0 Hz, 1H), 3.54 (tdd, J = 15.0, 
14.0, 6.0 Hz, 2H), 3.29 (app dt, J = 15.0, 6.0 Hz, 1H), 3.15 (app dt, J = 15.0, 6.0 Hz, 1H), 
2.68-2.61 (m, 1H), 2.45 (s, 6H), 2.44 (s, 3H), 2.36-2.29 (m, 1H); 13C NMR (125 MHz, 
CDCl3): δ 173.7, 156.6, 150.7, 148.85, 148.3, 146.3, 145.8, 145.3, 135.8, 135.6, 134.2, 
130.39, 130.35, 130.0, 129.4, 128.7, 128.3, 127.9, 120.5, 118.75, 115.65, 111.5, 111.1, 
73.9, 63.7, 60.6, 60.2, 60.0, 56.1, 556.0, 54.1, 52.8, 47.1, 44.8, 44.5, 42.4, 37.8, 33.5, 29.9, 
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22.0, 21.9, 21.3, 14.4; MS (MALDI) calcd for C46H51ClN4O13S3 [M+H]+: 999, [M+Na]+: 
1021, [M+K]+: 1037; found [M+H]+: 999, [M+Na]+: 1287, [M+K]+: 1303.  
 
 
 
 
 
 
 
 
Bis-azide 305. Method A: To a solution of diol 301 (20.5 mg, 0.0205 mmol) in 5.0 mL 
of anhydrous CH2Cl2 cooled to 0 ºC was added Et3N (100 µL, 0.707 mmol), followed by 
MsCl (40 µL, 0.52 mmol) and the resulting reaction mixture was stirred at 0 °C for 1 h. 
Water (~ 10 mL) was then added, and the mixture was allowed to warm to 20 ºC then 
extracted with EtOAc (2 X 25 mL), and the combined organic phase was dried over 
MgSO4, filtered and concentrated in vacuo. This crude material was dissolved in 4.0 mL 
of anhydrous DMF and NaN3 (26.7 mg, 0.41 mmol) was added in one portion. The 
resulting mixture was heated to 50 ºC and stirred for 13 h, then allowed to cool to 20 ºC. 
Water (~ 50 mL) was then added, and the mixture was then extracted with EtOAc (3 X 
30 mL), and the combined organic phase was washed with water (1 X 20 mL) and brine 
(1 X 20 mL) then dried over MgSO4, filtered and concentrated in vacuo. Purification by 
flash chromatography on SiO2 eluting with hexanes/EtOAc (50:50  20:80) gave 16 mg 
(74% 2 steps) of bis-azide 305 as an off-white foam. 
Bis-azide 305. Method B: To a solution of imidazolone azide 251 (222 mg, 0.211 mmol) 
in 6 mL of anhydrous THF/MeOH (95:5) cooled to 0 ºC was added LiBH4 (1.3 mL, 2.6 
mmol), and the resulting reaction mixture was stirred at 0 °C for 10 minutes. A saturated 
solution of NH4Cl (~10 mL) was then slowly added and the mixture was allowed to 
warm to 20 ºC while stirring vigorously for 10 minutes. The mixture was then extracted 
with EtOAc (3 X 15 mL), and the combined organic phase was dried over MgSO4, 
filtered and concentrated in vacuo. The crude material was dissolved in 15 mL of 
anhydrous CH2Cl2 and cooled to 0 ºC, then Et3N (100 µL, 0.707 mmol) was added, 
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followed by MsCl (40 µL, 0.52 mmol) and the resulting reaction mixture was stirred at 0 
°C for 5 h. A saturated solution of NaHCO3 (~ 15 mL) was then added, and the mixture 
was allowed to warm to 20 ºC then the organic layer was separated. The aqueous residue 
was extracted with EtOAc (2 X 10 mL), and the combined organic phase was dried over 
MgSO4, filtered and concentrated in vacuo. This crude material1 this was dissolved in 9 
mL of anhydrous DMF and NaN3 (92 mg, 1.41 mmol) was added in one portion. The 
resulting mixture was heated to 50 ºC and stirred for 15 h, then allowed to cool to 
ambient temperature. Water (~ 30 mL) was then added, followed by brine (~ 5 mL) and 
the mixture was extracted with EtOAc (3 X 25 mL), and the combined organic phase was 
washed with water (2 X 20 mL), dried over MgSO4, filtered and concentrated in vacuo. 
Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (50:50  
20:80) gave 127 mg (58% 3 steps) of bis-azide 305 as an off-white foam: Rf = 0.33 (75% 
EtOAc/Hexanes); [α]D21 = -22.4 (c = 0.0134, CH2Cl2); IR (thin film): 3124, 3064, 2934, 
2106, 1772, 1719, 1594, 1455, 1148 cm-1;  1H NMR (500 MHz, CDCl3): δ 7.87 (d, J = 
8.5 Hz, 2H), 7.82 (d, J = 8.5 Hz, 2H), 7.61 (d, J = 8.0 Hz, 2H), 7.36 (app d, J = 8.0 Hz, 
4H), 7.30 (d, J = 8.5 Hz, 2H), 7.00 (d, J = 2.0 Hz, 1H), 6.96 (dd, J = 8.5, 2.0 Hz, 1H), 
6.77 (d, J = 8.5 Hz, 1H), 6.63 (d, J = 1.0 Hz, 1H), 4.94 (d, J = 15.5 Hz, 1H), 4.20 (d, J = 
11.5 Hz, 1H), 4.09 (dd, J = 9.5, 1.0 Hz, 1H), 4.03-3.92 (m, 3H),  3.96 (d, J = 15.5 Hz, 
1H), 3.84 (s, 3H), 3.81 (s, 3H), 3.68 (ddd, J = 16.0, 13.0, 3.0 Hz, 2H), 3.58 (app d, J = 5.5 
Hz, 2H), 3.53 (ddd, J = 6.0, 5.0, 3.0 Hz, 2H), 3.32 (ddd, J = 8.0, 7.0, 5.0 Hz, 1H), 3.17 
(ddd, J = 14.5, 6.0, 3.5 Hz, 1H), 2.65 (app dt, J = 11.0, 3.0 Hz, 1H), 2.454 (s, 3H), 2.450 
(s, 3H), 2.44 (s, 3H), 2.29 (ddd, J = 14.0, 11.0, 6.0 Hz, 1H); 13C NMR (125 MHz, CDCl3): 
δ 173.3, 156.4, 150.6, 149.0, 148.6, 146.5, 145.8, 145.2, 136.0, 135.7, 134.1, 130.4, 130.3, 
130.0, 129.45, 128.85, 128.4, 127.9, 121.2, 118.2, 115.4, 112.0, 111.0, 73.6, 59.6, 56.03, 
55.98, 54.45, 52.75, 52.3, 48.2, 44.4, 43.7, 43.1, 40.2, 37.8, 33.6, 22.0, 21.9; MS 
(MALDI) calcd for C46H49ClN10O11S3 [M+H]+: 1049, [M+Na]+: 1071, [M+K]+: 1087; 
found [M+H]+: 1049, [M+Na]+: 1071, [M+K]+: 1087. 
 
                                                
1 NOTE: this mesylate intermediate was alternatively purified at this stage (on SiO2 
eluting with hexanes/EtOAc (40:60  20:80)) and used for the synthesis of 
phthalimide 325a. 
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Bis-azide 310. To a solution of bis-azide 305 (23.6 mg, 0.0225 mmol) in 8.0 mL of 
anhydrous THF cooled to 0 ºC was added a ~ 0.06 M solution of freshly prepared SmI2, 
as needed to dive the reaction to completion, as monitored by TLC. The reaction was 
quenched by the addition of a saturated solution of NaHCO3 (~10 mL) and it was allowed 
to warm to 20 ºC. A saturated solution of Na2S2O3 (~ 8 mL) was then added and the 
mixture was extracted with EtOAc (3 X 25 mL), and the combined organic phase was 
dried over MgSO4, filtered and concentrated in vacuo to afford a yellow foam. 
Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (50:50  
0:100) gave 13.5 mg (68%) of detosylated bis-azide 310 as an off-white foam: Rf = 0.67 
(EtOAc); IR (thin film): 3340, 2928, 2102, 1771, 1717, 1682, 1451, 1146 cm-1; 1H NMR 
(500 MHz, CDCl3): δ 8.76 (br s, 1H), 7.89 (d, J = 8.5 Hz, 2H), 7.74 (d, J = 8.0 Hz, 2H), 
7.42 (d, J = 8.5 Hz, 2H), 7.34 (d, J = 9.0 Hz, 2H), 6.96 (d, J = 2.0 Hz, 1H), 6.91 (dd, J = 
8.0, 2.0 Hz, 1H), 6.78 (d, J = 8.5 Hz, 1H), 6.47 (app t, J = 1.5 Hz, 1H), 4.97 (d, J = 16.5 
Hz, 1H), 4.20-4.11 (m, 2H), 4.13 (d, J = 11.5 Hz, 1H), 3.94 (d, J = 16.0 Hz, 1H), 3.89 
(ddd, J = 15.0, 7.0, 3.5 Hz, 1H), 3.84 (s, 3H), 3.81 (s, 3H), 3.76 (dd, J = 13.0, 2.5 Hz, 2H), 
3.68-3.59 (m, 4H), 3.57-3.52 (m, 2H), 3.50 (dd, J = 10.5, 1.0 Hz, 1H), 3.36 (ddd, J = 14.0, 
6.0, 4.0 Hz, 1H), 2.65 (app tt, J = 11.0, 3.0 Hz, 1H), 2.47 (s, 3H), 2.44 (s, 3H), 2.40-2.33 
(m, 1H); 13C NMR (125 MHz, CDCl3): δ 172.75, 155.8, 153.9, 149.2, 148.8, 145.9, 145.5, 
136.5, 134.8, 130.4, 130.3, 129.2, 128.7, 128.0, 120.7, 116.4, 111.4, 111.2, 111.0, 73.4, 
59.55, 56.01, 55.98, 55.2, 51.8, 51.2, 48.0, 45.2, 44.3, 43.7, 39.3, 37.5, 33.15, 29.9, 21.94, 
21.87; MS (MALDI) calcd for C39H43ClN10O9S2 [M+H]+: 895, [M+Na]+: 917, [M+K]+: 
933; found [M+H]+: 895, [M+Na]+: 917, [M+K]+: 933. 
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Bis-dibromopyrrole 312. A solution of bis-azide 305 (57 mg, 0.0540 mmol) in 8.0 mL 
of MeOH cooled tat 20 ºC was bubbled with NH3(g) for ~ 15 minutes. The reaction vessel 
was then sealed and heated at 55 ºC for 44 h, then allowed to cool to 20 ºC and 
concentrated in vacuo. The crude material (spectroscopically identical to bis-azide 310) 
was dissolved in 6.5 mL of THF and cooled to 0 ºC. Trimethylphosphine (1M in THF, 
220 µL, 0.220 mmol) was then added drop-wise and the mixture was stirred at 0 ºC for 
1.5 h. Water (~ 50 µL) was added and the mixture was allowed to warm to 20 ºC and 
stirred for an additional 3.5 h, then concentrated in vacuo. The crude material was 
dissolved in ~ 3 mL of HPLC grade benzene and reconcentrated in vacuo. After two 
cycles, the crude material appeared as a yellow foam. This crude material was dissolved 
in 5 mL of MeCN, dibromo-trichloroacylpyrrole 311 (70 mg, 0.189 mmol) was added in 
one portion, followed by diisopropylethylamine (125 µL, 0.717 mmol) and the resulting 
mixture was stirred at 20 ºC for 17 h, then concentrated in vacuo to afford a yellow foam. 
Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (50:50  
0:100), then with MeOH/EtOAc (5:95) gave 39 mg (53% for the 3 steps) of bis-pyrrole 
312 as a white solid: Rf = 0.39 (EtOAc); IR (thin film): 3351, 3124, 2925, 2851, 1771, 
1714, 1682, 1629, 1454, 1143 cm-1; 1H NMR (500 MHz, CD3OD): δ 7.83 (d, J = 8.5 Hz, 
2H), 7.78 (d, J = 8.0 Hz, 2H), 7.43 (d, J = 8.0 Hz, 2H), 7.39 (d, J = 8.0 Hz, 2H), 6.92 (d, 
J = 2.0 Hz, 1H), 6.89 (s, 1H), 6.81 (s, 1H), 6.72 (dd, J = 8.5, 2.0 Hz, 1H), 6.63 (d, J = 8.5 
Hz, 1H), 6.47 (d, J = 1.5 Hz, 1H), 4.65 (d, J = 16.5 Hz, 1H), 4.16 (d, J = 11.5 Hz, 1H), 
4.04 (d, J = 16.5 Hz, 1H), 3.89-3.54 (m, 8H), 3.79 (s, 3H), 3.69 (s, 3H), 3.53 (dd, J = 10.5, 
1.0 Hz, 1H), 3.45-3.27 (m, partially overlapping with solvent peak, 4H), 2.67 (app tt, J = 
11.5, 4.0 Hz, 1H), 2.48 (s, 3H), 2.45 (s, 3H), 2.44-2.37 (m, 1H); 13C NMR (125 MHz, 
CD3OD): δ 173.0, 161.2, 160.9, 156.2, 153.7, 148.9, 148.3, 145.6, 145.3, 136.0, 134.7, 
129.8, 129.75, 129.5, 128.3, 127.8, 127.3, 127.2, 119.6, 117.35, 113.4, 113.0, 111.3, 
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110.0, 110.9, 105.1, 105.0, 98.7, 98.6, 73.9, 60.9, 55.0, 53.75, 51.0, 45.0, 43.7, 43.55, 
41.6, 39.0, 37.0, 36.8, 32.7, 29.3, 20.3, 20.2; MS (MALDI) calcd for C39H43ClN10O9S2 
[M+Na]+: 1363; found [M+Na]+: 1363. 
Spectroscopic data in DMSO-d6: 1H NMR (500 MHz, DMSO-d6): δ 12.72, (br s, 1H), 
12.70 (br s, 1H), 10.00 (d, J = 1.0 Hz, 1H), 8.18 (app q, J = 6.5 Hz, 2H), 7.81 (d, J = 8.5 
Hz, 2H), 7.79 (d, J = 8.5 Hz, 2H), 7.46 (d, J = 8.0 Hz, 2H), 7.45 (d, J = 8.0 Hz, 2H), 6.99 
(s, 1H), 6.88 (s, 1H), 6.81 (d, J = 1.5 Hz, 1H), 6.64 (dd, J = 8.5, 1.5 Hz, 1H), 6.59 (d, J = 
8.5 Hz, 1H), 6.38 (app s, 1H), 4.30 (d, J = 16.5 Hz, 1H), 4.17 (d, J = 11.5 Hz, 1H), 3.97 
(d, J = 16.5 Hz, 1H), 3.77-3.67 (m, 4H), 3.69 (s, 3H), 3.65-3.58 (m, 3H) 3.62 (s, 3H), 
3.57-3.52 (m, 4H), 3.53 (dt, J = 14.0, 5.0 Hz, 1H), 3.29 (this signal is detected by 2D 
correlations but it is completely covered by the water peak from the solvent; 1H), 2.42 (s, 
6H), 2.42 (this signal is detected by 2D correlations but it is completely covered by the  
solvent peak; 1H)  2.29-2.23 (m, 1H). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) HPLC trace for bis-pyrrole 312. b) observed and c) predicted M+Na cluster for bis-
pyrrole 312 
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Phthalimide 325a: To a solution of mesylate 307 (17 mg, 0.02154 mmol) in 2.7 mL of 
dry DMF was added potassium phthalimide 324 (7.4 mg, 0.0399 mmol) in one portion, 
and the resulting reaction mixture was stirred at 45 °C for 12, then allowed to warm to 20 
ºC. Water (~20 mL) was added, followed by brine (~ mL) and the mixture was extracted 
with EtOAc (3 X 25 mL). The combined organic phase was washed with water (2 X 15 
mL), dried over MgSO4, filtered and concentrated in vacuo to afford a yellow oil. 
Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (60:40  
30:70) gave 13 mg (73%) of phthalimide 325a as a white solid: Rf = 0.37 (50% 
EtOAc/Hexanes; 3 elutions); IR (thin film): 2931, 2108, 1771, 1714, 1640, 1451, 1143 
cm-1; 1H NMR (500 MHz, CDCl3): δ 8.15 (d, J = 8.0 Hz, 2H), 7.87 (dd, J = 5.5, 3.0 Hz, 
2H), 7.77 (dd, J = 5.5, 3.0 Hz, 2H), 7.75 (d, J = 8.0 Hz, 2H), 7.61 (d, J = 8.5 Hz, 2H), 
7.42 (d, J = 8.5 Hz, 2H), 7.32 (d, J = 8.5 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 7.02 (d, J = 
2.0 Hz, 1H), 6.95 (dd, J = 8.5, 2.0 Hz, 1H), 6.75 (d, J = 8.5 Hz, 1H), 6.70 (d, J = 1.5 Hz, 
1H), 5.02 (d, J = 15.5 Hz, 1H), 4.25 (dd, J = 10.5, 1.5 Hz, 1H), 4.11 (d, J = 11.0 Hz, 1H), 
3.98 (dd, J = 13.0, 2.5 Hz, 1H), 3.93-3.85 (m, 4H), 3.82 (s, 3H), 3.80 (d, J = 15.5 Hz, 1H), 
3.79 (s, 3H), 3.76-3.69 (m, 2H), 3.64 (dd, J = 13.0, 2.5 Hz, 1H), 3.43 (ddd, J = 10.0, 6.0, 
3.0 Hz, 2H), 3.37 (ddd, J = 14.0, 8.0, 6.0 Hz, 1H), 3.10 (app dt J = 14.5, 5.0 Hz 1H), 2.59 
(app tt, J = 11.0, 2.5 Hz, 1H), 2.54-2.50 (m, 1H), 2.48 (s, 3H), 2.43 (s, 6H); 13C NMR 
(125 MHz, CDCl3): δ 173.0, 168.95, 156.2, 150.4, 148.8, 148.5, 146.0, 145.55, 144.9, 
135.7, 135.5, 134.45, 131.6, 130.2, 130.0, 129.8, 129.44, 129.41, 128.1, 127.8, 123.6, 
121.3, 118.8, 114.2, 112.15, 110.7, 72.9, 59.8, 55.79, 55.77, 55.74, 55.72, 54.1, 52.4, 
47.35, 44.1, 42.9, 42.6, 39.1, 37.6, 37.4, 33.35, 29.7, 21.8, 21.6; MS (MALDI) calcd for 
C54H53ClN8O13S3 [M+H]+: 1153, [M+Na]+: 1175, [M+K]+: 1191; found [M+H]+: 1153, 
[M+Na]+: 1175, [M+K]+: 1191. 
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Pyrrole 329b: To a solution of phthalimide 325a (7 mg, 0.00607 mmol) in 2.0 mL of 
absolute EtOH was added hydrazine (xs) and the resulting mixture was heated to 55 ºC 
for 15 h then it was allowed to cool to 20 ºC and concentrated in vacuo to afford a 
mixture of amines 328a/b. The crude material2 was dissolved in 2.0 mL of MeCN and 
trichloroacetylpyrrole 51 (2 mg, 0.00941 mmol) was added in one portion, followed by 
diisopropylethylamine (~ 25 µL, xs). The resulting mixture was stirred at 20 ºC for 17 h 
then it was concentrated in vacuo. Purification by flash chromatography on SiO2 eluting 
with hexanes/EtOAc (30:70  10:90  0:100) gave tosylated pyrrole 329a (1 mg, 15%), 
pyrrole 329b (3 mg, 51%) and a mixture of amines 328a/b (not quantified). The latter 
was resubjected to the reaction conditions generating additional 329a (0.6 mg, overall 
23% yield), and 329b (0.4 mg, overall 58% yield), Spectroscopic data for pyrrole 329b: 
Rf = 0.26 (EtOAc); IR (thin film): 3366, 2925, 2108, 1771, 1714, 1682, 1457, 1146 cm-1; 
1H NMR (500 MHz, CD3OD): δ 7.88 (d, J = 8.5 Hz, 2H), 7.81 (d, J = 8.5 Hz, 2H), 7.455 
(d, J = 8.0 Hz, 2H), 7.449 (d, J = 8.5 Hz, 2H), 6.96 (d, J = 2.0 Hz, 1H), 6.87 (dd, J = 8.5, 
2.0 Hz, 1H), 6.85 (dd, J = 2.5, 1.0 Hz, 1H), 6.84 (d, J = 8.5 Hz, 1H), 6.67 (dd, J = 3.5, 1.0 
Hz, 1H), 6.60 (d, J = 1.5 Hz, 1H), 6.11 (dd, J = 3.5, 2.5 Hz, 1H), 4.76 (d, J = 16.0 Hz, 
1H), 4.20 (d, J = 11.0 Hz, 1H), 3.99 (d, J = 16.5, Hz, 1H), 3.96-3.79 (m, 6H), 3.78 (s, 3H), 
3.77 (s, 3H), 3.65-3.61 (m, 4H), 3.60 (dd, J = 14.0, 4.5 Hz, 1H), 3.51 (dd, J = 10.0, 1.5 
Hz, 1H), 3.49 (dd, J = 14.0, 5.5 Hz, 1H), 2.60-2.49 (m, 2H), 2.48 (s, 3H), 2.45 (s, 3H); 
13C NMR (125 MHz, CD3OD): δ 174.3, 164.2, 157.6, 155.1, 150.3, 149.9, 147.0, 146.7, 
137.5, 136.35, 131.2, 130.9, 129.7, 129.25, 126.7, 123.2, 121.5, 118.8, 112.8, 112.7, 
112.6, 111.7, 110.3, 75.0, 61.3, 56.4, 55.0, 52.5, 46.4, 45.4, 45.1, 41.1, 40.9, 38.3, 21.65, 
                                                
2 In a separate experiment the two amines were separated and purified via preparative 
HPLC; spectroscopic data (1H NMR) are reported here, and 1H NMR spectra are 
attached below. 
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21.62; MS (MALDI) calcd for C44H58ClN9O10S2 [M+Na]+: 984, [M+K]+: 1000; found 
[M+Na]+: 984, [M+K]+: 1000. 
Spectroscopic data for amine 328a (R = Ts): 1H NMR (500 MHz, CD3OD): δ 8.49 (br s, 
1H), 7.89 (d, J = 8.5 Hz, 2H), 7.83 (d, J = 8.5 Hz, 2H), 7.65 (d, J = 8.0 Hz, 2H), 7.45 (d, 
J = 8.0 Hz, 2H), 7.44 (d, J = 8.0 Hz, 2H), 7.39 (d, J = 8.0 Hz, 2H), 7.03 (d, J = 2.0 Hz, 
1H), 7.00 (app s, 1H), 6.92 (dd, J = 8.5, 2.0 Hz, 1H), 6.83 (d, J = 8.5 Hz, 1H), 4.83 (d, J = 
16.0 Hz, 1H), 4.31 (d, J = 11.5 Hz, 1H), 4.05 (d, J = 16.0 Hz, 1H), 4.04 (app d, J = 9.5 
Hz, 1H), 3.90-3.80 (m, 5H), 3.782 (s, 3H), 3.778 (s, 3H), 3.67 (dd, J = 13.5, 4.0 Hz, 1H), 
3.53-3.42 (m, 4H), 3.12 (dd, J = 14.0, 4.5 Hz, 1H), 3.03 (dd, J = 14.0, 4.5 Hz, 1H),  2.66 
(app tt, J = 11.0, 3.5 Hz, 1H), 2.50-2.4 (m, 1H, partially overlapping with the next signal), 
2.46 (s, 3H), 2.45 (s, 3H), 2.44 (s, 3H). 
Spectroscopic data for amine 328b (R = H): 1H NMR (500 MHz, CD3OD): δ 8.51 (br s, 
1H), 7.93 (d, J = 8.5 Hz, 2H), 7.81 (d, J = 8.5 Hz, 2H), 7.51 (d, J = 8.0 Hz, 2H), 7.45 (d, 
J = 8.0 Hz, 2H), 7.00 (d, J = 2.0 Hz, 1H), 6.91 (dd, J = 8.0, 2.0 Hz, 1H), 6.85 (d, J = 8.5 
Hz, 1H), 6.71 (app s, 1H), 4.78 (d, J = 16.5 Hz, 1H), 4.29 (d, J = 11.5 Hz, 1H), 4.05-3.97 
(m, 3H), 3.97 (d, J = 16.5 Hz, 1H), 3.90 (app dt, J = 9.0, 6.0 Hz, 1H), 3.82 (dd, J = 13.0, 
2.5 Hz, 1H), 3.79 (s, 3H), 3.77 (s, 3H), 3.68-3.65 (m, 3H), 3.54 (app dd, J = 12.0, 5.5 Hz, 
2H), 3.51 (app d, J = 9.5 Hz, 1H), 3.23 (dd, J = 13.0, 3.5 Hz, 1H), 3.09 (dd, J = 13.0, 6.5 
Hz, 1H),  2.63 (app tt, J = 11.0, 3.5 Hz, 1H), 2.56-2.5 (m, 1H), 2.49 (s, 3H), 2.46 (s, 3H). 
Spectroscopic data for pyrrole 329a: Rf = 0.59 (EtOAc); 1H NMR (500 MHz, CD3OD): δ 
7.83 (d, J = 8.5 Hz, 2H), 7.82 (d, J = 8.0 Hz, 2H), 7.72 (d, J = 8.0 Hz, 2H), 7.45 (d, J = 
8.0 Hz, 2H), 7.40 (d, J = 8.0 Hz, 2H), 7.37 (d, J = 8.0 Hz, 2H), 7.03 (d, J = 2.0 Hz, 1H), 
6.98 (app s, 1H), 6.94 (dd, J = 8.0, 2.0 Hz, 1H), 6.87 (dd, J = 2.5, 1.5 Hz, 1H), 6.83 (d, J 
= 8.0 Hz, 1H), 6.60 (app dt, J = 4.0, 1.5 Hz, 1H), 6.09 (app t, J = 3.0 Hz, 1H), 4.9 (d, J = 
16.0 Hz, 1H; this signal is completely covered by the H2O peak from the solvent), 4.24 (d, 
J = 11.0 Hz, 1H), 4.00 (d, J = 16.0, Hz, 1H), 3.87-3.63 (m, 5H), 3.781 (s, 3H), 3.778 (s, 
3H), 3.72 (app t, J = 7.0 Hz, 1H), 3.67 (dd, J = 13.0, 2.0 Hz, 1H), 3.51-3.40 (m, 6H), 
2.63-2.60 (m, 2H), 2.46 (s, 3H), 2.45 (s, 3H), 2.43 (s, 3H). 
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Acetal 346. To a solution of ester 250 (55.5 mg, 0.0655 mmol) in 1.5 mL of CH2Cl2 was 
added Dess-Martin periodinane (45 mg, 0.106 mmol), and the resulting reaction mixture 
was stirred at 20 °C for 3 h. Upon completion of the reaction as indicated by TLC, 
anhydrous ether (Et2O, ~10 mL) was added and the mixture was filtered through a pad of 
Celite. Removal of solvents in vacuo afforded the desired aldehyde. The crude aldehyde 
was dissolved in 3.0 mL MeOH, and trimethylorthoformate (2.0 mL) was added, 
followed by a few crystals of p-toluenesulfonic acid. The reaction flask was fitted with an 
air condenser and the mixture was heated to 65 ºC for 4 h then allowed to cool to 20 ºC. 
A saturated NaHCO3 solution (~ 15 mL) was then added and the resulting mixture was 
extracted with EtOAc (3 x 15 mL), and the combined organic phase was dried over 
MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on SiO2 
eluting with hexanes/EtOAc (70:30  40:60) gave 48.3 mg (83% 2 steps) of acetal 346 
as a colorless foam: Rf = 0.58 (70% EtOAc/Hexanes); IR (thin film): 3280, 2931, 2836, 
2108, 1774, 1714, 1516, 1451, 1149 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.86 (d, J = 8.0 
Hz, 2H), 7.70 (d, J = 8.5 Hz, 2H), 7.40 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.5 Hz, 2H), 7.01 
(d, J = 2.0 Hz, 1H), 6.96 (dd, J = 8.5, 2.0 Hz, 1H), 6.84 (d, J = 8.0 Hz, 1H), 5.25 (d, J = 
16.0 Hz, 1H), 4.99-4.96 (m,1H), 4.25 (d, J = 16.0 Hz, 1H), 4.16 (d, J = 11.5 Hz, 1H), 
3.95-3.82 (m, 2H), 3.90 (s, 3H), 3.89 (s, 3H), 3.84 (s, 3H), 3.77 (app t, J = 3.0 Hz, 1H), 
3.56 (dd, J = 13.0, 2.5 Hz, 1H), 3.48-3.38 (m, 5H), 3.15 (s, 3H), 3.13 (app t, J = 12.0 Hz, 
1H; partially overlapping with the previous signal), 3.03 (s, 3H), 2.47 (s, 3H), 2.45 (s, 
3H), 2.38 (app tt, J = 11.5, 3.0 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 173.0, 172.1, 
156.2, 149.2, 148.8, 145.3, 144.0, 137.3, 135.3, 130.1, 129.7, 128.7, 128.2, 127.1, 120.3, 
110.85, 110.80, 105.2, 73.5, 59.7, 57.2, 56.5, 55.9, 55.8, 52.81, 52.76, 52.72, 47.5, 46.85, 
46.3, 46.05, 45.5, 33.05, 21.7, 21.5; MS (MALDI) calcd for C39H47ClN6O12S2 [M+Na]+: 
913, [M+K]+: 929; found [M+Na]+: 913, [M+K]+: 929. 
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Alcohol 347. To a solution of acetal 346 (48 mg, 0.0538 mmol) in 2.5 mL of anhydrous 
THF/MeOH (95:5) cooled to 0 ºC was added LiBH4 (0.16 mL, 0.32 mmol), and the 
resulting reaction mixture was stirred at 0 °C for 2 h, adding additional reagent every 30 
minutes. A saturated solution of NH4Cl (~10 mL) was then slowly added and the mixture 
was allowed to warm to 20 ºC while stirring vigorously for 10 minutes. The mixture was 
then extracted with EtOAc (3 X 15 mL), and the combined organic phase was dried over 
MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on SiO2 
eluting with hexanes/EtOAc (60:40  20:80) gave 34.5 mg (74%) of alcohol 347 as a 
colorless foam: Rf = 0.37 (50% EtOAc/Hexanes); IR (thin film): 3497, 3272, 2937, 2256, 
2105, 1770, 1714, 1593, 1451, 1152 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.85 (d, J = 8.5 
Hz, 2H), 7.77 (d, J = 8.0 Hz, 2H), 7.40 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 6.96 
(d, J = 2.0 Hz, 1H), 6.83 (dd, J = 8.0, 2.0 Hz, 1H), 6.79 (d, J = 8.0 Hz, 1H), 6.62 (app d, J 
= 10.5 Hz, 1H), 5.19 (d, J = 16.0 Hz, 1H), 4.12 (d, J = 11.5 Hz, 1H), 4.01 (d, J = 16.0 Hz, 
1H), 3.93 (d, J = 3.0 Hz, 1H), 3.93-3.87 (m, 3H), 3.88 (s, 3H), 3.87 (s, 3H), 3.84 (ddd, J 
= 14.0, 5.5, 3.5 Hz, 1H), 3.57-3.51 (m, 2H), 3.49-3.37 (m, 3H), 3.24 (s, 3H), 3.15 (s, 3H), 
2.85 (dd, J = 11.5, 5.0 Hz, 1H), 2.48-2.45 (m, 1H; signal completely overlapping with the 
next signal; detected through 2D correlations), 2.47 (s, 3H), 2.42 (s, 3H), 2.13 (app tt, J = 
11.5, 3.0 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 173.0, 156.05, 149.0, 148.6, 145.3, 
143.8, 138.2, 135.3, 130.1, 129.8, 128.9, 128.2, 126.9, 120.4, 111.1, 110.7, 106.3, 75.4, 
64.7, 59.7, 57.9, 57.1, 55.8, 55.7, 52.8, 52.3, 47.7, 47.3, 45.6, 45.0, 41.2, 32.95, 21.65, 
21.5; MS (MALDI) calcd for C38H47ClN6O11S2 [M+Na]+: 885, [M+K]+: 901; found 
[M+Na]+: 885, [M+K]+: 901. 
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Pyrrolidine 349. To a solution of alcohol 347 (33 mg, 0.0382 mmol) in 3.0 mL of 
anhydrous CH2Cl2 cooled to 0 ºC was added Et3N (50 µL, 0.35 mmol), followed by MsCl 
(~ 3 µL, 0.0388 mmol) and the resulting reaction mixture was stirred at 0 °C for 2 h. It 
was then allowed to warm to 20 ºC and it was stirred for an additional 5.5 h, and then 
concentrated in vacuo. Purification by flash chromatography on SiO2 eluting with 
hexanes/EtOAc (70:30  50:50) gave 28 mg (87%) of pyrrolidine 349 as a colorless 
foam: Rf = 0.28 (50% EtOAc/Hexanes); IR (thin film): 2937, 2256, 2105, 1777, 1717, 
1593, 1516, 1451 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.87 (d, J = 8.5 Hz, 2H), 7.84 (d, 
J = 8.0 Hz, 2H), 7.48 (d, J = 8.0 Hz, 2H), 7.39 (d, J = 8.0 Hz, 2H), 6.81 (d, J = 2.0 Hz, 
1H), 6.72 (d, J = 8.5 Hz, 1H), 6.16 (dd, J = 8.5, 2.0 Hz, 1H), 5.08 (d, J = 16.0 Hz, 1H), 
4.68 (d, J = 2.5 Hz, 1H), 3.95 (app dt, J = 14.0, 7.5 Hz, 1H), 3.88 (s, 3H), 3.87 (s, 3H), 
3.85-3.78 (m, 2H), 3.83 (d, J = 9.5 Hz, 1H), 3.58 (s, 3H), 3.49 (app dt, J = 14.0, 7.5 Hz, 
1H),  3.43-3.35 (m, 3H), 3.27 (s, 3H), 3.19 (dd, J = 15.0, 10.5 Hz, 1H), 3.11 (app t, J = 
11.0 Hz, 1H); 3.10 (d, J = 16.0 Hz, 1H), 2.93 (dd, J = 12.5, 6.0 Hz, 1H), 2.49 (s, 3H), 
2.47 (s, 3H), 2.02 (dddd, J = 11.5, 9.5, 6.0, 3.5 Hz, 1H), 1.40 (dddd, J = 15.0, 11.0, 11.0, 
6.0 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 170.4, 155.8, 149.9, 149.0, 145.2, 144.6, 
135.5, 134.5, 130.3, 130.1, 128.8, 128.35, 127.6, 118.8, 110.4, 110.0, 104.8, 69.7, 63.3, 
59.4, 58.6, 56.3, 56.2, 55.9, 52.7, 52.5, 50.8, 49.7, 47.1, 45.6, 44.4, 33.1, 21.70, 21.68; 
MS (MALDI) calcd for C38H45ClN6O10S2 [M+Na]+: 867, [M+K]+: 883; found [M+Na]+: 
867, [M+K]+: 883. 
 
 
 
 
 
Boc-amine 352. To a solution of pyrrolidine 349 (28 mg, 0.0331 mmol) in 3.0 mL of 
anhydrous THF cooled to 0 ºC was added trimethylphosphine (1M in THF, ~50 µL, 0.05 
mmol) drop-wise and the mixture was stirred at 0 ºC for 1.5 h. Water (~ 100 µL) was 
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added and the mixture was allowed to warm to 20 ºC and stirred for an additional 2 h, 
then concentrated in vacuo. The crude material was dissolved in ~ 0.5 mL of HPLC grade 
benzene and it was reconcentrated, then dried under vacuum. The crude dry material was 
then dissolved in 3.0 mL of CH2Cl2 and Boc2O (xs) was added in one portion. After 
stirring at 20 ºC for 1 h, the mixture was concentrated in vacuo to afford a clear oil. 
Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (80:20  
50:50) gave 24 mg (80%) of Boc-amine 352 as a colorless foam: Rf = 0.29 (40% 
EtOAc/Hexanes, 4 elutions); IR (thin film): 3390, 2934, 1777, 1720, 1593, 1516, 1454, 
1158 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.87 (d, J = 8.5 Hz, 2H), 7.84 (d, J = 8.5 Hz, 
2H), 7.47 (d, J = 8.0 Hz, 2H), 7.38 (d, J = 8.0 Hz, 2H), 6.76 (d, J = 8.5 Hz, 1H), 6.74 
(app s, 1H), 6.23 (app d, J = 7.0 Hz, 1H), 4.95 (d, J = 16.0 Hz, 1H), 4.67 (d, J = 1.5 Hz, 
1H), 4.47 (app dd, J = 8.0, 5.5 Hz, 1H), 3.98-3.90 (m, 2H), 3.88 (s, 6H), 3.86 (app d J = 
7.0 Hz, 1H), 3.84-3.76 (m, 2H), 3.65 (d, J = 10.0 Hz, 1H), 3.58 (s, 3H), 3.47 (app dt, J = 
14.5, 7.5 Hz, 1H), 3.37 (app dt, J = 14.5, 7.5 Hz, 1H), 3.24 (s, 3H), 3.13 (dd, J = 15.0, 
10.5 Hz, 1H); 3.11 (app t, J = 11.0 Hz, 1H), 2.96-2.80 (m, 2H), 2.86 (d, J = 16.0 Hz, 1H), 
2.46 (s, 3H), 2.43 (s, 3H), 1.85 (app dq, J = 10.0, 3.5 Hz, 1H), 1.54 (s, 9H), 1.50-1.45 (m, 
1H); 13C NMR (125 MHz, CDCl3): δ 170.4, 156.2, 155.7, 149.8, 148.9, 145.2, 144.3, 
135.5, 134.4, 130.2, 130.0, 129.1, 128.4, 128.0, 118.8, 110.8, 109.9, 104.9, 79.9, 70.0, 
64.4, 59.5, 58.2, 56.18, 56.15, 55.9, 52.75, 51.7, 49.7, 47.5, 44.1, 40.4. 33.1, 28.5, 21.69, 
21.66; MS (MALDI) calcd for C43H55ClN4O10S2 [M+Na]+: 941; found [M+Na]+: 941. 
 
 
 
 
 
 
 
 
Pyrrolidine 353. To a stirred solution of Boc-amine 352 (16.9 mg, 0.0184 mmol) in 1.0 
mL of anhydrous THF cooled to -78 ºC was added freshly prepared sodium 
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naphthalenide (1M in THF) 3 drop-wise until the completion of the reaction as indicated 
by the persistence of the deep dark color of the reagent solution. PH 7 buffer solution (~ 4 
mL) was then added and the mixture was allowed to warm to 20 ºC with vigorous stirring. 
The mixture was then extracted with EtOAc (3 X 8 mL; the aqueous layer was saturated 
with solid NaCl before the last extraction) and the combined organic phase was dried 
over MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography on 
SiO2 eluting with hexanes/EtOAc (80:20  40:60) and then with MeOH/EtOAc (15:85) 
gave 8.4 mg (78%) of pyrrolidine 353 and 3.8 mg (22%) of unreacted Boc-amine 352. 
Resubjecting the latter to the reaction conditions provided additional pyrrolidine 353 (0.6 
mg, overall yield 84%) as a colorless foam; IR (thin film): 3423, 2934, 1771, 1717, 1646, 
1513, 1259, 1161 cm-1; 1H NMR (500 MHz, CD3OD): δ 7.02 (br s, 1H), 6.94 (br s, 2H), 
4.75 (d, J = 16.5 Hz, 1H), 4.47 (d, J = 16.0 Hz, 1H), 4.25 (d, J = 10.5 Hz, 1H), 4.05 (d, J 
= 7.5 Hz, 1H), 3.84 (s, 3H), 3.83 (s, 3H), 3.29 (s, 3H), 3.21 (s, 3H), 3.18 (dd J = 14.5, 3.5 
Hz, 1H), 3.10 (dd J = 10.5, 6.5 Hz, 1H), 2.99 (dd, J = 14.5, 8.5 Hz, 1H), 2.90 (dd, J = 
11.0, 7.5 Hz, 1H), 2.61 (dd, J = 14.5, 11.0 Hz, 1H), 2.56 (app t, J = 10.5 Hz, 1H), 2.25-
2.18 (m, 1H), 2.06-1.96 (m, 1H), 1.44 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 172.2, 
156.3, 156.0, 149.6, 148.7, 129.7, 119.4, 111.0, 110.2, 107.0, 79.7, 71.75, 65.8, 57.8, 
55.87, 55.85, 55.5, 54.1, 53.3, 49.7, 49.0, 46.4, 44.25, 40.0, 28.35; MS (MALDI) calcd 
for C27H39ClN4O8 [M+H]+: 583; found [M+H]+: 583. 
 
 
 
 
 
 
 
Pyrrole 355. To a stirred solution of pyrrolidine 353 (3.8 mg, 0.00652 mmol) and acyl 
chloride 148 (1.6 mg, 0.0124 mmol) in 0.8 mL of anhydrous CH2Cl2 at 0 ºC was added 
                                                
3 Preparation: 128 mg of naphthalene were dissolved in 1 mL of anhydrous THF at 20 ºC 
and 3 small pieces of sodium metal (washed with hexanes) were added in one portion. 
The mixture was stirred for 1 h at 20 ºC during which time a deep dark color developed. 
The solution (1 M) was used directly. 
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Et3N (~ 5 µL, 0.0353 mmol) and the resulting mixture was stirred at 20 ºC for 4.5 h, then 
it was concentrated in vacuo. The procedure was repeated on 4.4 mg (0.00755 mmol) of 
353 (with 2.2 mg, 0.0170 mmol of 148) and the crude materials were combined   
Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (80:20  
0:100) gave 5.9 mg (76% overall) of pyrrole 355; Rf 0.39 (EtOAc); IR (thin film): 3369, 
3275. 2931, 1771, 1720, 1593, 1516, 1436 cm-1; 1H NMR (500 MHz, acetone-d6): δ 
10.62 (br s, 1H), 7.05 (br s, 1H), 6.99 (dt, J = 2.5, 1.5 Hz, 1H), 6.94 (app d, J = 8.0 Hz, 
1H), 6.89 (d, J = 8.5 Hz, 1H), 6.57 (br s, 1H), 6.23 (app t, J = 6.0 Hz, 1H), 6.20 (dd, J = 
6.0, 2.5 Hz, 1H), 4.96 (d, J = 16.0 Hz, 1H), 4.91 (br s, 1H), 4.41 (d, J = 16.0 Hz, 1H), 
4.24 (dd, J = 9.0, 6.5 Hz, 1H), 4.21 (d, J = 10.0 Hz, 1H), 4.00 (dd, J = 11.0, 2.5 Hz, 1H), 
3.79 (s, 3H), 3.78 (s, 3H), 3.40 (t, J = 9.5 Hz, 1H), 3.31 (s, 3H), 3.29 (s, 3H), 3.26-3.22 
(m, 1H), 3.18 (dd J = 14.5, 11.0 Hz, 1H), 3.02 (app dt J = 14.0, 8.0 Hz, 1H), 2.32-2.24 (m, 
1H), 2.22-2.16 (m, 1H), 1.36 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 171.7, 162.1, 156.2, 
156.0, 149.65, 148.8, 129.6, 124.7, 123.6, 121.8, 119.1, 113.3, 111.2, 110.0, 109.9, 102.4, 
79.9, 72.1, 65.0, 58.6, 57.6, 56.1, 55.9, 51.8, 49.5, 46.95, 44.5, 40.2, 29.7, 28.3; MS 
(MALDI) calcd for C32H42ClN5O9 [M+H]+: 676, [M+Na]+: 698, [M+K]+: 714; found 
[M+H]+: 676, [M+Na]+: 698, [M+K]+: 714. 
 
 
 
 
 
 
 
Dibromoyrrole 356. To a stirred solution of pyrrolidine 353 (8.4 mg, 0.0144 mmol) in 
1.0 mL of anhydrous CH2Cl2 at 0 ºC was added acyl chloride 357 (7.8 mg, 0.027 mmol) 
as a solution in 0.1 mL of CH2Cl2, followed by Et3N (~ 10 µL, 0.0707 mmol) and the 
resulting mixture was stirred at 20 ºC for 0.5 h, then it was concentrated in vacuo. 
Purification by flash chromatography on SiO2 eluting with hexanes/EtOAc (80:20  
0:100) and then with MeOH/EtOAc (15:85) gave a semi-pure material (not quantified). 
Further purification by preparative TLC (60% EtOAc/Hexanes, 6 elutions, Rf 0.50), gave 
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pure dibromopyrrole 356 (yield not determined); Rf 0.50 (60% EtOAc/Hexanes, 6 
elutions); IR (thin film): 3177, 2928, 1771, 1717, 1593, 1513, 1436 cm-1; 1H NMR (500 
MHz, CD3OD): δ 7.00 (br s, 1H), 6.97 (app d, J = 8.0 Hz, 1H), 6.94 (d, J = 8.0 Hz, 1H), 
6.65 (br s, 1H), 4.82 (d, J = 16.5 Hz, 1H), 4.41 (d, J = 16.5 Hz, 1H), 4.16 (d, J = 10.0 Hz, 
1H), 4.02 (dd, J = 9.0, 6.0 Hz, 1H), 3.84 (s, 3H), 3.81 (s, 3H), 3.75 (dd, J = 11.5, 2.5 Hz, 
1H), 3.39 (app t, J = 10.0 Hz, 1H), 3.35 (s, 3H), 3.34 (s, 3H), 3.15-3.09 (m, 2H), 3.00 (dd 
J = 14.0, 9.5 Hz, 1H), 2.20-2.06 (m, 2H), 1.36 (s, 9H); 13C NMR (125 MHz, CD3OD): δ 
174.5, 162.2, 159.2, 158.55, 150.8, 150.3, 131.9, 127.9, 121.2, 116.9, 113.1, 112.1, 106.8, 
103.9, 100.0, 80.4, 73.8, 66.4, 58.7, 58.5, 56.43, 56.39, 55.7, 55.4, 51.2, 48.0, 44.7, 41.4, 
28.8; MS (MALDI) calcd for C32H40Br2ClN5O9 [M+Na]+: 854; found [M+Na]+: 854. 
 
 
 
 
 
 
 
Enamine 366. To a stirred solution of pyrrole 355 (3.0 mg, 0.00444 mmol) in 0.8 mL of 
acetone at 20 ºC was added p-toluenesulfonic acid (a few small crystals) and the mixture 
was heated to 50 ºC for 2.5 h, then it was allowed to cool to 20 ºC. A satirated solution of 
NaHCO3 was then added (~ 1 mL) and the organic solvent was evaporated under a flow 
of nitrogen. The aqueous residue was extracted with EtOAc (3 X 5 mL) and the 
combined organic phase was dried over MgSO4, filtered and concentrated in vacuo. 
Purification by preparative TLC (30% EtOAc/Hexanes 3 elutions, 50% EtOAc/Hexanes 
2 elutions, 100% EtOAc 2 elutions; Rf 0.20), gave pure enamine 366 (yield not 
determined). ; Rf 0.14 (60% EtOAc/Hexanes, 6 elutions); 1H NMR (500 MHz, CD3OD): 
δ 7.25 (d, J = 2.7 Hz, 1H), 6.92 (d, J = 2.0 Hz, 1H), 6.75 (dd, J = 8.5, 2.0 Hz, 1H), 6.62 
(d, J = 8.5 Hz, 1H), 6.25 (d, J = 2.7 Hz, 1H), 6.01 (d, J = 1.5 Hz, 1H), 4.58 (dd, J = 10.5, 
6.5 Hz, 1H), 4.57 (d, J = 16.0 Hz, 1H), 4.42 (d, J = 16.0 Hz, 1H), 4.35 (d, J = 9.5 Hz, 1H), 
3.86 (dd, J = 15.0, 1.5 Hz, 1H), 3.77 (s, 3H), 3.62 (s, 3H), 3.55 (app. t, J = 10.5 Hz, 1H), 
3.31 (this signal is completely covered by the solvent peak but is identified through 2D 
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correlation, 1H), 3.08 (dd, J = 14.0, 8.0 Hz, 1H), 2.59 (dddd, J = 15.0, 10.5, 10.0, 6.5 Hz, 
1H), 2.39-2.30 (m, 1H), 1.49 (s, 9H); MS (MALDI) calcd for C30H34ClN5O7 [M+H]+: 
612, [M+Na]+: 634; found [M+H]+: 612, [M+Na]+: 634. 
 
Coupling constant comparison with values reported originally for styloguanidine 
Proton 366 mult (J)a styloguanidine mult (J)a 
4 d (2.7) d (2.7) 
5 d (2.7) d (2.7) 
6 d (1.5) s 
11 dd (15.0, 1.5) d (14.2) 
12  
dddd (15.0, 10.5, 10.5, 6.0) 
mb 
dddd (14.6, 10.2, 9.0, 7.2)c 
13 dd (10.5, 6.5 ) dd (10.4, 7.2) 
13 d (10.5) d (10.4) 
17 d (9.5) d (8.3) 
a =  values are in Hertz. b = originally reported multiplicity. 65 c = as reported by Quinn 
for palau’amine. 3b 
 
 
 
 
 
 
 
 
Carbinolamine 367. To a stirred solution of dibromopyrrole 356 (not quantified) in 1 
mL of acetone at 20 ºC was added p-toluenesulfonic acid (a few small crystals) and the 
mixture was heated to 50 ºC for 4 h, then it was allowed to cool to ambient temperature. 
A satirated solution of NaHCO3 was then added (~ 1 mL) and the organic solvent was 
evaporated under a flow of nitrogen. The aqueous residue was extracted with EtOAc (3 X 
5 mL) and the combined organic phase was dried over MgSO4, filtered and concentrated 
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MAZ-V-205T1.D: UV Chromatogram, 252-256 nm
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in vacuo. Purification by preparative TLC (60% EtOAc/Hexanes 6 elutions) gave 
carbinolamine 367 (Rf 0.6; yield not determined) and recovered dibromopyrrole 356 (Rf 
0.5; yield not determined); LC/MS data are reported below. 
 
 
 
 
 
 
 
 
 
 
 
a) Total ion count b) mass (positive mode) c) HPLC trace d) observed M+H cluster and e) 
predicted M+H cluster for carbinolamine 367 
 
a 
b 
c 
d 
e 
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Table 1.  Crystal data and structure refinement for ester 184 
Identification code  dr68 
Empirical formula  C60 H65 Br Cl N3 O13 S2 Si 
Formula weight  1243.72 
Temperature  110(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 12.230(3) Å α= 90°. 
 b = 30.116(7) Å β= 96.462(13)°. 
 c = 33.616(9) Å γ = 90°. 
Volume 12303(5) Å3 
Z 8 
Density (calculated) 1.343 Mg/m3 
Absorption coefficient 2.657 mm-1 
F(000) 5184 
Crystal size 0.20 x 0.10 x 0.01 mm3 
Theta range for data collection 3.03 to 60.00°. 
Index ranges -13<=h<=13, -33<=k<=33, -37<=l<=37 
Reflections collected 94122 
Independent reflections 17537 [R(int) = 0.2192] 
Completeness to theta = 60.00° 95.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9739 and 0.6186 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 17537 / 0 / 1476 
Goodness-of-fit on F2 1.000 
Final R indices [I>2sigma(I)] R1 = 0.0685, wR2 = 0.1255 
R indices (all data) R1 = 0.1840, wR2 = 0.1688 
Extinction coefficient 0.00032(2) 
Largest diff. peak and hole 0.650 and -0.437 e.Å-3 
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American Chemical Society’s Policy on Theses and Dissertations 
      
If your university requires a signed copy of this letter see contact information below. 
 
Thank you for your request for permission to include your paper(s) or portions of text from your paper(s) in your 
thesis. Permission is now automatically granted; please pay special attention to the implications paragraph below. The 
Copyright Subcommittee of the Joint Board/Council Committees on Publications approved the following:  
    
Copyright permission for published and submitted material from theses and dissertations   
ACS extends blanket permission to students to include in their theses and dissertations their own articles, or 
portions thereof, that have been published in ACS journals or submitted to ACS journals for publication, 
provided  that the ACS copyright credit line is noted on the appropriate page(s).     
 
Publishing implications of electronic publication of theses and dissertation material 
Students and their mentors should be aware that posting of theses and dissertation material on the Web prior to 
submission of material from that thesis or dissertation to an ACS journal may affect publication in that journal. 
Whether Web posting is considered prior publication may be evaluated on a case-by-case basis by the journal’s 
editor.  If an ACS journal editor considers Web posting to be “prior publication”, the paper will not be accepted 
for publication in that journal.  If you intend to submit your unpublished paper to ACS for publication, check 
with the appropriate editor prior to posting your manuscript electronically.     
 
If your paper has not yet been published by ACS, we have no objection to your including the text or portions of the text  
in your thesis/dissertation in print and microfilm formats; please note, however, that electronic distribution or Web  
posting of the unpublished paper as part of your thesis in electronic formats might jeopardize publication of your paper  
by ACS. Please print the following credit line on the first page of your article: "Reproduced (or 'Reproduced in part')  
with permission from [JOURNAL NAME], in press (or 'submitted for publication').  Unpublished work copyright  
[CURRENT YEAR] American Chemical Society."  Include appropriate information.     
 
If your paper has already been published by ACS and you want to include the text or portions of the text in your  
thesis/dissertation in print or microfilm formats, please print the ACS copyright credit line on the first page of your  
article: “Reproduced (or 'Reproduced in part') with permission from [FULL REFERENCE CITATION.]  Copyright  
[YEAR] American Chemical Society."  Include appropriate information.  
 
Submission to a Dissertation Distributor:  If you plan to submit your thesis to UMI or to another dissertation 
distributor, you should not include the unpublished ACS paper in your thesis if the thesis will be disseminated  
electronically, until ACS has published your paper.  After publication of the paper by ACS, you may release the entire 
thesis (not the individual ACS article by itself) for electronic dissemination through the distributor; ACS’s copyright  
credit line should be printed on the first page of the ACS paper.  
 
Use on an Intranet:  The inclusion of your ACS unpublished or published manuscript is permitted in your thesis in 
print and microfilm formats.  If ACS has published your paper you may include the manuscript in your thesis on an 
intranet that is not publicly available. Your ACS article cannot be posted electronically on a publicly available medium  
(i.e. one that is not password protected), such as but not limited to, electronic archives, Internet, library server, etc.  The 
only material from your paper that can be posted on a public electronic medium is the article abstract, figures, and 
tables, and you may link to the article’s DOI or post the article’s author-directed URL link provided by ACS.  This 
paragraph does not pertain to the dissertation distributor paragraph above.   
 
           
Questions?  Call +1 202/872-4368/4367.  Send e-mail to copyright@acs.org or fax to +1 202-776-8112.      10/10/03, 01/15/04, 06/07/06 
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